TOXINS ACTIVE AGAINST PESTS

Abstract: The subject invention concerns materials and methods useful in the control of non-mammalian pests and, particularly, plant pests. In a specific embodiment, the subject invention provides new Bacillus thuringiensis toxins useful for the ocntrol of lepidopterans. The subject invention further provides nucleotide sequences which encode the toxins of the subject invention. The nucleotide sequences of the subject invention can be used to transform hosts, such as plants, to express the pesticidal toxins of the subject invention. The subject invention further concerns novel nucleotide primers for the identification of genes encoding toxins active against pests. The primers are useful in PCR techniques to produce gene fragments which are characteristic of genes encoding these toxins. The primers are also useful as nucleotide probes to detect the toxin-encoding genes.

Description: DESCRIPTION TOXINS ACTIVE AGAINST PESTS Cross-Reference to a Related Application This application is a continuation-in-part of application Seπal No 08/674,002, filed July 1, 1996 Background of the Invention The soil microbe Bacillus thuringiensis (B t ) is a Gram-positive, spore-forming bacterium Most strains of B t do not exhibit pesticidal activity Some 5 / strains produce, and can be characteπzed by, parasporal crystalline protein inclusions These "δ-endotoxins" are different from exotoxins, which have a non-specific host range These inclusions often appear microscopically as distinctively shaped crystals The proteins can be highly toxic to pests and specific in their toxic activity Certain B t toxin genes have been isolated and sequenced, and recombinant DNA-based B t products have been produced and approved for use. In addition, with the use of genetic engineering techniques, new approaches for delivering B t toxins to agricultural environments are under development, including the use of plants genetically engineered with B t toxm genes for insect resistance and the use of stabilized intact microbial cells as B t toxm delivery vehicles (Gaertner, F.H., L Kim [1988] TIBTECH 6 S4-S7) Thus, isolated B t endotoxin genes are becoming commercially valuable Until the last fifteen years, commercial use of B t pesticides has been largely restricted to a narrow range of lepidopteran (cateφillar) pests. Preparations of the spores and crystals of B thuringiensis subsp. kurstaki have been used for many years as commercial insecticides for lepidopteran pests For example, B thuringiensis var. kurstaki HD-1 produces a crystalline δ- endotox which is toxic to the larvae of a number of lepidopteran insects In recent years, however, investigators have discovered B t pesticides with specificities for a much broader range of pests. For example, other species o B t , namely israelensis and momsoni (a.k a. tenebrioms, a.k a. B t M-7, a.k.a. B t san diego), have been used commercially to control insects of the orders Diptera and Coleoptera, respectively (Gaertner, F.I I [1989] "Cellular Delivery Systems for Insecticidal Proteins: Living and Non-Living Microorganisms," m Controlled Delivery of Crop Protection Agents, R.M Wilkms, ed., Taylor and Francis, New York and London, 1990, pp 245-255 ) See also Couch, T.L. (1980) "Mosquito Pathogenicity of Bacillus thuringiensis var israelensis," Developments in Industrial Microbiology 22:61-76, and Beegle, C.C. (1978) "Use of Entomogenous Bacteria m Agroecosystems," Developments in Industrial Microbiology 20:97-104 Krieg, A., A.M. Huger, G A Langenbruch, W Schnetter (1983) Z ang. Ent. 96:500-508 describe Bacillus thuringiensis var. tenebrioms, which is reportedly active against two beetles in the order Coleoptera. These are the Colorado potato beetle, Leptmotarsa decemhneata, and Agelastica aim. Recently, new subspecies of B.t have been identified, and genes responsible for active δ-endotoxm proteins have been isolated (Hδfte, H., H.R. Whiteley [1989] Microbiological Reviews 52(2).242-255) Hόfte and Whiteley classified B t crystal protein genes into four major classes. The classes were Cryl (Lepidoptera-specific), Cryll (Lepidoptera- and Diptera-specific), Crylll (Coleoptera-specific), and Cry_V (Diptera-specific). The discovery of strains specifically toxic to other pests has been reported (Feitelson, J.S., J Payne, L. Kim [1992] Bio/Technology 10:271-275). CryV has been proposed to designate a class of toxin genes that are nematode- specific. Lambert et al. (Lambert, B., L. Buysse, C. Decock, S. Jansens, C Piens, B. Saey, J Seuπnck, K. van Audenhove, J. Van Rie, A. Van Vhet, M Peferoen [1996] Appl Environ Microbiol 62(l)-80-86) and Shevelev et al ([1993] FEBS Lett 336 79-82) describe the characteπzation of Cry9 toxins active against lepidopterans. Published PCT applications WO 94/05771 and WO 94/24264 also descπbe B t isolates active against lepidopteran pests. Gleave et al ([1991] JGM 138:55-62) and Smulevitch et al ([1991] FEBS Lett. 293:25-26) also describe /? , toxins. A number of other classes of B t genes have now been identified. The cloning and expression of a B t crystal protein gene in Escherichia coli has been descπbed m the published literature (Schnepf, H.E., H R Whiteley [1981] Proc Natl. Acad Set USA 78:2893-2897.). U.S Patent 4,448,885 and U.S Patent 4,467,036 both disclose the expression of B t crystal protein in E. coli. U.S. Patents 4,990,332, 5,039,523, 5,126,133, 5,164,180; and 5,169,629 are among those which disclose B t toxins having activity against lepidopterans PCT application WO96/05314 discloses PS86W1, PS86V1, and other B t isolates active against lepidopteran pests The PCT patent applications published as W094/24264 and WO94/05771 descπbe B t. isolates and toxins active against lepidopteran pests. B t proteins with activity against members of the family Noctuidae are described by Lambert et al , supra. U.S. Patents 4,797,276 and 4,853,331 disclose B thuringiensis strain tenebrioms which can be used to control coleopteran pests in vanous environments U.S Patent No 4,918,006 discloses B.t. toxins having activity against dipterans. U.S. Patent No. 5,151,363 and U.S. Patent No. 4,948,734 disclose certain isolates of B t which have activity against nematodes. Other U.S. patents which disclose activity against nematodes include 5,093,120, 5,236,843; 5,262,399, 5,270,448; 5,281,530; 5,322,932; 5,350,577; 5,426,049; and 5,439,881 As a result of extensive research and investment of resources, other patents have issued for new B l isolates and new uses of B.t. isolates. See Feitelson et al., supra, for a review. However, the discovery of new B.t. isolates and new uses of known B.t isolates remains an empirical, unpredictable art. Isolating responsible toxin genes has been a slow empiπcal process. Carozzi et al (Carozzi, N.B., V.C. Kramer, G.W. Warren, S. Evola, G. Koziel (\99\) Appl. Env. Microbwl 57(1 1):3057-3061) describe methods for identifying nove B.t. isolates This report does not disclose or suggest the specific pnmers, probes, toxins, and genes of the subject invention for lepidopteran-active toxin genes. U.S. Patent No. 5,204,237 describes specific and universal probes for the isolation of B.t. toxin genes. This patent, however, does not describe the probes, primers, toxins, and genes of the subject invention. WO 94/21795 and Estruch, J.J. et al. ([1996] PNAS 93:5389-5394) describe toxins obtained from Bacillus microbes. These toxins are reported to be produced during vegetative cell growth and were thus termed vegetative insecticidal proteins (VIP). These toxins were reported to be distinct from crystal-forming δ-endotoxins. Activity of these toxins against lepidopteran pests was reported. Black cutworm (Agrotis ipsilon (Hufnagel); Lepidoptera: Noctuidae) is a serious pest of many crops including maize, cotton, cole crops (Brassica, broccoli, cabbages, Chinese cabbages), and turf. Secondary host plants include beetroots, Capsicum (peppers), chickpeas, faba beans, lettuces, lucerne, onions, potatoes, radishes, rape (canola), rice, soybeans, strawberries, sugarbeet, tobacco, tomatoes, and forest trees. In North America, pests of the genus Agrotis feed on clover, corn, tobacco, hemp, onion, strawbernes, blackbemes, raspberπes, alfalfa, barley, beans, cabbage, oats, peas, potatoes, sweetpotatoes, tomato, garden flowers, grasses, lucerne, maize, asparagus, grapes, almost any kind of leaf, weeds, and many other crops and garden plants. Other cutworms m the Tribe Agrotmi are pests, in particular those in the genus Feltia (e.g., F. jaculifera (Guenee); equivalent to ducens subgothica) and Euxoa (e.g., E. messoria (Harris), E. scandens (Riley), E. auxiliaris Smith, _.. detersa (Walker), __. tessellata (Harris), E. ochrogaster (Guenee). Host plants include various crops, including rape. Cutworms are also pests outside North Ameπca, and the more economically significant pests attack chickpeas, wheat, vegetables, sugarbeet, lucerne, maize, potatoes, turnips, rape, lettuces, strawbernes, loganbernes, flax, cotton, soybeans, tobacco, beetroots, Chinese cabbages, tomatoes, aubergines, sugarcane, pastures, cabbages, groundnuts, Cucurbita, turnips, sunflowers, Brassica, onions, leeks, celery, sesame, asparagus, rhubarb, chicory, greenhouse crops, and spinach. The black cutworm A. ipsilon occurs as a pest outside North Amenca, including Central America, Europe, Asia, Australasia, Africa, India, Taiwan, Mexico, Egypt, and New Zealand. Cutworms progress through several instars as larvae Although seedling cutting by later instar larvae produces the most obvious damage and economic loss, leaf feeding commonly results in yield loss m crops such as maize Upon reaching the fourth larval instar, larvae begin to cut plants and plant parts, especially seedlings. Because of the shift in feeding behavior, economically damaging populations may build up unexpectedly with few early warning signs Their nocturnal habit and behavior of burrowing into the ground also makes detection problematic. Large cutworms can destroy several seedlings per day, and a heavy infestation can remove entire stands of crops Cultural controls for A ipsilon such as peripheral weed control can help prevent heavy infestations; however, such methods are not always feasible or effective. Infestations are very sporadic, and applying an insecticide prior to planting or at planting has not been effective m the past Some baits are available for control of cutworms in crops To protect turfgrass such as creeping bentgrass, chemical insecticides have been employed. Use of chemical pesticides is a particular concern in turf because of the close contact the public has with treated areas (e.g , golf greens, athletic fields, parks and other recreational areas, professional landscaping, home lawns). Natural products (e.g , nematodes, azadirachtin) generally perform poorly To date, Bacillus thuringiensis products have not been widely used to control black cutworm because highly effective toxins have not been available Brief Summary of the Invention The subject invention concerns materials and methods useful in the control of non- mammalian pests and, particularly, plant pests. In a specific embodiment, the subject invention provides new toxins useful for the control of lepidopterans. In a particularly preferred embodiment, the toxms of the subject invention are used to control black cutworm. The subject invention further provides nucleotide sequences which encode the lepidopteran-active toxins of the subject invention. The subject invention further provides nucleotide sequences and methods useful in the identification and characterization of genes which encode pesticidal toxins. The subject invention further provides new Bacillus thuringiensis isolates having pesticidal activities In one embodiment, the subject invention concerns unique nucleotide sequences which are useful as primers in PCR techniques The primers produce characteristic gene fragments which can be used in the identification and isolation of specific toxin genes The nucleotide sequences of the subject invention encode toxins which are distinct from previously-described δ-endotoxms In one embodiment of the subject invention, B t isolates can be cultivated under conditions resulting in high multiplication of the microbe. After treating the microbe to provide single-stranded genomic nucleic acid, the DNA can be contacted with the pnmers of the invention and subjected to PCR amplification Characteristic fragments of toxm-encoding genes will be amplified by the procedure, thus identifying the presence of the toxin-encodmg gene(s) A further aspect of the subject invention is the use of the disclosed nucleotide sequences as probes to detect, identify, and charactenze genes encoding B t toxins which are active against lepidopterans. Further aspects of the subject invention include the genes and isolates identified using the methods and nucleotide sequences disclosed herein. The genes thus identified encode toxins active against lepidopterans. Similarly, the isolates will have activity against these pests. New pesticidal B t isolates of the subject invention include PS31 G 1 , PS 185U2, PS 11 B, PS218G2, PS213E5, PS28C, PS86BB1, PS89J3, PS94R1, PS27J2, PS101DD, and PS202S As described herein, the toxins useful according to the subject invention may be chimeπc toxins produced by combining portions of multiple toxins. In a preferred embodiment, the subject invention concerns plants cells transformed with at least one polynucleotide sequence of the subject invention such that the transformed plant cells express pesticidal toxins in tissues consumed by the target pests Such transformation of plants can be accomplished using techniques well known to those skilled in the art and would typically involve modification of the gene to optimize expression of the toxin m plants Alternatively, the B t isolates of the subject invention, or recombinant microbes expressing the toxms descnbed herein, can be used to control pests. In this regard, the invention includes the treatment of substantially intact B.t cells, and or recombinant cells containing the expressed toxins of the invention, treated to prolong the pesticidal activity when the substantially intact cells are applied to the environment of a target pest The treated cell acts as a protective coating for the pesticidal toxin. The toxin becomes active upon mgestion by a target insect. Brief Description of the Sequences SEQ ID NO. 1 is a forward pπmer useful according to the subject invention SEQ ID NO. 2 is a reverse primer useful according to the subject invention SEQ ID NO. 3 is a forward pπmer useful according to the subject invention SEQ ID NO. 4 is a reverse primer useful according to the subject invention. SEQ ID NO. 5 is a forward pπmer useful according to the subject invention SEQ ID NO. 6 is a reverse pπmer useful according to the subject invention SEQ ID NO. 7 is an ammo acid sequence of the toxin designated 11B1AR. SEQ ID NO. 8 is a nucleotide sequence encoding an amino acid sequence of toxm HBlAR (SEQ ID NO. 7). SEQ ID NO. 9 is an amino acid sequence of the toxin designated 11B1BR. SEQ ID NO. 10 is a nucleotide sequence encoding an amino acid sequence of toxin 1 1B1BR (SEQ ID N0. 9). SEQ ID NO. 11 is an amino acid sequence of the toxin designated 1291 A. SEQ ID NO. 12 is a nucleotide sequence encoding an amino acid sequence of toxin 1291A (SEQ ID NO. 1 1) SEQ ID NO. 13 is an ammo acid sequence of the tox designated 1292A. SEQ ID NO. 14 is a nucleotide sequence encoding an ammo acid sequence of toxin 1292A (SEQ ID NO. 13). SEQ ID NO. 15 is an amino acid sequence of the tox designated 1292B SEQ ID NO. 16 is a nucleotide sequence encoding an amino acid sequence of toxin 1292B (SEQ ID NO. 15). SEQ ID NO. 17 is an amino acid sequence of the toxin designated 31GA SEQ ID NO. 18 is a nucleotide sequence encoding an amino acid sequence of toxm 31GA (SEQ ID NO. 17). SEQ ID NO. 19 is an ammo acid sequence of the toxin designated 31 GBR SEQ ID NO. 20 is a nucleotide sequence encoding an amino acid sequence of toxm 31GBR (SEQ ID NO. 19). SEQ ID NO.21 is an amino acid sequence of the toxin designated 85N1R identified by the method of the subject invention. SEQ ID NO. 22 is a nucleotide sequence encoding an amino acid sequence of toxin 85N1R (SEQ ID N0. 21). SEQ ID NO. 23 is an ammo acid sequence of the toxin designated 85N2. SEQ ID NO. 24 is a nucleotide sequence encoding an ammo acid sequence of toxm 85N2 (SEQ ID NO. 23). SEQ ID NO. 25 is an ammo acid sequence of the toxin designated 85N3. SEQ ID NO. 26 is a nucleotide sequence encoding an ammo acid sequence of toxin 85N3 (SEQ ID NO. 25) SEQ ID NO. 27 is an amino acid sequence of the tox designated 86V1Cι1 SEQ ID NO. 28 is a nucleotide sequence encoding an amino acid sequence of toxin 86V 1C1 (SEQ ID NO. 27) SEQ ID NO. 29 is an ammo acid sequence of the toxin designated 86 V 1C2. SEQ ID NO. 30 is a nucleotide sequence encoding an amino acid sequence of toxin 86V1C2 (SEQ ID N0. 29). SEQ ID NO. 31 is an ammo acid sequence of the toxm designated 86V1C3R. SEQ ID NO. 32 is a nucleotide sequence encoding an ammo acid sequence of toxin 86VlC3R (SEQ ID NO. 31). SEQ ID NO. 33 is an amino acid sequence of the toxm designated F525A. SEQ ID NO. 34 is a nucleotide sequence encoding an am o acid sequence of toxin F252A (SEQ ID NO. 33) SEQ ID NO. 35 is an ammo acid sequence of the toxin designated F525B SEQ ID NO. 36 is a nucleotide sequence encoding an amino acid sequence of tox F525B (SEQ ID NO. 35). SEQ ID NO. 37 is an amino acid sequence of the toxin designated F525C. SEQ ID NO. 38 is a nucleotide sequence encoding an ammo acid sequence of toxin F525C (SEQ ID NO. 37). SEQ ID NO. 39 is an amino acid sequence of the toxin designated F573A SEQ ID NO. 40 is a nucleotide sequence encoding an ammo acid sequence of toxm F573A (SEQ ID NO. 39). SEQ ID NO. 41 is an ammo acid sequence of the tox designated F573B. SEQ ID NO. 42 is a nucleotide sequence encoding an amino acid sequence of toxin F573B (SEQ ID N0. 41). SEQ ID NO. 43 is an ammo acid sequence of the toxm designated F573C SEQ ID NO. 44 is a nucleotide sequence encoding an ammo acid sequence of toxin F573C (SEQ ID NO. 43). SEQ ID NO. 45 is an amino acid sequence of the toxm designated FBB1A. SEQ ID NO. 46 is a nucleotide sequence encoding an amino acid sequence of tox FBB1A (SEQ ID N0. 45) SEQ ID NO. 47 is an amino acid sequence of the toxm designated FBB1BR SEQ ID NO. 48 is a nucleotide sequence encoding an amino acid sequence of toxin FBB lBR (SEQ ID NO 47) SEQ ID NO. 49 is an ammo acid sequence of the toxm designated FBBIC. SEQ ID NO. 50 is a nucleotide sequence encoding an ammo acid sequence of toxin FBBIC (SEQ ID NO. 49). SEQ ID NO. 51 is an amino acid sequence of the tox designated FBB1D. SEQ ID NO. 52 is a nucleotide sequence encoding an amino acid sequence of toxin FBBlD (SEQ ID NO. 51). SEQ ID NO. 53 is an amino acid sequence of the toxm designated J31AR. SEQ ID NO. 54 is a nucleotide sequence encoding an am o acid sequence of toxin J31AR (SEQ ID NO. 53). SEQ ID NO. 55 is an amino acid sequence of the toxin designated J32AR SEQ ID NO. 56 is a nucleotide sequence encoding an amino acid sequence of toxm J32AR (SEQ ID NO. 55). SEQ ID NO. 57 is an am o acid sequence of the toxin designated W1FAR SEQ ID NO. 58 is a nucleotide sequence encoding an ammo acid sequence of toxin WlFAR (SEQ ID NO. 57). SEQ ID NO. 59 is an ammo acid sequence of the toxin designated W1FBR SEQ ID NO. 60 is a nucleotide sequence encoding an amino acid sequence of toxin WlFBR (SEQ ID NO. 59). SEQ ID NO. 61 is an ammo acid sequence of the toxm designated WIFC. SEQ ID NO. 62 is a nucleotide sequence encoding an amino acid sequence of toxin WIFC (SEQ ID NO. 61). SEQ ID NO. 63 is an oligonucleotide useful as a PCR primer or hybπdization probe according to the subject invention. SEQ ID NO. 64 is an oligonucleotide useful as a PCR pπmer or hybridization probe according to the subject invention. SEQ ID NO. 65 is an oligonucleotide useful as a PCR pπmer or hybridization probe according to the subject invention. SEQ ID NO. 66 is an oligonucleotide useful as a PCR primer or hybridization probe according to the subject invention. SEQ ID NO. 67 is an oligonucleotide useful as a PCR pπmer or hybπdization probe according to the subject invention. SEQ ID NO. 68 is an oligonucleotide useful as a PCR primer or hybridization probe according to the subject invention. SEQ ID NO. 69 is an oligonucleotide useful as a PCR primer or hybridization probe according to the subject invention. SEQ ID NO. 70 is an amino acid sequence of the toxm designated 86BBl(a). SEQ ID NO. 71 is a nucleotide sequence encoding an ammo acid sequence of toxin 86BBl(a). SEQ ID NO. 72 is an ammo acid sequence of the toxm designated 86BBl(b) SEQ ID NO. 73 is a nucleotide sequence encoding an amino acid sequence of toxin 86BBl(b). SEQ ID NO. 74 is an ammo acid sequence of the tox designated 3 lGl(a). SEQ ID NO. 75 is a nucleotide sequence encoding an amino acid sequence of toxin 31Gl(a). SEQ ID NO. 76 is an ammo acid sequence of the toxin designated 129HD chimeπc. SEQ ID NO. 77 is a nucleotide sequence encoding an amino acid sequence of toxin 129HD chimeπc. SEQ ID NO. 78 is an amino acid sequence of the toxin designated 1 lB(a) SEQ ID NO. 79 is a nucleotide sequence encoding an amino acid sequence of toxin HB(a). SEQ ID NO. 80 is an amino acid sequence of the toxin designated 31Gl(b). SEQ ID NO. 81 is a nucleotide sequence encoding an ammo acid sequence of toxm 31Gl(b). SEQ ID NO. 82 is an ammo acid sequence of the tox designated 86BBl(c). SEQ ID NO. 83 is a nucleotide sequence encoding an amino acid sequence of toxin 86BBl(c). SEQ ID NO. 84 is an ammo acid sequence of the toxin designated 86V 1(a) SEQ ID NO. 85 is a nucleotide sequence encoding an ammo acid sequence of tox 86V 1(a). SEQ ID NO. 86 is an amino acid sequence of the toxin designated 86Wl(a). SEQ ID NO. 87 is a nucleotide sequence encoding an ammo acid sequence of toxm 86Wl(a). SEQ ID NO. 88 is a partial ammo acid sequence of the toxm designated 94Rl(a). SEQ ID NO. 89 is a partial nucleotide sequence encoding an ammo acid sequence of toxin 94Rl(a). SEQ ID NO. 90 is an ammo acid sequence of the tox designated 185U2(a). SEQ ID NO. 91 is a nucleotide sequence encoding an ammo acid sequence of toxin 185U2(a). SEQ ID NO. 92 is an ammo acid sequence of the toxin designated 202S(a). SEQ ID NO. 93 is a nucleotide sequence encoding an amino acid sequence of toxin 202S(a). SEQ ID NO. 94 is an amino acid sequence of the toxin designated 213E5(a). SEQ ID NO. 95 is a nucleotide sequence encoding an amino acid sequence of toxin 213E5(a). SEQ ID NO. 96 is an amino acid sequence of the toxin designated 218G2(a). SEQ ID NO. 97 is a nucleotide sequence encoding an amino acid sequence of toxin 218G2(a). SEQ ID NO. 98 is an amino acid sequence of the toxm designated 29HD(a) SEQ ID NO. 99 is a nucleotide sequence encoding an amino acid sequence of tox 29HD(a). SEQ ID NO. 100 is an amino acid sequence of the toxin designated 110HD(a) SEQ ID NO. 101 is a nucleotide sequence encoding an amino acid sequence of toxin HOHD(a). SEQ ID NO. 102 is an amino acid sequence of the toxin designated 129HD(b). SEQ ID NO. 103 is a nucleotide sequence encoding an amino acid sequence of toxin 129HD(b). SEQ ID NO. 104 is a partial ammo acid sequence of the toxin designated 573HD(a) SEQ ID NO. 105 is a partial nucleotide sequence encoding an amino acid sequence of toxin 573HD(a) Detailed Disclosure of the Invention The subject invention concerns mateπals and methods for the control of non-mammahan pests. In specific embodiments, the subject invention pertains to new Bacillus thuringiensis isolates and toxins which have activity against lepidopterans. In a particularly preferred embodiment, the toxins and methodologies described herein can be used to control black cutworm. The subject invention further concerns novel genes which encode pesticidal toxins and novel methods for identifying and characteπzmg B.t. genes which encode toxms with useful properties. The subject invention concerns not only the polynucleotide sequences which encode these toxms, but also the use of these polynucleotide sequences to produce recombinant hosts which express the toxms. Certain proteins of the subject invention are distinct from the crystal or "Cry" proteins which have previously been isolated from Bacillus thuringiensis A further aspect of the subject invention concerns novel isolates and the tox s and genes obtainable from these isolates. The novel B.t. isolates of the subject invention have been designated PS31G1, PS185U2, PS11B, PS218G2, PS213E5, PS28C, PS86BB1, PS89J3, PS94R1 , PS202S, PS101DD, and PS27J2. The new toxins and polynucleotide sequences provided here are defined according to several parameters. One critical characteristic of the toxins described herein is pesticidal activity. In a specific embodiment, these tox s have activity against lepidopteran pests. The toxms and genes of the subject invention can be further defined by their ammo acid and nucleotide sequences. The sequences of the molecules can be defined in terms of homology to certain exemplified sequences as well as m terms of the ability to hybπdize with, or be amplified by, certain exemplified probes and primers. The toxins provided herein can also be identified based on their lmmunoreactivity with certain antibodies. Methods have been developed for making useful chimenc toxins by combining portions of S .. crystal proteins The portions which are combined need not, themselves, be pesticidal so long as the combination of portions creates a chimenc protein which is pesticidal. This can be done using restriction enzymes, as descnbed in, for example, European Patent 0 228 838; Ge, A.Z., N.L. Shivarova, D.H. Dean (1989) Proc Natl. Acad. Sci. USA 86:4037-4041 ; Ge, A.Z., D. Rivers, R. Milne, D.H. Dean (1991) J. Biol. Chem. 266: 17954-17958; Schnepf, H.E., K. Tomczak, J.P. Ortega, H.R. Whiteley (1990) 7. Biol Chem. 265:20923-20930; Honee, G., D. Convents, J. Van Rie, S. Jansens, M. Peferoen, B. Visser (1991) Mol Microbwl. 5:2799-2806 Alternatively, recombination using cellular recombination mechanisms can be used to achieve similar results. See, for example, Caramon, T., A.M. Albertim, A. Ga zzi (1991) Gene 98:37- 44; Widner, W.R., H.R. Whiteley (1990) J. Bacteriol 172.2826-2832; Bosch, D., B. Schipper, H. van der Kliej, R.A. de Maagd, W.J. Stickema (1994) Biotechnology 12:915-918. A number of other methods are known in the art by which such chimeπc DNAs can be made. The subject invention is meant to include chimeπc proteins that utilize the novel sequences identified in the subject application. With the teachings provided herein, one skilled m the art could readily produce and use the various toxins and polynucleotide sequences descnbed herein. B t. isolates useful according to the subject invention have been deposited in the permanent collection of the Agncultural Research Service Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peona, Illinois 61604, USA. The culture repository numbers of the B t strains are as follows Culture Repository No Deposit Date B t PS1 1B (MT274) NRRL B-21556 April 18, 1996 B t PS86BB1 (MT275) NRRL B-21557 April 18, 1996 B t PS86V1 (MT276) NRRL B-21558 April 18, 1996 B t PS86W1 (MT277) NRRL B-21559 April 18, 1996 B t PS31G1 (MT278) NRRL B-21560 April 18, 1996 B t PS89J3 (MT279) NRRL B-21561 April 18, 1996 B t PS185U2 (MT280) NRRL B-21562 April 18, 1996 B t PS27J2 NRRL B- July 1, 1997 B t PS28E NRRL B- July 1, 1997 B t PS94R1 NRRL B- July 1, 1997 B t PS101DD NRRL B- July 1, 1997 B t PS202S NRRL B- July 1, 1997 B t PS213E5 NRRL B- July 1, 1997 B t PS218G2 NRRL B- July 1, 1997 E coli NM522 (MR 922) NRRL B-21794 June 27, 1997 (pMYC2451) E coli NM522 (MR 923) NRRL B-21795 June 27, 1997 (pMYC2453) E coli NM522 (MR 924) NRRL B-21796 June 27, 1997 (pMYC2454) Cultures which have been deposited for the puφoses of this patent application were deposited under conditions that assure that access to the cultures is available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 CFR 1.14 and 35 U.S.C. 122 The deposits will be available as required by foreign patent laws countπes wherein counteφarts of the subject application, or its progeny, are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action Further, the subject culture deposits will be stored and made available to the public in accord with the provisions of the Budapest Treaty for the Deposit of Microorganisms, i e , they will be stored with all the care necessary to keep them viable and uncontaminated for a period of at least five years after the most recent request for the furnishing of a sample of the deposit, and in any case, for a period of at least thirty (30) years after the date of deposit or for the enforceable life of any patent which may issue disclosing the culture(s) The depositor acknowledges the duty to replace the deposιt(s) should the depository be unable to furnish a sample when requested, due to the condition of a deposit All restrictions on the availability to the public of the subject culture deposits will be irrevocably removed upon the granting of a patent disclosing them. Following is a table which provides characteristics of certain isolates useful according to the subject invention. ND = not determined In one embodiment, the subject invention concerns materials and methods including nucleotide pnmers and probes for isolating and identifying Bacillus thuringiensis (B t ) genes encoding protein toxins which are active against lepidopteran pests. The nucleotide sequences descnbed herein can also be used to identify new pesticidal B t. isolates The invention further concerns the genes, isolates, and toxins identified using the methods and materials disclosed herein. Genes and toxins. The genes and toxms useful according to the subject invention include not only the full length sequences but also fragments of these sequences, variants, mutants, and fusion proteins which retain the characteristic pesticidal activity of the toxms specifically exemplified herein. Chimenc genes and toxins, produced by combining portions from more than one B t toxin or gene, may also be utilized according to the teachings of the subject invention As used herein, the terms "vanants" or "variations" of genes refer to nucleotide sequences which encode the same toxins or which encode equivalent toxins having pesticidal activity As used herein, the term "equivalent toxms" refers to toxms having the same or essentially the same biological activity against the target pests as the exemplified toxms It should be apparent to a person skilled in this art that genes encoding active toxins can be identified and obtained through several means. The specific genes exemplified herein may be obtained from the isolates deposited at a culture depository as descnbed above These genes, or portions or vaπants thereof, may also be constructed synthetically, for example, by use of a gene synthesizer. Vaπations of genes may be readily constructed using standard techniques for making point mutations. Also, fragments of these genes can be made using commercially available exonucleases or endonucleases according to standard procedures. For example, enzymes such as BaBl or site-directed mutagenesis can be used to systematically cut off nucleotides from the ends of these genes. Also, genes which encode active fragments may be obtained using a vaπety of restnction enzymes Proteases may be used to directly obtain active fragments of these toxins. Equivalent toxms and/or genes encoding these equivalent toxins can be derived from B t isolates and/or DNA libraries using the teachings provided herein There are a number of methods for obtaining the pesticidal toxins of the instant invention. For example, antibodies to the pesticidal toxins disclosed and claimed herein can be used to identify and isolate other toxins from a mixture of proteins. Specifically, antibodies may be raised to the portions of the toxins which are most constant and most distinct from other B.t toxins. These antibodies can then be used to specifically identify equivalent toxins with the characteristic activity by immunoprecipitation, enzyme linked immunosorbent assay (ELISA), or western blotting Antibodies to the toxins disclosed herein, or to equivalent toxins, or fragments of these toxins, can readily be prepared using standard procedures in this art The genes which encode these toxins can then be obtained from the microorganism. Fragments and equivalents which retain the pesticidal activity of the exemplified toxms would be within the scope of the subject invention. Also, because of the redundancy of the genetic code, a variety of different DNA sequences can encode the amino acid sequences disclosed herein. It is well within the skill of a person trained in the art to create these alternative DNA sequences encoding the same, or essentially the same, toxins. These variant DNA sequences are within the scope of the subject invention. As used herein, reference to "essentially the same" sequence refers to sequences which have amino acid substitutions, deletions, additions, or insertions which do not materially affect pesticidal activity. Fragments retaining pesticidal activity are also included in this definition. A further method for identifying the toxins and genes of the subject invention is through the use of oligonucleotide probes. These probes are detectable nucleotide sequences Probes provide a rapid method for identifying toxin-encoding genes of the subject invention. The nucleotide segments which are used as probes according to the invention can be synthesized using a DNA synthesizer and standard procedures Certain toxms of the subject invention have been specifically exemplified herein Since these toxins are merely exemplary of the toxins of the subject invention, it should be readily apparent that the subject invention comprises variant or equivalent toxins (and nucleotide sequences coding for equivalent toxms) having the same or similar pesticidal activity of the exemplified toxin Equivalent toxms will have amino acid homology with an exemplified toxin This ammo acid identity will typically be greater than 60%, preferably be greater than 75%, more preferably greater than 80%, more preferably greater than 90%, and can be greater than 95%. The amino acid homology will be highest in critical regions of the toxin which account for biological activity or are involved in the determination of three-dimensional configuration which ultimately is responsible for the biological activity In this regard, certain amino acid substitutions are acceptable and can be expected if these substitutions are in regions which are not cπtical to activity or are conservative amino acid substitutions which do not affect the three- dimensional configuration of the molecule For example, ammo acids may be placed in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby an ammo acid of one class is replaced with another amino acid of the same type fall within the scope of the subject invention so long as the substitution does not mateπally alter the biological activity of the compound. Table 2 provides a listing of examples of ammo acids belonging to each class Table 2. Class of Amino Acid Examples of Amino Acids Nonpolar Ala, Val, Leu, He, Pro, Met, Phe, Tφ Uncharged Polar Gly, Ser, Thr, Cys, Tyr, Asn, Gin Acidic Asp, Glu Basic Lys, Arg, His In some instances, non-conservative substitutions can also be made The critical factor is that these substitutions must not significantly detract from the biological activity of the toxm The toxins of the subject invention can also be characteπzed in terms of the shape and location of toxm inclusions, which are descnbed above. As used herein, reference to "isolated" polynucleotides and or "punfied" toxms refers to these molecules when they are not associated with the other molecules with which they would be found in nature. Thus, "punfied" toxins would include, for example, the sub j ect toxins expressed in plants. Reference to "isolated and purified" signifies the involvement of the "hand of man" as described herein Chimeπc toxins and genes also involve the "hand of man " Recombinant hosts. The toxm-encoding genes harbored by the isolates of the sub j ect invention can be introduced into a wide variety of microbial or plant hosts. Expression of the toxin gene results, directly or indirectly, in the lntracellular production and maintenance of the pesticide. With suitable microbial hosts, e.g., Pseudomonas, the microbes can be applied to the situs of the pest, where they will proliferate and be ingested. The result is a control of the pest Alternatively, the microbe hosting the toxm gene can be treated under conditions that prolong the activity of the toxin and stabilize the cell The treated cell, which retains the toxic activity, then can be applied to the environment of the target pest. Where the B.t. toxm gene is introduced via a suitable vector into a microbial host, and said host is applied to the environment in a living state, it is essential that certain host microbes be used Microorganism hosts are selected which are known to occupy the "phytosphere" (phylloplane, phyllosphere, rhizosphere, and or rhizoplane) of one or more crops of interest These microorganisms are selected so as to be capable of successfully competing m the particular environment (crop and other insect habitats) with the wild-type microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inactivation. A large number of microorganisms are known to inhabit the phylloplane (the surface of the plant leaves) and/or the rhizosphere (the soil surrounding plant roots) of a wide vanety of important crops. These microorganisms include bacteria, algae, and fungi Of particular interest are microorganisms, such as bactena, e g , genera Pseudomonas, Erwima, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophihus. Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alca genes, fungi, particularly yeast, e.g , genera Saccharomyces , Cryptococcus . Kluyveromyces, Sporobolomyces, Rhodotorula, and Aureobasidium. Of particular interest are such phytosphere bacterial species as Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xvhnum, Agrobacterium tumefaciens, Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti, Alcaligenes entrophus, and Azotobacter vinlandu, and phytosphere yeast species such as Rhodotorula rubra, R glutims, R marina, R aurantiaca, Cryptococcus albidus, C diffluens, C laurenth, Saccharomyces rosei, S pretoriensis, S cerevisiae, Sporobolomyces roseus, S odorus, Kluyveromyces veronae, and Aureobasidium pollulans. Of particular interest are the pigmented microorganisms A wide variety of ways are available for introducing a B t gene encoding a toxin into a microorganism host under conditions which allow for stable maintenance and expression of the gene These methods are well known to those skilled in the art and are descnbed, for example, in United States Patent No. 5,135,867, which is mcoφorated herein by reference Control of lepidopterans, including black cutworm, using the isolates, toxms, and genes of the subject invention can be accomplished by a vanety of methods known to those skilled in the art These methods include, for example, the application of 2. t isolates to the pests (or their location), the application of recombinant microbes to the pests (or their locations), and the transformation of plants with genes which encode the pesticidal toxins of the subject invention Recombinant microbes may be, for example, & B t , E coli, or Pseudomonas Transformations can be made by those skilled in the art using standard techniques Matenals necessary for these transformations are disclosed herein or are otherwise readily available to the skilled artisan Synthetic genes which are functionally equivalent to the toxms of the subject invention can also be used to transform hosts Methods for the production of synthetic genes can be found in, for example, U S Patent No 5,380,831 Treatment of cells As mentioned above, B t or recombinant cells expressing a B t toxin can be treated to prolong the toxm activity and stabilize the cell The pesticide microcapsule that is formed comprises the B t toxin within a cellular structure that has been stabilized and will protect the toxin when the microcapsule is applied to the environment of the target pest Suitable host cells may include either prokaryotes or eukaryotes, normally being limited to those cells which do not produce substances toxic to higher organisms, such as mammals However, organisms which produce substances toxic to higher organisms could be used, where the toxic substances are unstable or the level of application sufficiently low as to avoid any possibility of toxicity to a mammalian host As hosts, of particular interest will be the prokaryotes and the lower eukaryotes, such as fungi The cell will usually be intact and be substantially in the prohferative form when treated, rather than in a spore form, although in some instances spores may be employed Treatment of the microbial cell, e.g., a microbe containing the B.t. toxin gene, can be by chemical or physical means, or by a combination of chemical and/or physical means, so long as the technique does not deleteriously affect the properties of the toxin, nor diminish the cellular capability of protecting the toxin. Examples of chemical reagents are halogenating agents, particularly halogens of atomic no. 17-80. More particularly, iodine can be used under mild conditions and for sufficient time to achieve the desired results. Other suitable techniques include treatment with aldehydes, such as glutaraldehyde; anti-infectives, such as zephiran chloride and cetylpyridinium chloride; alcohols, such as isopropyl and ethanol; various histologic fixatives, such as Lugol iodine, Bouin's fixative, various acids and Helly's fixative (See: Humason, Gretchen L., Animal Tissue Techniques, W.H. Freeman and Company, 1967); or a combination of physical (heat) and chemical agents that preserve and prolong the activity of the toxin produced in the cell when the cell is administered to the host environment. Examples of physical means are short wavelength radiation such as gamma-radiation and X- radiation, freezing, UV irradiation, lyophilization, and the like. Methods for treatment of microbial cells are disclosed in United States Patent Nos. 4,695,455 and 4,695,462, which are incoφorated herein by reference. The cells generally will have enhanced structural stability which will enhance resistance to environmental conditions. Where the pesticide is in a proform, the method of cell treatment should be selected so as not to inhibit processing of the proform to the mature form of the pesticide by the target pest pathogen. For example, formaldehyde will crosslink proteins and could inhibit processing of the proform of a polypeptide pesticide. The method of treatment should retain at least a substantial portion of the bio-availability or bioactiviry of the toxin. Characteristics of particular interest in selecting a host cell for puφoses of production include ease of introducing the B.t. gene into the host, availability of expression systems, efficiency of expression, stability of the pesticide in the host, and the presence of auxiliary genetic capabilities. Characteristics of interest for use as a pesticide microcapsule include protective qualities for the pesticide, such as thick cell walls, pigmentation, and intracellular packaging or formation of inclusion bodies; survival in aqueous environments; lack of mammalian toxicity; attractiveness to pests for ingestion; ease of killing and fixing without damage to the toxin; and the like. Other considerations include ease of formulation and handling, economics, storage stability, and the like. Growth of cells. The cellular host containing the B.t. insecticidal gene may be grown in any convenient nutrient medium, where the DNA construct provides a selective advantage, providing for a selective medium so that substantially all or all of the cells retain the B.t. gene. These cells may then be harvested in accordance with conventional ways Alternatively, the cells can be treated prior to harvesting. The B t cells of the invention can be cultured using standard art media and fermentation techniques. Upon completion of the fermentation cycle the bacteria can be harvested by first separating the B t. spores and crystals from the fermentation broth by means well known m the art. The recovered B t spores and crystals can be formulated into a wettable powder, liquid concentrate, granules or other formulations by the addition of surfactants, dispersants, inert earners, and other components to facilitate handling and application for particular target pests. These formulations and application procedures are all well known m the art Methods and formulations for control of pests. Control of lepidopterans using the isolates, toxms, and genes of the subject invention can be accomplished by a vanety of methods known to those skilled m the art. These methods include, for example, the application of B.t isolates to the pests (or their location), the application of recombinant microbes to the pests (or their locations), and the transformation of plants with genes which encode the pesticidal toxins of the subject invention Recombinant microbes may be, for example, a B.t , E. coli, or Pseudomonas. Transformations can be made by those skilled in the art using standard techniques Matenals necessary for these transformations are disclosed herein or are otherwise readily available to the skilled artisan. Formulated bait granules containing an attractant and spores and crystals of the B.t isolates, or recombinant microbes comprising the genes obtainable from the B.t isolates disclosed herein, can be applied to the soil. Formulated product can also be applied as a seed- coating or root treatment or total plant treatment at later stages of the crop cycle. Plant and soil treatments of 5 . cells may be employed as wettable powders, granules or dusts, by mixing with various inert materials, such as inorganic minerals (phyllosihcates, carbonates, sulfates, phosphates, and the like) or botanical materials (powdered corncobs, nee hulls, walnut shells, and the like). The formulations may include spreader-sticker adjuvants, stabilizing agents, other pesticidal additives, or surfactants. Liquid formulations may be aqueous-based or non-aqueous and employed as foams, gels, suspensions, emulsifiable concentrates, or the like. The ingredients may include rheological agents, surfactants, emulsifiers, dispersants, or polymers. As would be appreciated by a person skilled in the art, the pesticidal concentration will vary widely depending upon the nature of the particular formulation, particularly whether it is a concentrate or to be used directly. The pesticide will be present in at least 1 % by weight and may be 100% by weight. The dry formulations will have from about 1-95% by weight of the pesticide while the liquid formulations will generally be from about 1-60% by weight of the solids in the liquid phase. The formulations will generally have from about 10 2 to about 10 4 cells/mg These formulations will be administered at about 50 mg (liquid or dry) to 1 kg or more per hectare The formulations can be applied to the environment of the pest, e g , soil and foliage, by spraying, dusting, sprinkling, or the like. Mutants. Mutants of the isolates of the invention can be made by procedures well known m the art. For example, an asporogenous mutant can be obtained through ethylmethane sulfonate (EMS) mutagenesis of an isolate The mutants can be made using ultraviolet light and nitrosoguanidine by procedures well known in the art A smaller percentage of the asporogenous mutants will remain mtact and not lyse for extended fermentation peπods; these strains are designated lysis minus (-) Lysis minus strains can be identified by screening asporogenous mutants in shake flask media and selecting those mutants that are still intact and contain toxin crystals at the end of the fermentation Lysis minus strains are suitable for a cell treatment process that will yield a protected, encapsulated toxin protein To prepare a phage resistant variant of said asporogenous mutant, an aliquot of the phage lysate is spread onto nutπent agar and allowed to dry An aliquot of the phage sensitive bacterial strain is then plated directly over the dried lysate and allowed to dry The plates are incubated at 30 °C The plates are incubated for 2 days and, at that time, numerous colonies could be seen growing on the agar Some of these colonies are picked and subcultured onto nutπent agar plates. These apparent resistant cultures are tested for resistance by cross streaking with the phage lysate. A line of the phage lysate is streaked on the plate and allowed to dry The presumptive resistant cultures are then streaked across the phage line Resistant bacterial cultures show no lysis anywhere in the streak across the phage line after overnight incubation at 30 °C The resistance to phage is then reconfirmed by plating a lawn of the resistant culture onto a nutπent agar plate. The sensitive strain is also plated in the same manner to serve as the positive control. After drying, a drop of the phage lysate is placed m the center of the plate and allowed to dry. Resistant cultures showed no lysis m the area where the phage lysate has been placed after incubation at 30°C for 24 hours Polynucleotide probes. It is well known that DNA possesses a fundamental property called base complementarity. In nature, DNA ordinarily exists m the form of pairs of anti- parallel strands, the bases on each strand projecting from that strand toward the opposite strand The base adenme (A) on one strand will always be opposed to the base thymine (T) on the other strand, and the base gua ne (G) will be opposed to the base cytos e (C). The bases are held in apposition by their ability to hydrogen bond in this specific way Though each individual bond is relatively weak, the net effect of many adjacent hydrogen bonded bases, together with base stacking effects, is a stable joining of the two complementary strands These bonds can be broken by treatments such as high pH or high temperature, and these conditions result in the dissociation, or "denaturation," of the two strands If the DNA is then placed in conditions which make hydrogen bonding of the bases thermodynamically favorable, the DNA strands will anneal, or "hybridize," and reform the ongmal double stranded DNA If earned out under appropriate conditions, this hybridization can be highly specific That is, only strands with a high degree of base complementarity will be able to form stable double stranded structures The relationship of the specificity of hybridization to reaction conditions is well known Thus, hybπdization may be used to test whether two pieces of DNA are complementary in their base sequences. It is this hybπdization mechanism which facilitates the use of probes of the subject invention to readily detect and charactenze DNA sequences of interest. The probes may be RNA or DNA. The probe will normally have at least about 10 bases, more usually at least about 18 bases, and may have up to about 50 bases or more, usually not having more than about 200 bases if the probe is made synthetically. However, longer probes can readily be utilized, and such probes can be, for example, several kilobases length The probe sequence is designed to be at least substantially complementary to a gene encoding a toxin of interest The probe need not have perfect complementarity to the sequence to which it hybridizes The probes may be labelled utilizing techniques which are well known to those skilled in this art One approach for the use of the subject invention as probes entails first identifying by Southern blot analysis of a gene bank of the B t isolate all DNA segments homologous with the disclosed nucleotide sequences. Thus, it is possible, without the aid of biological analysis, to know m advance the probable activity of many new B t isolates, and of the individual endotoxin gene products expressed by a given B.t. isolate. Such a probe analysis provides a rapid method for identifying potentially commercially valuable insecticidal endotoxin genes within the multifarious subspecies of B.t One hybπdization procedure useful accordmg to the subject invention typically includes the initial steps of isolating the DNA sample of interest and punfying it chemically Either lysed bacteria or total fractionated nucleic acid isolated from bacteria can be used Cells can be treated using known techniques to liberate their DNA (and/or RNA). The DNA sample can be cut into pieces with an appropriate restriction enzyme. The pieces can be separated by size through electrophoresis in a gel, usually agarose or acrylamide. The pieces of interest can be transferred to an immobilizing membrane in a manner that retains the geometry of the pieces. The membrane can then be dried and prehybridized to equilibrate it for later immersion in a hybridization solution. The manner in which the nucleic acid is affixed to a solid support may vary. This fixing of the DNA for later processing has great value for the use of this technique in field studies, remote from laboratory facilities. The particular hybridization technique is not essential to the subject invention. As improvements are made in hybridization techniques, they can be readily applied. As is well known in the art, if the probe molecule and nucleic acid sample hybridize by forming a strong non-covalent bond between the two molecules, it can be reasonably assumed that the probe and sample are essentially identical. The probe's detectable label provides a means for determining in a known manner whether hybridization has occurred. The nucleotide segments of the subject invention which are used as probes can be synthesized by use of DNA synthesizers using standard procedures. In the use of the nucleotide segments as probes, the particular probe is labeled with any suitable label known to those skilled in die art, including radioactive and non-radioactive labels. Typical radioactive labels include 32 P, 35 S, or the like. A probe labeled with a radioactive isotope can be constructed from a nucleotide sequence complementary to the DNA sample by a conventional nick translation reaction, using a DNase and DNA polymerase. The probe and sample can then be combined in a hybridization buffer solution and held at an appropriate temperature until annealing occurs. Thereafter, the membrane is washed free of extraneous materials, leaving the sample and bound probe molecules typically detected and quantified by autoradiography and/or liquid scintillation counting. For synthetic probes, it may be most desirable to use enzymes such as polynucleotide kinase or terminal transferase to end-label the DNA for use as probes. Non-radioactive labels include, for example, ligands such as biotin or thyroxine, as well as enzymes such as hydrolases or perixodases, or the various chemiluminescers such as luciferin, or fluorescent compounds like fluorescein and its derivatives. The probes may be made inherently fluorescent as described in International Application No. WO93/16094. The probe may also be labeled at both ends with different types of labels for ease of separation, as, for example, by using an isotopic label at the end mentioned above and a biotin label at the other end. The amount of labeled probe which is present in the hybridization solution will vary widely, depending upon the nature of the label, the amount of the labeled probe which can reasonably bind to the filter, and the stringency of the hybridization. Generally, substantial excesses of the probe will be employed to enhance the rate of binding of the probe to the fixed DNA Vanous degrees of stπngency of hybπdization can be employed The more severe the conditions, the greater the complementaπty that is required for duplex formation. Severity can be controlled by temperature, probe concentration, probe length, ionic strength, time, and the like. Preferably, hybridization is conducted under stπngent conditions by techniques well known in the art, as descnbed, for example, m Keller, G.H., M.M. Manak (1987) DNA Probes, Stockton Press, New York, NY., pp. 169-170. As used herein "stringent" conditions for hybridization refers to conditions which achieve the same, or about the same, degree of specificity of hybridization as the conditions employed by the current applicants Specifically, hybridization of immobilized DNA on Southern blots with 32P-labeled gene-specific probes was performed by standard methods (Maniatis, T., E.F. Fntsch, J. Sambrook [ 1982] Molecular Cloning. A Laboratory Manual, Cold Spnng Harbor Laboratory, Cold Spπng Harbor, NY). In general, hybπdization and subsequent washes were earned out under stπngent conditions that allowed for detection of target sequences with homology to the exemplified toxin genes. For double-stranded DNA gene probes, hybndization was earned out overnight at 20-25° C below the melting temperature (Tm) of the DNA hybπd in 6X SSPE, 5X Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA The melting temperature is described by the following formula (Beltz, G.A., K.A. Jacobs, T.H Eickbush, P.T Cherbas, and F.C. Kafatos [1983] Methods ofEnzymology, R. Wu, L Grossman and K. Moldave [eds.] Academic Press, New York 100:266-285). Tm=81.5° C+16.6 Log[Na+]+0.41(%G+C)-0.61(%formamιde)-600/length of duplex in base pairs. Washes are typically earned out as follows: (1) Twice at room temperature for 15 minutes m IX SSPE, 0 1% SDS (low stπngency wash). (2) Once at Tm-20°C for 15 minutes m 0.2X SSPE, 0.1% SDS (moderate stringency wash). For oligonucleotide probes, hybπdization was earned out overnight at 10-20°C below the melting temperature (Tm) of the hybnd in 6X SSPE, 5X Denhardt's solution, 0.1% SDS, 0 1 mg/ml denatured DNA. Tm for oligonucleotide probes was determined by the following formula Tm (° C)=2(number T/A base pairs) +4(number G/C base pairs) (Suggs, S.V., T. Miyake, E.H. Kawashime, M.J. Johnson, K. Itakura, and R.B. Wallace [1981] ICN-UCLA Symp Dev Biol Using Purified Genes, D.D. Brown [ed ], Academic Press, New York, 23:683-693). Washes were typically carried out as follows' ( 1 ) Twice at room temperature for 15 minutes IX SSPE, 0.1 % SDS (low stπngency wash). (2) Once at the hybridization temperature for 15 minutes in 1 X SSPE, 0.1 % SDS (moderate stπngency wash). Duplex formation and stability depend on substantial complementaπty between the two strands of a hybnd, and, as noted above, a certain degree of mismatch can be tolerated. Therefore, the nucleotide sequences of the subject invention include mutations (both single and multiple), deletions, insertions of the descnbed sequences, and combinations thereof, wherein said mutations, insertions and deletions permit formation of stable hybπds with the target polynucleotide of interest. Mutations, insertions, and deletions can be produced in a given polynucleotide sequence in many ways, and these methods are known to an ordinanly skilled artisan. Other methods may become known in the future. The known methods include, but are not limited to: ( 1 ) synthesizing chemically or otherwise an artificial sequence which is a mutation, insertion or deletion of the known sequence; (2) using a nucleotide sequence of the present invention as a probe to obtain via hybπdization a new sequence or a mutation, insertion or deletion of the probe sequence; and (3) mutating, inserting or deleting a test sequence in vitro or in vivo. It is important to note that the mutational, lnsertional, and deletional vaπants generated from a given probe may be more or less efficient than the ongmal probe. Notwithstanding such differences in efficiency, these vaπants are within the scope of the present invention. Thus, mutational, insertional, and deletional vaπants of the disclosed nucleotide sequences can be readily prepared by methods which are well known to those skilled in the art. These vaπants can be used m the same manner as the exemplified pπmer sequences so long as the variants have substantial sequence homology with the original sequence. As used herein, substantial sequence homology refers to homology which is sufficient to enable the variant to function in the same capacity as the ongmal probe. Preferably, this homology is greater than 50%; more preferably, this homology is greater than 75%; and most preferably, this homology is greater than 90%. The degree of homology needed for the vaπant to function m its intended capacity will depend upon the intended use of the sequence. It is well withm the skill of a person trained in this art to make mutational, insertional, and deletional mutations which are designed to improve the function of the sequence or otherwise provide a methodological advantage PCR technology Polymerase Cham Reaction (PCR) is a repetitive, enzymatic, primed synthesis of a nucleic acid sequence. This procedure is well known and commonly used by those skilled in this art (see Mulhs, U.S Patent Nos 4,683,195, 4,683,202, and 4,800,159, Saiki, Randall K , Stephen Scharf, Fred Faloona, Kary B. Mul s, Glenn T. Horn, Henry A Erlich, Norman Arnheim [1985] "Enzymatic Amplification of β-Globin Genomic Sequences and Restnction Site Analysis for Diagnosis of Sickle Cell Anemia," Science 230.1350-1354 ) PCR is based on the enzymatic amplification of a DNA fragment of interest that is flanked by two oligonucleotide pnmers that hybndize to opposite strands of the target sequence The primers are onented with the 3 ' ends pointing towards each other Repeated cycles of heat denaturation of the template, annealing of the pnmers to their complementary sequences, and extension of the annealed pnmers with a DNA polymerase result in the amplification of the segment defined by the 5' ends of the PCR pnmers. Since the extension product of each pπmer can serve as a template for the other pπmer, each cycle essentially doubles the amount of DNA fragment produced in the previous cycle This results in the exponential accumulation of the specific target fragment, up to several million-fold in a few hours By using a thermostable DNA polymerase such as Taq polymerase, which is isolated from the thermophilic bactenum Thermus aquaticus, the amplification process can be completely automated. The DNA sequences of the subject invention can be used as pnmers for PCR amplification In performing PCR amplification, a certain degree of mismatch can be tolerated between pπmer and template Therefore, mutations, deletions, and insertions (especially additions of nucleotides to the 5' end) of the exemplified pnmers fall withm the scope of the subject invention Mutations, insertions and deletions can be produced in a given pnmer by methods known to an ordmanly skilled artisan. It is important to note that the mutational, insertional, and deletional vanants generated from a given pnmer sequence may be more or less efficient than the ongmal sequences. Notwithstanding such differences in efficiency, these vaπants are within the scope of the present invention. Following are examples which illustrate procedures for practicing the invention These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted. Example 1 - Cultuπng of B.t. Isolates Useful According to the Invention A subculture of B.t isolates, or mutants thereof, can be used to inoculate the following peptone, glucose, salts medium: Bacto Peptone 7.5 g/1 Glucose 1.0 g/1 KH 2 P0 4 3.4 g/1 K 2 HP0 4 4.35 g/1 Salt Solution 5.0 ml/1 CaCL Solution 5.0 ml/1 pH 7.2 Salts Solution (100 ml) MgS0 4 -7H 2 0 2.46 g MnS0 4 -H 2 0 0.04 g ZnS0 4 -7H,0 0.28 g FeS0 4 -7H 2 0 0.40 g CaCl 2 Solution (100 ml) CaCl 2 -2H 2 0 3.66 g The salts solution and CaCl 2 solution are filter-sterilized and added to the autoclaved and cooked broth at the time of inoculation. Flasks are incubated at 30 °C on a rotary shaker at 200 φm for 64 hr. The above procedure can be readily scaled up to large fermentors by procedures well known in the art. The B.t. spores and or crystals, obtained in the above fermentation, can be isolated by procedures well known in the art. A frequently-used procedure is to subject the harvested fermentation broth to separation techniques, e.g., centnfugation. Alternatively, a subculture of B.t. isolates, or mutants thereof, can be used to inoculate the following medium, known as TB broth: Tryptone Yeast Extract Glycerol KH 2 P0 4 K,HP0 4 pH 7.4 The potassium phosphate was added to the autoclaved broth after cooling. Flasks were incubated at 30°C on a rotary shaker at 250 φm for 24-36 hours. The above procedure can be readily scaled up to large fermentors by procedures well known in the art. The B.t. obtained m the above fermentation, can be isolated by procedures well known in the art. A frequently-used procedure is to subject the harvested fermentation broth to separation techniques, e.g., centrifugation. In a specific embodiment, B.t proteins useful according the present invention can be obtained from the supernatant. The culture supernatant containing the active protem(s) was used in bioassays as discussed below. Example 2 — Identification of Genes Encoding Novel Lepidopteran-Active Bacillus thuringiensis Toxms Two pπmer pairs useful for the identification and classification of novel toxin genes by PCR amplification of polymoφhic DNA fragments near the 3' ends of B.t. toxin genes were designed. These oligonucleotide primers allow the discrimination of genes encoding toxms in the Cry7, Cry8, or Cry9 subfamilies from genes for the more common lepidopteran-active toxins in the Cryl subfamily based on size differences for the amplified DNA. The sequences of these pnmers are: Forward 1 5 ' CGTGGCTATATCCTTCGTGTYAC 3 ' (SEQ ID NO. 1 ) Reverse 1 5 ' ACRATRAATGTTCCTTCYGTTTC 3 ' (SEQ ID NO. 2) Forward 2 5 ' GGATATGTMTTACGTGTAACWGC 3 ' (SEQ ID NO. 3) Reverse 2 5' CTACACTTTCTATRTTGAATRYACCTTC 3' (SEQ ID NO 4) Standard PCR amplification (Perkin Elmer, Foster City, CA) using pπmer pair 1 (SEQ ID NOS. 1 and 2) of the subject invention yields DNA fragments approximately 415-440 base pairs in length from B t. toxin genes related to the cryl subfamily. PCR amplification using primer pair 2 (SEQ ID NOS. 3 and 4) according to the sub j ect invention yields DNA fragments approximately 230-290 base pairs in length from cryl, cry8, or cry 9 subfamily toxin genes. These primers can be used according to the subject invention to identify genes encoding novel toxins. Crude DNA templates for PCR were prepared from B.t. strains. A loopful of cells was scraped from an overnight plate culture of Bacillus thuringiensis and resuspended in 300 ml TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 8.0). Proteinase K was added to 0.1 mg/ml and the cell suspension was heated to 55 °C for 15 minutes. The suspension was then boiled for 15 minutes. Cellular debris was pelleted in a microfuge and the supernatant containing the DNA was transferred to a clean tube. PCR was carried out using the primer pair consisting of the Forward 2 (SEQ ID NO. 3) and Reverse 2 (SEQ ID NO. 4) oligonucleotides described above. Strains were identified that contained genes characterized by amplification of DNA fragments approximately 230-290 bp in length. Spore-crystal preparations from these strains were subsequently tested for bioactivity against Agrotis ipsilon and additional lepidopteran targets. PS185U2 was examined using both primer pairs 1 and 2 (SEQ ID NOS. 1 and 2 and SEQ ID NOS. 3 and 4, respectively). In this strain, primer pair 1 (SEQ ID NOS. 1 and 2) yielded a DNA band of the size expected for toxin genes related to the cry] subfamilv. Example 3 - Restriction Fragment Length Polymoφhism fRFLP) Analysis of Bacillus thuringiensis Toxin Genes Present in Lepidopteran-Active Strains Total cellular DNA was prepared from Bacillus thuringiensis (B.t.) strains grown to an optical density, at 600 nm, of 1.0. Cells were pelleted by centrifugation and resuspended in protoplast buffer (20 mg/ml lysozyme in 0.3 M sucrose, 25 M Tris-Cl [pH 8.0], 25 mM EDTA). After incubation at 37°C for 1 hour, protoplasts were lysed by two cycles of freezing and thawing. Nine volumes of a solution of 0.1 M NaCl, 0.1% SDS, 0.1 M Tris-Cl were added to complete lysis. The cleared lysate was extracted twice with phenol: chloroform (1:1). Nucleic acids were precipitated with two volumes of ethanol and pelleted by centrifugation. The pellet was resuspended in TE buffer and RNase was added to a final concentration of 50 g/ml. After incubation at 37°C for 1 hour, the solution was extracted once each with phenol :chloroform (1 : 1) and TE-saturated chloroform. DNA was precipitated from the aqueous phase by the addition of one-tenth volume of 3M NaOAc and two volumes of ethanol. DNA was pelleted by centrifugation, washed with 70% ethanol, dried, and resuspended in TE buffer. Two types of PCR-amplified, 32 P-labeled DNA probes were used in standard Southern hybridizations of total cellular B.t. DNA to characterize toxin genes by RFLP. The first probe (A) was a DNA fragment amplified using the following primers: Forward 3: 5' CCAGWTTTAYAGGAGG 3' (SEQ ID NO. 5) Reverse 3: 5' GTAAACAAGCTCGCCACCGC 3 ' (SEQ ID NO. 6) The second probe (B) was either the 230-290 bp or 415-440 bp DNA fragment amplified with the primers described in the previous example. Hybridization of immobilized DNA on Southern blots with the aforementioned 32 P-labeled probes was performed by standard methods (Mamatis, T., E.F. Fπtsch, J. Sambrook [1982] Molecular Cloning: A Laboratory Manual, Cold Spπng Harbor Laboratory, Cold Spπng Harbor, NY). In general, hybndization and subsequent washes were earned out under moderate stnngency. For double-stranded DNA gene probes, hybridization was carried out overnight at 20-25°C below the melting temperature (Tm) of the DNA hybπd m 6X SSPE, 5X Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. The melting temperature is described by the following formula (Beltz, G.A., K.A. Jacobs, T.H. Eickbush, P.T. Cherbas, and F.C. Kafatos [1983] In Methods in Enzymology, R. Wu, L. Grossman and K. Moldave (eds.), Academic Press, New York. 100:266-285): Tm= 81.5°C + 16.6 Log[Na+] + 0.41(%G+C) -0.61(%formamιde)- 600/length of duplex in base pairs. Washes were typically carried out as follows: (1) Twice at room temperature for 15 minutes in IX SSPE, 0.1% SDS (low stringency wash). (2) Once at Tm -20°C for 15 minutes m 0.2X SSPE, 0.1% SDS (moderate stringency wash). RFLP data was obtained for the ten strains most active on Agrotis ipsilon (Tables 3 and 4). The hybndizmg DNA bands descnbed here contain all or part of the novel toxin genes under investigation. 10 15 20 Xal 5 9312 763 3870 5911 25 630 3258 2827 2093 2636 1521 1760 1010 625 30 Table 4. RFLP data for Bacillus thuringiensis strains using probe B Approximate size (base pairs) Bacillus thuringiensis Strain PS185U2 PS89J3 PS1 1B HD129 PS86BB1 PS86W1 PS86V1 PS31G1 HD573 HD525 Digest 10 15 Xbal 5262 5048 4563 5716 4921 9684 5549 5840 3985 3048 3386 4455 3583 6630 3501 3685 20 Example 4 — DNA Sequencing of Toxin Genes PCR-amphfied segments of toxin genes present in B.t. strains active on Agrotis ipsilon were sequenced. To accomplish this, amplified DNA fragments obtained using pnmers Forward 3 (SEQ ID NO. 5) and Reverse 3 (SEQ ID NO. 6) were first cloned into the PCR DNA TA-cloning plasmid vector, pCRII, as described by the supplier (Invitrogen, San Diego, CA) Several individual pCRII clones from the mixture of amplified DNA fragments from each B.t strain were chosen for sequencing. Colonies were lysed by boiling to release crude plasmid DNA. DNA templates for automated sequencing were amplified by PCR using vector-specific primers flanking the plasmid multiple cloning sites. These DNA templates were sequenced using Applied Biosystems (Foster City, CA) automated sequencing methodologies. Toxm gene sequences and their corresponding nucleotide sequences, described below (SEQ ID NO. 7 through SEQ ID NO. 62), were identified by this method. These sequences are listed in Table 5 The polypeptide sequences deduced from these nucleotide sequences are also shown. From these partial gene sequences, seven ohgonucleotides useful as PCR primers or hybπdization probes were designed. The sequences of these ohgonucleotides are the following. 5'GTTCATTGGTATAAGAGTTGGTG 3' (SEQ ID NO. 63) 5'CCACTGCAAGTCCGGACCAAATTCG 3' (SEQ ID NO. 64) 5'GAATATATTCCCGTCYATCTCTGG 3' (SEQ ID NO. 65) 5'GCACGAATTACTGTAGCGATAGG 3' (SEQ ID NO. 66) 5 'GCTGGTAACTTTGGAGATATGCGTG 3 ' (SEQ ID NO. 67) 5'GATTTCTTTGTAACACGTGGAGG 3' (SEQ ID NO. 68) 5'CACTACTAATCAGAGCGATCTG 3' (SEQ ID NO. 69) Specific gene toxin sequences and the oligonucleotide probes that enable identification of these genes by hybndization, or by PCR in combination with the Reverse 3 primer described above, are listed in Table 5. Example 5 - Isolation and DNA Sequencing of Full-Length Toxin Genes Total cellular DNA was extracted from B t. strains using standard procedures known in the art. See, e.g., Example 3, above. Gene libraries of size-fractionated Saul A partial restriction fragments of total cellular DNA were constructed in the bactenophage vector, Lambda-Geml l . Recombinant phage were packaged and plated on E coli KW251 cells Plaques were screened by hybridization with radiolabeled gene-specific probes denved from DNA fragments PCR-amphfied with oligonucleotide primers SEQ ID NOS. 5 and 6 Hybridizing phage were plaque-purified and used to infect liquid cultures of __ coli KW251 cells for isolation of DNA by standard procedures (Maniatis, T., E.F. Fritsch, J. Sambrook [ 1982] Molecular Cloning A Laboratory Manual, Cold Spnng Harbor Laboratory, Cold Spnng Harbor, NY). Toxm genes were subsequently subcloncd into pBluescipt vectors (Stratagene) for DNA sequence analysis. The full-length toxm genes listed below were sequenced using Applied Biosystems (Foster Cιty,CA) automated sequencing methodologies. The toxin gene sequences and the respective predicted polypeptide sequences are listed below. Source Strain Peptide SEQ ID Nucleotide SEQ ID Toxin designation PS86BB1 SEQ ID NO. 70 SEQ ID NO. 71 86BBl(a) PS86BB1 SEQ ID NO. 72 SEQ ID NO. 73 86BBl(b) PS31G1 SEQ ID NO 74 SEQ ID NO. 75 31Gl(a) Recombinant E coli NM522 strains containing these plasmids encoding these tox s were deposited with NRRL on June 27, 1997. Strain Plasmid Toxin designation NRRL number MR922 pMYC2451 86BBl(a) B-21794 MR923 pMYC2453 86BBl(b) B-21795 MR924 pMYC2454 31Gl(a) B-21796 Example 6 - Heterologous Expression of Novel B t Toxins m Pseudomonas fluorescens (PI) Full-length toxin genes were engineered into plasmid vectors by standard DNA cloning methods, and transformed into Psuedomonas flourescens for expression. Recombmant bactenal strains (Table 6) were grown in shake flasks for production of toxin for expression and quantitative bioassay against a variety of lepidopteran insect pests. Example 7 - Processing of Endotoxms with Trypsin Cultures of Pseudomonas fluorescens were grown for 48 hrs. as per standard procedures Cell pellets were harvested by centrifugation and washed three times with water and stored at - 70°C. Endotoxin inclusions were isolated from cells treated with lysozyme and DNAse by differential centrifugation. Toxms isolated in this manner were then processed to limit peptides by trypsinolysis and were then used for bioassays on lepidopteran pests. Detailed protocols follow. Toxin inclusion bodies were prepared from the washed crude cell pellets as follows: 4L of Lysis Buffer (prepare day of use) g Adjust pH to 7.5 with HC1 and bring up to final volume (4L.) with distilled water. 1. Thaw frozen cell pellet in 37°C water bath. 2. Add the lysis buffer until the 500 ml polycarbonate centrifuge bottles are as full as possible -400 ml total volume. Disperse by inversion of the bottle or using the Polytron at low rpm. 3. Centnfuge ( 10,000 x g) for 20 minutes at 4 ° C. 4. Decant and discard supernatant. 5. Resuspend pellet in 5 ml of lysis buffer for every gram of pellet, using the Polytron at low rpm to disperse the pellet. 6 Add 25 mg/ml lysosyme solution to the suspension to a final concentration of 0.6 mg/ml. 7. Incubate at 37 °C for 4 minutes. Invert every 30 seconds. 8. Place suspension on ice for 1 hour. 9. Add 2.5M MgCl-6H 2 0 to the tubes to a final concentration of 60 M. Add a 40 mg/ml deoxyribonuclease I (Sigma) solution to get a final concentration of 0.5 mg/ml. 10. Incubate overnight at 4°C. 11 Homogenize the lysate using the Polytron at low rpm. 12 Centnfuge at 10,000g at 4°C for 20 minutes. Decant and discard supernatant 13 Resuspend the inclusion pellet m lysis buffer Check microscopically for complete cell lysis. 14. Wash the inclusion pellet in lysis buffer 5 times (repeat steps 2-5) 15 Store as a suspension of 10 mM Tπs-Cl pH 7.5, 0 1 mM PMSF and stored at -70°C in 1.5 ml Eppitubes. Digestion of inclusions with trypsin is performed as follows. Digestion solution: 1 2 ml lM NaCAPS pH 10.5 2 Inclusion preparation (as much as 100 mg protein) 3 Trypsin at a 1 : 100 ratio with the amount of protein to be cleaved (added dunng the procedure) 4 H 2 0 to a final volume of 10 ml Trypsin treatment is performed as follows: 1. Incubate the digestion solution, minus trypsin, at 37 °C for 15 minutes. 2. Add trypsin at 1 : 100 (trypsιn:toxm protein wt/wt) 3. Incubate solution for 2 hours at 37°C with occasional mixing by inversion 4. Centnfuge the digestion solution for 15 minutes at 15,000g at 4°C. 5. Remove and save the supernatant. 6. Supernatant is analyzed by SDS-PAGE and used for bioassay as discussed below. Example 8 - Expression of a Gene from B.t. strain HP 129 in a Chimenc Construct A gene was isolated from B.t strain HD129. This gene appears to be a pseudogene with no obvious translational initiation codon. To express this gene from HD129, we designed and constructed a gene fusion with the first 28 codons of cry I Ac in Pseudomonas expression system The nucleotide and peptide sequences of this chimenc toxm are shown in SEQ ID NOS. 76 and 77 Upon induction, recombmant P. fluorescens containing this novel chimeπc toxm expressed the polypeptide of the predicted size. Example 9 - Further Sequencing of Toxin Genes DNA of soluble toxins from the isolates listed in Table 7 were sequenced The SEQ ID NOS of the sequences thus obtained are also reported in Table 7. Table 7. Source Isolate Protein SEQ ID NO Nucleotide SEQ ID NO Toxin Name Example 10 — Black Cutworm Bioassav Suspensions of powders containing B.t. isolates were prepared by mixing an appropnate amount of powder with distilled water and agitating vigorously. Suspensions were mixed with black cutworm artificial diet (BioServ, Frenchtown, NJ) amended with 28 grams alfalfa powder (BioServ) and 1.2 ml formalin per liter of finished diet Suspensions were mixed with finished artificial diet at a rate of 3 ml suspension plus 27 ml diet. After vortexing, this mixture was poured into plastic trays with compartmentalized 3 ml wells (Nutrend Container Corporation, Jacksonville, FL). A water blank containing no B.t. served as the control. Early first-instar Agrotis ipsilon larvae (French Agπcultural Services, Lamberton, MN) were placed singly onto the diet mixture. Wells were then sealed with "MYLAR" sheeting (ClearLam Packaging, IL) using a tacking iron, and several pmholes were made m each well to provide gas exchange. Larvae were held at 29°C for four days in a 14 10 (hgh dark) holding room Mortality was recorded after four days The following B t isolates were found to have activity against black cutworm PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1 , HD525, HD573, PS27J2, HD110, HD10, PS202S, HD29, PS101DD, HD129, and PS31G1 Bioassay results are shown in Table 8 Strains were tested as supernatant cultures Samples were applied to black cutworm artificial diet (BioServ, Frenchtown, NJ) and allowed to air dry before larval infestation A water blank containing no B t served as the control Eggs were applied to each treated well and were then sealed with "MYLAR" sheeting (ClearLam Packaging, IL) using a tacking iron, and several pmholes were made m each well to provide gas exchange Bioassays were held at 25 °C for 7 days in a 14 10 (hght:dark) holding room Mortality was recorded after seven days Strains exhibiting mortality against A ipsilon (greater than water control) are reported in Table 9 Table 9. Larvacidal activity of B t concentrated supematants in a top load bioassay on A ipsilon neonates Strain Activity PS86W1 + PS28C + PS86BB1 + PS89J3 + PS86V1 + PS94R1 + HD573 + Example 12 - Activity of B.t Isolates Pseudomonas fluorescens Clones Against Hehothis virescens (Fabπciusl and Helicoverpa zea (Boddie) Strains were tested as either frozen Pseudomonas fluorescens clones or B t supernatant culture samples Suspensions of clones were prepared by individually mixing samples with distilled water and agitating vigorously. For diet incorporation bioassays, suspensions were mixed with the artificial diet at a rate of 6 mL suspension plus 54 mL diet After vortexing, this mixture was poured into plastic trays with compartmentalized 3-ml wells (Nutrend Container Corporation, Jacksonville, FL). Supernatant samples were mixed at a rate of 3-6 ml with the diet as outlined above. In top load bioassays, suspensions or supematants were applied to the top of the artificial diet and allowed to air dry before larval mfestataion. A water blank served as the control First mstar larvae (USDA-ARS, Stoneville, MS) were placed singly onto the diet mixture. Wells were then sealed with "MYLAR" sheeting (ClearLam Packaging) using a tacking iron, and several pmholes were made in each well to provide gas exchange. Larvae were held at 25 °C for 6 days m a 14: 10 (lιght:dark) holding room Mortality was recorded after six days Results are as follows. Table 10. Larvacidal activity of B.t. concentrated supematants in a top load bioassay Total Protein H. virescens H. zea Strain (μg/cm 2 ) % Mortality Stunting % Mortality Stunting Table 11. Strains tested in diet incorporation bioassay on H. virescens and H. zca 'Protein information not available. Table 12. H virescens dose response in diet incorporation bioassays using frozen spore crystal preparations MR# LC50 (μg/ml) 1259 13.461 1259 trypsin 1.974 1260 12.688 1260 trypsin 0.260 1264 95.0 1264 trypsin 2.823 Example 13 - Insertion of Toxin Genes Into Plants One aspect of the subject invention is the transformation of plants with genes encoding the insecticidal tox The transformed plants are resistant to attack by the target pest Genes encoding pesticidal toxins, as disclosed herein, can be inserted into plant cells using a vanety of techniques which are well known in the art. For example, a large number of cloning vectors comprising a replication system in E coli and a marker that permits selection of the transformed cells are available for preparation for the insertion of foreign genes into higher plants The vectors compnse, for example, pBR322, pUC series, M13mp series, pAC YC 184, etc Accordingly, the sequence encoding the B t toxm can be inserted into the vector at a suitable restπction site. The resulting plasmid is used for transformation into E coli The E coli cells are cultivated in a suitable nutrient medium, then harvested and lysed The plasmid is recovered Sequence analysis, restriction analysis, electrophoresis, and other biochemical-molecular biological methods are generally carried out as methods of analysis. After each manipulation, the DNA sequence used can be cleaved and joined to the next DNA sequence. Each plasmid sequence can be cloned in the same or other plasmids. Depending on the method of inserting desired genes into the plant, other DNA sequences may be necessary If, for example, the Ti or Ri plasmid is used for the transformation of the plant cell, then at least the right border, but often the nght and the left border of the Ti or Ri plasmid T-DNA, has to be joined as the flanking region of the genes to be inserted The use of T-DNA for the transformation of plant cells has been intensively researched and sufficiently descnbed in EP 120 516, Ηoekema (1985) In: The Binary Plant Vector System, Offset-durkkenj Kanters B V., Alblasserdam, Chapter 5, Fraley et al , Crit Rev Plant Sci 4 1- 46, and An et al. (1985) EMBOJ 4.277-287 Once the inserted DNA has been integrated in the genome, it is relatively stable there and, as a rule, does not come out again. It normally contains a selection marker that confers on the transformed plant cells resistance to a biocide or an antibiotic, such as kanamycin, G 418, bleomycm, hygromycin, or chloramphenicol, inter alia. The individually employed marker should accordingly permit the selection of transformed cells rather than cells that do not contain the inserted DNA. A large number of techniques are available for inserting DNA into a plant host cell Those techniques include transformation with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agent, fusion, injection, biolistics (microparticle bombardment), or electroporation as well as other possible methods If Agrobacteπa are used for the transformation, the DNA to be inserted has to be cloned into special plasmids, namely either into an intermediate vector or into a binary vector The intermediate vectors can be integrated into the Ti or Ri plasmid by homologous recombination owing to sequences that are homologous to sequences in the T-DNA. The Ti or Ri plasmid also comprises the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate themselves in Agrobacteπa The intermediate vector can be transferred into Agrobacterium tumefaciens by means of a helper plasmid (conjugation). Binary vectors can replicate themselves both in E coli and in Agrobacteπa. They comprise a selection marker gene and a linker or polylinker which are framed by the nght and left T-DNA border regions They can be transformed directly into Agrobactena (Holsters et al. [1978] Mol Gen Genet 163:181-187). The Agrobacterium used as host cell is to comprise a plasmid carrying a vir region. The vir region is necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be contained The bactenum so transformed is used for the transformation of plant cells Plant explants can advantageously be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes for the transfer of the DNA into the plant cell. Whole plants can then be regenerated from the infected plant matenal (for example, pieces of leaf, segments of stalk, roots, but also protoplasts or suspension- cultivated cells) in a suitable medium, which may contain antibiotics or biocides for selection The plants so obtained can then be tested for the presence of the inserted DNA No special demands are made of the plasmids in the case of injection and electroporation. It is possible to use ordinary plasmids, such as, for example, pUC derivatives The transformed cells grow mside the plants in the usual manner They can form germ cells and transmit the transformed traιt(s) to progeny plants. Such plants can be grown in the normal manner and crossed with plants that have the same transformed hereditary factors or other hereditary factors. The resulting hybrid individuals have the corresponding phenotypic properties. In a preferred embodiment of the subject invention, plants will be transformed with genes wherein the codon usage has been optimized for plants. See, for example, U.S. Patent No. 5,380,831, which is hereby incorporated by reference. Also, advantageously, plants encoding a truncated toxin will be used. The truncated toxin typically will encode about 55% to about 80% of the full length toxm. Methods for creating synthetic B.t. genes for use in plants are known in the art. It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included with the spiπt and purview of this application and the scope of the appended claims. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: Applicant Name(s) MYCOGEN CORPORATION Street address 5501 Oberlin Drive City San Diego State/Province California Country US Postal code/Zip 92121 Phone number (619) 453-8030 Fax number: (619) 453-6991 (ii) TITLE OF INVENTION: Toxins Active Against Pests (iii) NUMBER OF SEQUENCES: 105 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Saliwanchik, Lloyd & Saliwanchik (B) STREET: 2421 N.W. 41st Street, Suite A-1 (C) CITY: Gainesville (D) STATE: Florida (E) COUNTRY: USA (F) ZIP: 32606 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: US (B) FILING DATE: (C) CLASSIFICATION: (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/674,002 (B) FILING DATE: 01-JUL-1996 (C) CLASSIFICATION: (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Sanders, Jay M. (B) REGISTRATION NUMBER: 39,355 (C) REFERENCE/DOCKET NUMBER: MA-701C1 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: (352) 375-8100 (B) TELEFAX: (352) 372-5800 (2) INFORMATION FOR SEQ ID NO : 1 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 1 : CGTGGCTATA TCCTTCGTGT YAC 23 (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: ACRATRAATG TTCCTTCYGT TTC 23 (2) INFORMATION FOR SEQ ID NO : 3 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: GGATATGTMT TACGTGTAAC WGC 23 (2) INFORMATION FOR SEQ ID NO : 4 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: CTACACTTTC TATRTTGAAT RYACCTTC 28 (2) INFORMATION FOR SEQ ID NO : 5 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5 : CCAGWTTTAY AGGAGG 16 (2) INFORMATION FOR SEQ ID NO : 6 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: GTAAACAAGC TCGCCACCGC 20 (2) INFORMATION FOR SEQ ID NO : 7 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 7 : Pro Gly Phe Xaa Gly Gly Asp lie Leu Arg Arg Thr Ser Pro Xaa Gin 1 5 10 15 lie Ser Xaa Leu Arg Val Aεn lie Thr Ala Pro Leu Ser Gin Arg Tyr 20 25 30 Arg Val Arg lie Xaa Xaa Ala Ser Thr Thr Xaa Xaa Gin Phe His Thr 35 40 45 Ser lie Xaa Gly Arg Pro lie Asn Gin Gly Asn Phe Ser Xaa Thr Met 50 55 60 Ser Ser Gly Ser Asn Leu Gin Ser Gly Xaa Phe Arg Thr Val Gly Phe 65 70 75 80 Thr Thr Pro Xaa Asn Phe Ser Asn Gly Ser Ser Val Phe Thr Leu Ser 85 90 95 Xaa His Val Phe Asn Ser Gly Asn Glu Val Tyr lie Asp Arg lie Glu 100 105 110 Phe Val Pro Ala Glu Val Thr Phe Glu Ala Glu Tyr Asp Leu Glu Arg 115 120 125 Ala Xaa Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 8 : CCAGGATTTA YAGGAGGAGA TATTCTTCGA AGAACTTCAC CTGKSCAGAT TTCAWCCTTA 60 AGAGTAAATA TTACTGCACC ATTATCACAA AGATATCGGG TAAGAATTCR CWACGCTTCT 120 ACYACAWATT TWCAATTCCA TACATCAATT GRCGGAAGAC CTATTAATCA GGGKAATTTT 180 TCASCAACTA TGAGTAGTGG GAGTAATTTA CAGTCCGGAA KCTTTAGGAC TGTAGGTTTT 240 ACTACTCCGT KTAACTTTTC AAATGGATCA AGTGTATTTA CGTTAAGTKC TCATGTCTTC 300 AATTCAGGCA ATGAAGTTTA TATAGATCGA ATTGAATTTG TTCCGGCAGA AGTAACCTTT 360 GAGGCAGAAT ATGATTTAGA AAGAGCACMA AAGGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO : 9 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 9 : Pro Gly Phe Thr Gly Gly Asp lie Leu Arg Arg Thr Asp Gly Gly Xaa 1 5 10 15 Val Gly Thr lie Arg Ala Asn Val Asn Ala Pro Leu Thr Gin Gin Tyr 20 25 30 Arg lie Arg Leu Arg Tyr Ala Ser Thr Thr Ser Phe Val Val Asn Leu 35 40 45 Phe Val Asn Asn Ser Ala Ala Gly Phe Thr Leu Pro Ser Thr Met Ala 50 55 60 Gin Asn Gly Ser Leu Thr Xaa Glu Ser Phe Asn Thr Leu Glu Val Thr 65 70 75 80 His Xaa lie Arg Phe Ser Gin Ser Asp Thr Thr Leu Arg Leu Asn lie 85 90 95 Phe Pro Ser lie Ser Gly Gin Xaa Val Tyr Val Asp Lys Xaa Glu lie 100 105 110 Val Pro Xaa Asn Pro Thr Arg Glu Ala Glu Glu Asp Leu Glu Asp Xaa 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: CCAGGWTTTA CAGGAGGGGA TATACTTCGA AGAACGGaCG GTGGTRCAGT TGGAACGATT 60 AGAGCTAATG TTAATGCCCC ATTAACACAA CAATATCGTA TAAGATTACG CTATGCTTCG 120 ACAACAAGTT TTGTTGTTAA TTTATTTGTT AATAATAGTG CGGCTGGCTT TACTTTACCG 180 AGTACAATGG CTCAAAATGG TTCTTTAACA YRCGAGTCGT TTAATACCTT AGAGGTAACT 240 CATWCTATTA GATTTTCACA GTCAGATACT ACACTTAGGT TGAATATATT CCCGTCYATC 300 TCTGGTCAAG RAGTGTATGT AGATAAACWT GAAATCGTTC CAWTTAACCC GACACGAGAA 360 GCGGAAGAAG ATTTAGAAGA TSCAAAGAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: Pro Gly Phe Xaa Gly Gly Asp lie Leu Arg Arg Thr Gly Val Gly Thr 1 5 10 15 Phe Gly Thr lie Arg Val Arg Xaa Thr Ala Pro Leu Thr Gin Arg Tyr 20 25 30 Arg lie Arg Phe Arg Phe Ala Xaa Thr Thr Asn Leu Phe lie Gly lie 35 40 45 Arg Val Gly Asp Arg Gin Val Asn Tyr Phe Asp Phe Gly Arg Thr Met 50 55 60 Asn Arg Gly Asp Glu Leu Arg Tyr Glu Ser Phe Ala Thr Arg Glu Phe 65 70 75 80 Thr Thr Asp Phe Asn Phe Arg Gin Pro Gin Glu Leu lie Ser Val Phe 85 90 95 Ala Asn Ala Phe Ser Ala Gly Gin Glu Val Tyr Phe Asp Arg lie Glu 100 105 110 lie lie Pro Val Asn Pro Ala Arg Glu Ala Lys Glu Asp Leu Glu Ala 115 120 125 Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO : 12 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: CCAGGTTTTA YAGGAGGGGA TATACTCCGA AGAACAGGGG TTGGTACATT TGGAACAATA 60 AGGGTAAGGA YTACTGCCCC CTTAACACAA AGATATCGCA TAAGATTCCG TTTCGCTTYT 120 ACCACAAATT TGTTCATTGG TATAAGAGTT GGTGATAGAC AAGTAAATTA TTTTGACTTC 180 GGAAGAACAA TGAACAGAGG AGATGAATTA AGGTACGAAT CTTTTGCTAC AAGGGAGTTT 240 ACTACTGATT TTAATTTTAG ACAACCTCAA GAATTAATCT CAGTGTTTGC AAATGCATTT 300 AGCGCTGGTC AAGAAGTTTA TTTTGATAGA ATTGAGATTA TCCCCGTTAA TCCCGCACGA 360 GAGGCGAAAG AGGATYTAGA AGCAGCAAAG AAAGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO : 13 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 135 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: Gly Phe lie Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser Leu 1 5 10 15 Gly Val Leu Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr Arg 20 25 30 lie Xaa Val Arg Tyr Ala Xaa Thr Thr Asn lie Arg Leu Ser Val Asn 35 40 45 Gly Ser Phe Gly Thr lie Ser Gin Asn Leu Pro Ser Thr Met Arg Leu 50 55 60 Gly Glu Asp Leu Arg Tyr Gly Ser Phe Ala lie Arg Glu Phe Asn Thr 65 70 75 80 Ser lie Arg Pro Thr Ala Ser Pro Asp Gin lie Arg Leu Thr lie Glu 85 90 95 Pro Ser Phe lie Arg Gin Glu Val Tyr Val Asp Arg lie Glu Phe lie 100 105 110 Pro Val Asn Pro Thr Arg Glu Ala Lys Glu Asp Leu Glu Ala Ala Lys 115 120 125 Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 407 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: GGMTTTATAG GAGGAGCTCT ACTTCAAAGG ACTGACCATG GTTCGCTTGG AGTATTGAGG 60 GTCCAATTTC CACTTCACTT AAGACAACAA TATCGTATTA SAGTCCGTTA TGCTTYTACA 120 ACAAATATTC GATTGAGTGT GAATGGCAGT TTCGGTACTA TTTCTCAAAA TCTCCCTAGT 180 ACAATGAGAT TAGGAGAGGA TTTAAGATAC GGATCTTTTG CTATAAGAGA GTTTAATACT 240 TCTATTAGAC CCACTGCAAG TCCGGACCAA ATTCGATTGA CAATAGAACC ATCTTTTATT 300 AGACAAGAGG TCTATGTAGA TAGAATTGAG TTCATTCCAG TTAATCCGAC GCGAGAGGCG 360 AAAGAGGATC TAGAAGCAGC AAAAAAAGCG GTGGCGAGCT TGTTTAC 407 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: Pro Gly Phe Thr Gly Gly Asp lie Leu Arg Arg Thr Ser Pro Gly Gin 1 5 10 15 lie Ser Thr Leu Arg Val Asn lie Thr Ala Pro Leu Ser Gin Arg Tyr 20 25 30 Arg Val Arg lie Arg Tyr Ala Ser Thr Thr Asn Leu Gin Phe His Thr 35 40 45 Ser lie Asp Gly Arg Pro lie Asn Gin Gly Asn Phe Ser Ala Thr Met 50 55 60 Ser Ser Gly Ser Asn Leu Gin Ser Gly Ser Phe Arg Thr Val Gly Phe 65 70 75 80 Thr Thr Pro Phe Asn Phe Ser Asn Gly Ser Ser Val Phe Thr Leu Ser 85 90 95 Ala His Val Phe Asn Ser Gly Asn Glu Val Tyr lie Asp Arg lie Glu 100 105 110 Phe Val Pro Ala Glu Val Thr Phe Glu Ala Glu Tyr Asp Leu Glu Arg 115 120 125 Ala Gin Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 16 : CCAGGATTTA CAGGAGGAGA TATTCTTCGA AGAACTTCAC CTGGCCAGAT TTCAACCTTA 60 AGAGTAAATA TTACTGCACC ATTATCACAA AGATATCGGG TAAGAATTCG CTACGCTTCT 120 ACCACAAATT TACAATTCCA TACATCAATT GACGGAAGAC CTATTAATCA GGGGAATTTT 180 TCAGCAACTA TGAGTAGTGG GAGTAATTTA CAGTCCGGAA GCTTTAGGAC TGTAGGTTTT 240 ACTACTCCGT TTAACTTTTC AAATGGATCA AGTGTATTTA CGTTAAGTGC TCATGTCTTC 300 AATTCAGGCA ATGAAGTTTA TATAGATCGA ATTGAATTTG TTCCGGCAGA AGTAACCTTT 360 GAGGCAGAAT ATGATTTAGA AAGAGCGCAA AAGGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: Pro Gly Phe Xaa Gly Gly Asp lie Leu Arg Arg Thr Asp Gly Gly Ala 1 5 10 15 Val Gly Thr lie Arg Ala Asn Val Asn Ala Pro Leu Thr Gin Gin Tyr 20 25 30 Arg lie Arg Leu Arg Tyr Ala Ser Thr Thr Ser Phe Val Val Asn Leu 35 40 45 Phe Val Asn Asn Ser Ala Ala Gly Phe Thr Leu Pro Ser Thr Met Ala 50 55 60 Gin Asn Gly Ser Leu Thr Tyr Glu Ser Phe Asn Thr Leu Glu Val Thr 65 70 75 80 His Thr lie Arg Phe Ser Gin Ser Asp Thr Thr Leu Arg Leu Asn lie 85 90 95 Phe Pro Ser lie Ser Gly Gin Glu Val Tyr Val Asp Lys Leu Glu lie 100 105 110 Val Pro lie Asn Pro Thr Arg Glu Ala Glu Glu Asp Leu Glu Asp Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: CCAGGWTTTA YAGGAGGGGA TATACTTCGA AGAACGGACG GTGGTGCAGT TGGAACGATT 60 AGAGCTAATG TTAATGCCCC ATTAACACAA CAATATCGTA TAAGATTACG CTATGCTTCG 120 ACAACAAGTT TTGTTGTTAA TTTATTTGTT AATAATAGTG CGGCTGGCTT TACTTTACCG 180 AGTACAATGG CTCAAAATGG TTCTTTAACA TACGAGTCGT TTAATACCTT AGAGGTAACT 240 CATACTATTA GATTTTCACA GTCAGATACT ACACTTAGGT TGAATATATT CCCGTCTATC 300 TCTGGTCAAG AAGTGTATGT AGATAAACTT GAAATCGTTC CAATTAACCC GACACGAGAA 360 GCGGAAGAAG ATTTAGAAGA TGCAAAGAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: Pro Gly Phe Xaa Gly Gly Asp lie Leu Arg Arg Thr Ser Pro Gly Gin 1 5 10 15 lie Ser Thr Leu Arg Val Asn lie Thr Ala Pro Leu Ser Gin Arg Tyr 20 25 30 Arg Val Arg lie Arg Tyr Ala Xaa Thr Thr Asn Leu Gin Phe His Thr 35 40 45 Ser lie Asp Gly Arg Pro lie Asn Gin Gly Asn Phe Ser Ala Thr Met 50 55 60 Ser Ser Gly Ser Asn Leu Gin Ser Gly Ser Phe Arg Thr Val Gly Phe 65 70 75 80 Thr Thr Pro Phe Asn Phe Ser Asn Gly Ser Ser Val Phe Thr Leu Ser 85 90 95 Ala His Val Phe Asn Ser Gly Aεn Glu Val Tyr lie Asp Arg lie Glu 100 105 110 Phe Val Pro Ala Glu Val Thr Phe Glu Ala Glu Tyr Asp Leu Glu Arg 115 120 125 Ala Gin Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: CCAGGWTTTA YAGGAGGAGA TATTCTTCGA AGAACTTCAC CTGGCCAGAT TTCAACCTTA 60 AGAGTAAATA TTACTGCACC ATTATCACAA AGATATCGGG TAAGAATTCG CTACGCTTYT 120 ACYACAAATT TACAATTCCA TACATCAATT GACGGAAGAC CTATTAATCA GGGKAATTTT 180 TCAGCAACTA TGAGTAGTGG GAGTAATTTA CAGTCCGGAA GCTTTAGGAC TGTAGGTTTT 240 ACTACTCCGT TTAACTTTTC AAATGGATCA AGTGTATTTA CGTTAAGTGC TCATGTCTTC 300 AATTCAGGCA ATGAAGTTTA TATAGATCGA ATTGAATTTG TTCCGGCAGA AGTAACCTTT 360 GAGGCAGAAT ATGATTTAGA AAGAGCACAA AAGGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 106 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: Phe Thr Gly Gly Asp lie Leu Arg Arg Asn Thr lie Gly Glu Phe Val 1 5 10 15 Ser Leu Gin Val Asn lie Asn Ser Pro lie Thr Gin Arg Tyr Arg Leu 20 25 30 Arg Phe Arg Tyr Ala Ser Ser Arg Asp Ala Arg lie Thr Val Ala He 35 40 45 Gly Gly Gin He Arg Val Asp Met Thr Leu Glu Lys Thr Met Glu He 50 55 60 Gly Glu Ser Leu Thr Xaa Arg Thr Phe Ser Tyr Thr Asn Phe Ser Asn 65 70 75 80 Pro Phe Ser Phe Arg Ala Aεn Pro Asp He He Arg He Ala Glu Glu 85 90 95 Leu Pro He Arg Gly Gly Glu Leu Val Tyr 100 105 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 318 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: TTTACAGGAG GGGATATCCT TCGAAGAAAT ACCATTGGTG AGTTTGTGTC TTTACAAGTC 60 AATATTAACT CACCAATTAC CCAAAGATAC CGTTTAAGAT TTCGTTATGC TTCCAGTAGG 120 GATGCACGAA TTACTGTAGC GATAGGAGGA CAAATTAGAG TAGATATGAC CCTTGAAAAA 180 ACCATGGAAA TTGGGGAGAG CTTAACATYT AGAACATTTA GCTATACCAA TTTTAGTAAT 240 CCTTTTTCAT TTAGGGCTAA TCCAGATATA ATTAGAATAG CTGAAGAACT TCCTATTCGC 300 GGTGGCGAGC TTGTTTAC 318 (2) INFORMATION FOR SEQ ID NO: 23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 96 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: He Pro Leu Val Ser Leu Cys Leu Tyr Lys Ser He Leu Thr His Gin 1 5 10 15 Leu Pro Lys Asp Thr Val Xaa Xaa Phe Val Met Leu Pro Val Gly Met 20 25 30 His Glu Leu Leu Xaa Arg Xaa Glu Asp Lys Leu Glu Xaa He Xaa Pro 35 40 45 Leu Lys Lys Pro Trp Lys Leu Gly Arg Ala Xaa His Leu Glu His Leu 50 55 60 Ala He Pro He Leu Val He Leu Phe His Leu Gly Leu He Gin He 65 70 75 80 Xaa Leu Glu Xaa Leu Lys Asn Phe Leu Phe Ala Val Ala Ser Leu Phe 85 90 95 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 292 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: AAATACCATT GGTGAGTTTG TGTCTTTACA AGTCAATATT AACTCACCAA TTACCCAAAG 60 ATACCGTTTA ARATTTCGTT ATGCTTCCAG TAGGGATGCA CGAATTACTG TAGCGATAGG 120 AGGACAAATT AGAGTAGATA TGACCCTTGA AAAAACCATG GAAATTGGGG AGAGCTTAAC 180 ATCTAGAACA TTTAGCTATA CCAATTTTAG TAATCCTTTT TCATTTAGGG CTAATCCAGA 240 TATAATTAGA ATAGCTGAAG AACTTCCTAT TCGCGGTGGC GAGCTTGTTT AC 292 (2) INFORMATION FOR SEQ ID NO:25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 108 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: Pro Gly Phe Xaa Gly Gly Asp He Leu Arg Arg Asn Thr He Gly Glu 1 5 10 15 Phe Val Ser Leu Gin Val Asn He Asn Ser Pro He Thr Gin Arg Tyr 20 25 30 Arg Leu Arg Phe Arg Tyr Ala Ser Ser Arg Asp Ala Arg He Thr Val 35 40 45 Ala He Gly Gly Gin He Arg Val Xaa Met Thr Leu Glu Lys Thr Met 50 55 60 Glu He Gly Glu Ser Leu Thr Ser Arg Thr Phe Ser Tyr Thr Asn Phe 65 70 75 80 Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp He He Arg He Ala 85 90 95 Glu Glu Leu Pro He Arg Gly Gly Glu Leu Val Tyr 100 105 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 324 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 26: CCAGGWTTTA YAGGAGGGGA TATCCTTCGA AGAAATACCA TTGGTGAGTT TGTGTCTTTA 60 CAAGTCAATA TTAACTCACC AATTACCCAA AGATACCGTT TAAGATTTCG TTATGCTTCC 120 AGTAGGGATG CACGAATTAC TGTAGCGATA GGAGGACAAA TTAGAGTAKA TATGACCCTT 180 GAAAAAACCA TGGAAATTGG GGAGAGCTTA ACATCTAGAA CATTTAGCTA TACCAATTTT 240 AGTAATCCTT TTTCATTTAG GGCTAATCCA GATATAATTA GAATAGCTGA AGAACTTCCT 300 ATTCGCGGTG GCGAGCTTGT TTAC 324 (2) INFORMATION FOR SEQ ID NO: 27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 27: Gly Phe Xaa Gly Gly Asp Val He Arg Arg Thr Asn Thr Gly Gly Phe 1 5 10 15 Gly Ala He Arg Val Ser Val Thr Gly Pro Leu Thr Gin Arg Tyr Arg 20 25 30 He Arg Phe Arg Tyr Ala Ser Thr He Asp Phe Asp Phe Phe Val Thr 35 40 45 Arg Gly Gly Thr Thr He Asn Asn Phe Arg Phe Thr Arg Thr Met Asn 50 55 60 Arg Gly Gin Glu Ser Arg Tyr Glu Ser Tyr Arg Thr Val Glu Phe Thr 65 70 75 80 Thr Pro Phe Asn Phe Thr Gin Ser Gin Asp He He Arg Thr Xaa He 85 90 95 Gin Gly Leu Ser Gly Asn Gly Glu Val Tyr Leu Asp Arg He Glu He 100 105 110 He Pro Val Asn Pro Thr Arg Glu Ala Glu Glu Asp Leu Glu Ala Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 411 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28: AGGATTTAYA GGAGGAGATG TAATCCGAAG AACAAATACT GGTGGATTCG GAGCAATAAG 60 GGTGTCGGTC ACTGGACCGC TAACACAACG ATATCGCATA AGGTTCCGTT ATGCTTCGAC 120 AATAGATTTT GATTTCTTTG TAACACGTGG AGGAACTACT ATAAATAATT TTAGATTTAC 180 ACGTACAATG AACAGGGGAC AGGAATCAAG ATATGAATCC TATCGTACTG TAGAGTTTAC 240 AACTCCTTTT AACTTTACAC AAAGTCAAGA TATAATTCGA ACAYCTATCC AGGGACTTAG 300 TGGAAATGGG GAAGTATACC TTGATAGAAT TGAAATCATC CCTGTAAATC CAACACGAGA 360 AGCGGAAGAR GATTTAGAAG CGGCGAAGAA AGCGGTGGCG AGCTTGTTTA C 411 (2) INFORMATION FOR SEQ ID NO: 29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 29: Pro Gly Phe He Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser 1 5 10 15 Leu Gly Val Leu Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr 20 25 30 Arg He Arg Val Arg Tyr Ala Ser Thr Thr Asn He Arg Leu Ser Val 35 40 45 Asn Gly Ser Phe Gly Thr He Ser Gin Asn Leu Pro Ser Thr Met Arg 50 55 60 Leu Gly Glu Asp Leu Arg Tyr Gly Ser Phe Ala He Arg Glu Phe Asn 65 70 75 80 Thr Ser He Arg Pro Thr Ala Ser Pro Asp Gin He Arg Leu Thr He 85 90 95 Glu Pro Ser Phe He Arg Gin Glu Val Tyr Val Asp Arg He Glu Phe 100 105 110 He Pro Val Asn Pro Thr Arg Glu Ala Lys Glu Asp Leu Glu Ala Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 30: CCAGGATTTA TAGGAGGAGC TCTACTTCAA AGGACTGACC ATGGTTCGCT TGGAGTATTG 60 AGGGTCCAAT TTCCACTTCA CTTAAGACAA CAATATCGTA TTAGAGTCCG TTATGCTTCT 120 ACAACAAATA TTCGATTGAG TGTGAATGGC AGTTTCGGTA CTATTTCTCA AAATCTCCCT 180 AGTACAATGA GATTAGGAGA GGATTTAAGA TACGGATCTT TTGCTATAAG AGAGTTTAAT 240 ACTTCTATTA GACCCACTGC AAGTCCGGAC CAAATTCGAT TGACAATAGA ACCATCTTTT 300 ATTAGACAAG AGGTCTATGT AGATAGAATT GAGTTCATTC CAGTTAATCC GACGCGAGAG 360 GCGAAAGAGG ATCTAGAAGC AGCAAAAAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO: 31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 142 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 31: Pro Gly Phe Xaa Gly Gly Gly He Leu Arg Arg Thr Thr Asn Gly Thr 1 5 10 15 Phe Gly Thr Leu Arg Val Thr Val Asn Ser Pro Leu Thr Gin Arg Tyr 20 25 30 Arg Val Arg Val Arg Phe Ala Ser Ser Gly Asn Phe Ser He Arg He 35 40 45 Leu Arg Gly Asn Thr Ser He Ala Tyr Gin Arg Phe Gly Ser Thr Met 50 55 60 Asn Arg Gly Gin Glu Leu Thr Tyr Glu Ser Phe Val Thr Ser Glu Phe 65 70 75 80 Thr Thr Asn Gin Ser Asp Leu Pro Phe Thr Phe Thr Gin Ala Gin Glu 85 90 95 Asn Leu Thr He Leu Ala Glu Gly Val Ser Thr Gly Ser Glu Tyr Phe 100 105 110 He Asp Arg He Glu He He Pro Val Asn Pro Ala Arg Glu Ala Glu 115 120 125 Glu Asp Leu Glu Ala Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 140 (2) INFORMATION FOR SEQ ID NO: 32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 428 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32: CCAGGWTTTA YAGGAGGGGG TATACTCCGA AGAACAACTA ATGGCACATT TGGAACGTTA 60 AGAGTAACAG TTAATTCACC ATTAACACAA AGATATCGCG TAAGAGTTCG TTTTGCTTCA 120 TCAGGAAATT TCAGCATAAG GATACTGCGT GGAAATACCT CTATAGCTTA TCAAAGATTT 180 GGGAGTACAA TGAACAGAGG ACAGGAACTA ACTTACGAAT CATTTGTCAC AAGTGAGTTC 240 ACTACTAATC AGAGCGATCT GCCTTTTACA TTTACACAAG CTCAAGAAAA TTTAACAATC 300 CTTGCAGAAG GTGTTAGCAC CGGTAGTGAA TATTTTATAG ATAGAATTGA AATCATCCCT 360 GTGAACCCGG CACGAGAAGC AGAAGAGGAT TTAGAAGCRG CGAAGAAAGC GGTGGCGAGC 420 TTGTTTAC 428 (2) INFORMATION FOR SEQ ID NO:33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 33: Pro Gly Phe He Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser 1 5 10 15 Leu Gly Val Leu Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr 20 25 30 Arg He Arg Val Arg Tyr Ala Ser Thr Thr Asn He Arg Leu Ser Val 35 40 45 Asn Gly Ser Phe Gly Thr He Ser Gin Asn Leu Pro Ser Thr Met Arg 50 55 60 Leu Gly Glu Asp Leu Arg Tyr Gly Ser Phe Ala He Arg Glu Phe Asn 65 70 75 80 Thr Ser He Arg Pro Thr Ala Ser Pro Asp Gin He Arg Leu Thr He 85 90 95 Glu Pro Ser Phe He Arg Gin Glu Val Tyr Val Asp Arg He Glu Phe 100 105 110 He Pro Val Asn Pro Thr Arg Glu Ala Lys Glu Asp Leu Glu Ala Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 34: CCAGGATTTA TAGGAGGAGC TCTACTTCAA AGGACTGACC ATGGTTCGCT TGGAGTATTG 60 AGGGTCCAAT TTCCACTTCA CTTAAGACAA CAATATCGTA TTAGAGTCCG TTATGCTTCT 120 ACAACAAATA TTCGATTGAG TGTGAATGGC AGTTTCGGTA CTATTTCTCA AAATCTCCCT 180 AGTACAATGA GATTAGGAGA GGATTTAAGA TACGGATCTT TTGCTATAAG AGAGTTTAAT 240 ACTTCTATTA GACCCACTGC AAGTCCGGAC CAAATTCGAT TGACAATAGA ACCATCTTTT 300 ATTAGACAAG AGGTCTATGT AGATAGAATT GAGTTCATTC CAGTTAATCC GACGCGAGAG 360 GCGAAAGAGG ATCTAGAAGC AGCAAAAAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO: 35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 35: Pro Gly Phe Thr Gly Gly Asp He Leu Arg Arg Thr Gly Val Gly Thr 1 5 10 15 Phe Gly Thr He Arg Val Arg Thr Thr Ala Pro Leu Thr Gin Arg Tyr 20 25 30 Arg He Arg Phe Arg Phe Ala Ser Thr Thr Asn Leu Phe He Gly He 35 40 45 Arg Val Gly Asp Arg Gin Val Asn Tyr Phe Asp Phe Gly Arg Thr Met 50 55 60 Asn Arg Gly Asp Glu Leu Arg Tyr Glu Ser Phe Ala Thr Arg Glu Phe 65 70 75 80 Thr Thr Asp Phe Asn Phe Arg Gin Pro Gin Glu Leu He Ser Val Phe 85 90 95 Ala Asn Ala Phe Ser Ala Gly Gin Glu Val Tyr Phe Asp Arg He Glu 100 105 110 He He Pro Val Asn Pro Ala Arg Glu Ala Lys Glu Asp Leu Glu Ala 115 120 125 Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 36: CCAGGTTTTA CAGGAGGGGA TATACTCCGA AGAACAGGGG TTGGTACATT TGGAACAATA 60 AGGGTAAGGA CTACTGCCCC CTTAACACAA AGATATCGCA TAAGATTCCG TTTCGCTTCT 120 ACCACAAATT TGTTCATTGG TATAAGAGTT GGTGATAGAC AAGTAAATTA TTTTGACTTC 180 GGAAGAACAA TGAACAGAGG AGATGAATTA AGGTACGAAT CTTTTGCTAC AAGGGAGTTT 240 ACTACTGATT TTAATTTTAG ACAACCTCAA GAATTAATCT CAGTGTTTGC AAATGCATTT 300 AGCGCTGGTC AAGAAGTTTA TTTTGATAGA ATTGAGATTA TCCCCGTTAA TCCCGCACGA 360 GAGGCGAAAG AGGATCTAGA AGCAGCAAAG AAAGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:37: Pro Gly Phe Thr Gly Gly Asp He Leu Arg Arg Thr Ser Pro Gly Gin 1 5 10 15 He Ser Thr Leu Arg Val Asn He Thr Ala Pro Leu Ser Gin Arg Tyr 20 25 30 Arg Val Arg He Arg Tyr Ala Ser Thr Thr Asn Leu Gin Phe His Thr 35 40 45 Ser He Asp Gly Arg Pro He Asn Gin Gly Asn Phe Ser Ala Thr Met 50 55 60 Ser Ser Gly Ser Asn Leu Gin Ser Gly Ser Phe Arg Thr Val Gly Phe 65 70 75 80 Thr Thr Pro Phe Asn Phe Ser Asn Gly Ser Ser Val Phe Thr Leu Ser 85 90 95 Ala His Val Phe Asn Ser Gly Asn Glu Val Tyr He Asp Arg He Glu 100 105 110 Phe Val Pro Ala Glu Val Thr Phe Glu Ala Glu Tyr Asp Leu Glu Arg 115 120 125 Ala Gin Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 38: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 38: CCAGGWTTTA CAGGAGGAGA TATTCTTCGA AGAACTTCAC CTGGCCAGAT TTCAACCTTA 60 AGAGTAAATA TTACTGCACC ATTATCACAA AGATATCGGG TAAGAATTCG CTACGCTTCT 120 ACCACAAATT TACAATTCCA TACATCAATT GACGGAAGAC CTATTAATCA GGGGAATTTT 180 TCAGCAACTA TGAGTAGTGG GAGTAATTTA CAGTCCGGAA GCTTTAGGAC TGTAGGTTTT 240 ACTACTCCGT TTAACTTTTC AAATGGATCA AGTGTATTTA CGTTAAGTGC TCATGTCTTC 300 AATTCAGGCA ATGAAGTTTA TATAGATCGA ATTGAATTTG TTCCGGCAGA AGTAACCTTT 360 GAGGCAGAAT ATGATTTAGA AAGAGCACAR AAGGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 39: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 39: Pro Gly Phe Thr Gly Gly Asp He Leu Arg Arg Thr Gly Val Gly Thr 1 5 10 15 Phe Gly Thr He Arg Val Arg Thr Thr Ala Pro Leu Thr Gin Arg Tyr 20 25 30 Arg He Arg Phe Arg Phe Ala Ser Thr Thr Asn Leu Phe He Gly He 35 40 45 Arg Val Gly Asp Arg Gin Val Asn Tyr Phe Asp Phe Gly Arg Thr Met 50 55 60 Asn Arg Gly Asp Glu Leu Arg Tyr Glu Ser Phe Ala Thr Arg Glu Phe 65 70 75 80 Thr Thr Asp Phe Asn Phe Arg Gin Pro Gin Glu Leu He Ser Val Phe 85 90 95 Ala Asn Ala Phe Ser Ala Gly Gin Glu Val Tyr Phe Asp Arg He Glu 100 105 110 He He Pro Val Asn Pro Ala Arg Glu Ala Lys Glu Asp Leu Glu Ala 115 120 125 Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 40: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 40: CCAGGTTTTA CAGGAGGGGA TATACTCCGA AGAACAGGGG TTGGTACATT TGGAACAATA 60 AGGGTAAGGA CTACTGCCCC CTTAACACAA AGATATCGCA TAAGATTCCG TTTCGCTTCT 120 ACCACAAATT TGTTCATTGG TATAAGAGTT GGTGATAGAC AAGTAAATTA TTTTGACTTC 180 GGAAGAACAA TGAACAGAGG AGATGAATTA AGGTACGAAT CTTTTGCTAC AAGGGAGTTT 240 ACTACTGATT TTAATTTTAG ACAACCTCAA GAATTAATCT CAGTGTTTGC AAATGCATTT 300 AGCGCTGGTC AAGAAGTTTA TTTTGATAGA ATTGAGATTA TCCCCGTTAA TCCCGCACGA 360 GAGGCGAAAG AGGATCTAGA AGCAGCAAAG AAAGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 41: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 1 : Pro Gly Phe Thr Gly Gly Asp He Leu Arg Arg Thr Asn Ala Gly Asn 1 5 10 15 Phe Gly Asp Met Arg Val Asn He Thr Ala Pro Leu Ser Gin Arg Tyr 20 25 30 Arg Val Arg He Arg Tyr Ala Ser Thr Ala Asn Leu Gin Phe His Thr 35 40 45 Ser He Asn Gly Arg Ala He Asn Gin Ala Asn Phe Pro Ala Thr Met 50 55 60 Aεn Ser Gly Glu Asn Leu Gin Ser Gly Ser Phe Arg Val Ala Gly Phe 65 70 75 80 Thr Thr Pro Phe Thr Phe Ser Asp Ala Leu Ser Thr Phe Thr He Gly 85 90 95 Ala Phe Ser Phe Ser Ser Asn Asn Glu Val Tyr He Asp Arg He Glu 100 105 110 Phe Val Pro Ala Glu Val Thr Phe Ala Thr Glu Ser Asp Gin Asp Arg 115 120 125 Ala Gin Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 42: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 42: CCAGGWTTTA CAGGAGGGGA TATCCTTCGA AGAACGAATG CTGGTAACTT TGGAGATATG 60 CGTGTAAACA TTACTGCACC ACTATCACAA AGATATCGCG TAAGGATTCG TTATGCTTCT 120 ACTGCAAATT TACAATTCCA TACATCAATT AACGGAAGAG CCATTAATCA GGCGAATTTC 180 CCAGCAACTA TGAACAGTGG GGAGAATTTA CAGTCCGGAA GCTTCAGGGT TGCAGGTTTT 240 ACTACTCCAT TTACCTTTTC AGATGCACTA AGCACATTCA CAATAGGTGC TTTTAGCTTC 300 TCTTCAAACA ACGAAGTTTA TATAGATCGA ATTGAATTTG TTCCGGCAGA AGTAACATTT 360 GCAACAGAAT CTGATCAGGA TAGAGCACAA AAGGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 43: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 43: Pro Gly Phe He Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser 1 5 10 15 Leu Gly Val Leu Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr 20 25 30 Arg He Arg Val Arg Tyr Ala Ser Thr Thr Asn He Arg Leu Ser Val 35 40 45 Asn Gly Ser Phe Gly Thr He Ser Gin Asn Leu Pro Ser Thr Met Arg 50 55 60 Leu Gly Glu Asp Leu Arg Tyr Gly Ser Phe Ala He Arg Glu Phe Asn 65 70 75 80 Thr Ser He Arg Pro Thr Ala Ser Pro Asp Gin He Arg Leu Thr He 85 90 95 Glu Pro Ser Phe He Arg Gin Glu Val Tyr Val Asp Arg He Glu Phe 100 105 110 He Pro Val Asn Pro Thr Arg Glu Ala Lys Glu Asp Leu Xaa Ala Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 44: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44: CCAGGATTTA TAGGAGGAGC TCTACTTCAA AGGACTGACC ATGGTTCGCT TGGAGTATTG 60 AGGGTCCAAT TTCCACTTCA CTTAAGACAA CAATATCGTA TTAGAGTCCG TTATGCTTCT 120 ACAACAAATA TTCGATTGAG TGTGAATGGC AGTTTCGGTA CTATTTCTCA AAATCTCCCT 180 AGTACAATGA GATTAGGAGA GGATTTAAGA TACGGATCTT TTGCTATAAG AGAGTTTAAT 240 ACTTCTATTA GACCCACTGC AAGTCCGGAC CAAATTCGAT TGACAATAGA ACCATCTTTT 300 ATTAGACAAG AGGTCTATGT AGATAGAATT GAGTTCATTC CAGTTAATCC GACGCGAGAG 360 GCGAAAGAGG ATCTAKAAGC AGCAAAAAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO: 45: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 45: Gin Xaa Leu Ser Gly Gly Asp Val He Arg Arg Thr Asn Thr Gly Gly 1 5 10 15 Phe Gly Ala He Arg Val Ser Val Thr Gly Pro Leu Thr Gin Arg Tyr 20 25 30 Arg He Arg Phe Arg Tyr Ala Ser Thr He Asp Phe Asp Phe Phe Val 35 40 45 Thr Arg Gly Gly Thr Thr He Asn Asn Phe Arg Phe Thr Arg Thr Met 50 55 60 Aεn Arg Gly Gin Glu Ser Arg Tyr Glu Ser Tyr Arg Thr Val Glu Phe 65 70 75 80 Thr Thr Pro Phe Asn Phe Thr Gin Ser Gin Asp He He Arg Thr Ser 85 90 95 He Gin Gly Leu Ser Gly Asn Gly Glu Val Tyr Leu Asp Arg He Glu 100 105 110 He He Pro Val Asn Pro Thr Arg Glu Ala Glu Glu Asp Leu Glu Ala 115 120 125 Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 46: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 414 baεe pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: CCAGGWTTTA tCAGGAGGAG ATGTAATCCG AAGAACAAAT ACTGGTGGAT TCGGAGCAAT 60 AAGGGTGTCG GTCACTGGAC CGCTAACACA ACGATATCGC ATAAGGTTCC GTTATGCTTC 120 GACAATAGAT TTTGATTTCT TTGTAACACG TGGAGGAACT ACTATAAATA ATTTTAGATT 180 TACACGTACA ATGAACAGGG GACAGGAATC AAGATATGAA TCCTATCGTA CTGTAGAGTT 240 TACAACTCCT TTTAACTTTA CACAAAGTCA AGATATAATT CGAACATCTA TCCAGGGACT 300 TAGTGGAAAT GGGGAAGTAT ACCTTGATAG AATTGAAATC ATCCCTGTAA ATCCAACACG 360 AGAAGCGGAA GARGATTTAG AAGCGGCGAA GAAAGCGGTG GCGAGCTTGT TTAC 414 (2) INFORMATION FOR SEQ ID NO: 47: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 142 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 47: Pro Gly Phe Thr Gly Gly Gly He Leu Arg Arg Thr Thr Asn Gly Thr 1 5 10 15 Phe Gly Thr Leu Arg Val Thr Val Aεn Ser Pro Leu Thr Gin Arg Tyr 20 25 30 Arg Val Arg Val Arg Phe Ala Ser Ser Gly Asn Phe Ser He Arg He 35 40 45 Leu Arg Gly Asn Thr Ser He Ala Tyr Gin Arg Phe Gly Ser Thr Met 50 55 60 Asn Arg Gly Gin Glu Leu Thr Tyr Glu Ser Phe Val Thr Ser Glu Phe 65 70 75 80 Thr Thr Asn Gin Ser Asp Leu Pro Phe Thr Phe Thr Gin Ala Gin Glu 85 90 95 Asn Leu Thr He Leu Ala Glu Gly Val Ser Thr Gly Ser Glu Tyr Phe 100 105 110 He Asp Arg He Glu He He Pro Val Asn Pro Ala Arg Glu Ala Glu 115 120 125 Glu Asp Leu Glu Ala Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 140 (2) INFORMATION FOR SEQ ID NO: 48: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 428 baεe pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 48: CCAGGWTTTA CAGGAGGGGG TATACTCCGA AGAACAACTA ATGGCACATT TGGAACGTTA 60 AGAGTAACAG TTAATTCACC ATTAACACAA AGATATCGCG TAAGAGTTCG TTTTGCTTCA 120 TCAGGAAATT TCAGCATAAG GATACTGCGT GGAAATACCT CTATAGCTTA TCAAAGATTT 180 GGGAGTACAA TGAACAGAGG ACAGGAACTA ACTTACGAAT CATTTGTCAC AAGTGAGTTC 240 ACTACTAATC AGAGCGATCT GCCTTTTACA TTTACACAAG CTCAAGAAAA TTTAACAATC 300 CTTGCAGAAG GTGTTAGCAC CGGTAGTGAA TATTTTATAG ATAGAATTGA AATCATCCCT 360 GTGAACCCGG CACGAGAAGC AGAAGAGGAT TTAGAAGCAG CGAAGAAAGC GGTGGCGAGC 420 TTGTTTAC 428 (2) INFORMATION FOR SEQ ID NO: 49: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 49: Pro Gly Phe He Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser 1 5 10 15 Leu Gly Val Leu Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr 20 25 30 Arg He Arg Val Arg Tyr Ala Ser Thr Thr Asn He Arg Leu Ser Val 35 40 45 Asn Gly Ser Phe Gly Thr He Ser Gin Asn Leu Pro Ser Thr Met Arg 50 55 60 Leu Gly Glu Asp Leu Arg Tyr Gly Ser Phe Ala He Arg Glu Phe Asn 65 70 75 80 Thr Ser He Arg Pro Thr Ala Ser Pro Asp Gin He Arg Leu Thr He 85 90 95 Glu Pro Ser Phe He Arg Gin Glu Val Tyr Val Asp Arg He Glu Phe 100 105 110 He Pro Val Asn Pro Thr Arg Glu Ala Lys Glu Asp Leu Glu Ala Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 50: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 50: CCAGGWTTTA TAGGAGGAGC TCTACTTCAA AGGACTGACC ATGGTTCGCT TGGAGTATTG 60 AGGGTCCAAT TTCCACTTCA CTTAAGACAA CAATATCGTA TTAGAGTCCG TTATGCTTCT 120 ACAACAAATA TTCGATTGAG TGTGAATGGC AGTTTCGGTA CTATTTCTCA AAATCTCCCT 180 AGTACAATGA GATTAGGAGA GGATTTAAGA TACGGATCTT TTGCTATAAG AGAGTTTAAT 240 ACTTCTATTA GACCCACTGC AAGTCCGGAC CAAATTCGAT TGACAATAGA ACCATCTTTT 300 ATTAGACAAG AGGTCTATGT AGATAGAATT GAGTTCATTC CAGTTAATCC GACGCGAGAG 360 GCGAAAGAGG ATCTAGAAGC AGCAAAAAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO: 51: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 51: Pro Gly Phe Thr Gly Gly Asp He Leu Arg Arg Thr Gly Val Gly Thr 1 5 10 15 Phe Gly Thr He Arg Val Arg Thr Thr Ala Pro Leu Thr Gin Arg Tyr 20 25 30 Arg He Arg Phe Arg Phe Ala Ser Thr Thr Asn Leu Phe He Gly He 35 40 45 Arg Val Gly Asp Arg Gin Val Asn Tyr Phe Asp Phe Gly Arg Thr Met 50 55 60 Asn Arg Gly Asp Glu Leu Arg Tyr Glu Ser Phe Ala Thr Arg Glu Phe 65 70 75 80 Thr Thr Asp Phe Asn Phe Arg Gin Pro Gin Glu Leu He Ser Val Phe 85 90 95 Ala Asn Ala Phe Ser Ala Gly Gin Glu Val Tyr Phe Asp Arg He Glu 100 105 110 He He Pro Val Asn Pro Ala Arg Glu Ala Lys Glu Asp Leu Glu Ala 115 120 125 Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO:52: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 412 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 52: CCAGGTTTTA CAGGAGGGGA TATACTCCGA AGAACAGGGG TTGGTACATT TGGAACAATA 60 AGGGTAAGGA CTACTGCCCC CTTAACACAA AGATATCGCA TAAGATTCCG TTTCGCTTCT 120 ACCACAAATT TGTTCATTGG TATAAGAGTT GGTGATAGAC AAGTAAATTA TTTTGACTTC 180 GGAAGAACAA TGAACAGAGG AGATGAATTA AGGTACGAAT CTTTTGCTAC AAGGGAGTTT 240 ACTACTGATT TTAATTTTAG ACAACCTCAA GAATTAATCT CAGTGTTTGC AAATGCATTT 300 AGCGCTGGTC AAGAAGTTTA TTTTGATAGA ATTGAGATTA TCCCCGTTAA TCCCGCACGA 360 GAGGCGAAAG AGGATCTAGA AGCAGCAAAG AAAGCGGTGG CGAGCTTGTT TA 412 (2) INFORMATION FOR SEQ ID NO:53: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 53: Pro Gly Phe Thr Gly Gly Asp Val He Arg Arg Thr Asn Thr Gly Gly 5 10 15 Phe Gly Ala He Arg Val Ser Val Thr Gly Pro Leu Thr Gin Arg Tyr 20 25 30 Arg He Arg Phe Arg Tyr Ala Ser Thr He Asp Phe Asp Phe Phe Val 35 40 45 Thr Arg Gly Gly Thr Thr He Asn Asn Phe Arg Phe Thr Arg Thr Met 50 55 60 Asn Arg Gly Gin Glu Ser Arg Tyr Glu Ser Tyr Arg Thr Val Glu Phe 65 70 75 80 Thr Thr Pro Phe Asn Phe Thr Gin Ser Gin Asp He He Arg Thr Ser 85 90 95 He Gin Gly Leu Ser Gly Asn Gly Glu Val Tyr Leu Asp Arg He Glu 100 105 110 He He Pro Val Asn Pro Thr Arg Glu Ala Glu Glu Asp Xaa Glu Ala 115 120 125 Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 54: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairε (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 54: CCAGGATTTA CAGGAGGAGA TGTAATCCGA AGAACAAATA CTGGTGGATT CGGAGCAATA 60 AGGGTGTCGG TCACTGGACC GCTAACACAA CGATATCGCA TAAGGTTCCG TTATGCTTCG 120 ACAATAGATT TTGATTTCTT TGTAACACGT GGAGGAACTA CTATAAATAA TTTTAGATTT 180 ACACGTACAA TGAACAGGGG ACAGGAATCA AGATATGAAT CCTATCGTAC TGTAGAGTTT 240 ACAACTCCTT TTAACTTTAC ACAAAGTCAA GATATAATTC GAACATCTAT CCAGGGACTT 300 AGTGGAAATG GGGAAGTATA CCTTGATAGA ATTGAAATCA TCCCTGTAAA TCCAACACGA 360 GAAGCGGAAG AGGATTTWGA AGCGGCGAAG AAAGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 55: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 55: Pro Gly Phe He Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser 1 5 10 15 Leu Gly Val Leu Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr 20 25 30 Arg He Arg Val Arg Tyr Ala Ser Thr Thr Asn He Arg Leu Ser Val 35 40 45 Asn Gly Ser Phe Gly Thr He Ser Gin Asn Leu Pro Ser Thr Met Arg 50 55 60 Leu Gly Glu Asp Leu Arg Tyr Gly Ser Phe Ala He Arg Glu Phe Asn 65 70 75 80 Thr Ser He Arg Pro Thr Ala Ser Pro Asp Gin He Arg Leu Thr He 85 90 95 Glu Pro Ser Phe He Arg Gin Glu Val Tyr Val Asp Arg He Glu Phe 100 105 110 He Pro Val Asn Pro Thr Arg Glu Ala Lys Xaa Asp Leu Xaa Ala Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 56: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 56: CCAGGATTTA TAGGAGGAGC TCTACTTCAA AGGACTGACC ATGGTTCGCT TGGAGTATTG 60 AGGGTCCAAT TTCCACTTCA CTTAAGACAA CAATATCGTA TTAGAGTCCG TTATGCTTCT 120 ACAACAAATA TTCGATTGAG TGTGAATGGC AGTTTCGGTA CTATTTCTCA AAATCTCCCT 180 AGTACAATGA GATTAGGAGA GGATTTAAGA TACGGATCTT TTGCTATAAG AGAGTTTAAT 240 ACTTCTATTA GACCCACTGC AAGTCCGGAC CAAATTCGAT TGACAATAGA ACCATCTTTT 300 ATTAGACAAG AGGTCTATGT AGATAGAATT GAGTTCATTC CAGTTAATCC GACGCGAGAG 360 GCGAAAGAKG ATCTABAAGC AGCAAAAAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO: 57: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 57: Pro Gly Phe Thr Gly Gly Asp Val He Arg Arg Thr Asn Thr Gly Gly 1 5 10 15 Phe Gly Ala He Arg Val Ser Val Thr Gly Pro Leu Thr Gin Arg Tyr 20 25 30 Arg He Arg Phe Arg Tyr Ala Ser Thr He Asp Phe Asp Phe Phe Val 35 40 45 Thr Arg Gly Gly Thr Thr He Asn Asn Phe Arg Phe Thr Arg Thr Met 50 55 60 Asn Arg Gly Gin Glu Ser Arg Tyr Glu Ser Tyr Arg Thr Val Glu Phe 65 70 75 80 Thr Thr Pro Phe Asn Phe Thr Gin Ser Gin Asp He He Arg Thr Ser 85 90 95 He Gin Gly Leu Ser Gly Asn Gly Glu Val Tyr Leu Asp Arg He Glu 100 105 110 He He Pro Val Asn Pro Thr Arg Glu Ala Glu Glu Asp Leu Glu Ala 115 120 125 Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO: 58: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 413 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 58: CCAGGWTTTA CAGGAGGAGA TGTAATCCGA AGAACAAATA CTGGTGGATT CGGAGCAATA 60 AGGGTGTCGG TCACTGGACC GCTAACACAA CGATATCGCA TAAGGTTCCG TTATGCTTCG 120 ACAATAGATT TTGATTTCTT TGTAACACGT GGAGGAACTA CTATAAATAA TTTTAGATTT 180 ACACGTACAA TGAACAGGGG ACAGGAATCA AGATATGAAT CCTATCGTAC TGTAGAGTTT 240 ACAACTCCTT TTAACTTTAC ACAAAGTCAA GATATAATTC GAACATCTAT CCAGGGACTT 300 AGTGGAAATG GGGAAGTATA CCTTGATAGA ATTGAAATCA TCCCTGTAAA TCCAACACGA 360 GAAGCGGAAG AGGATTTAGA AGCGGCGAAG AAAGCGGTGG CGAGCTTGTT TAC 413 (2) INFORMATION FOR SEQ ID NO: 59: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 142 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 59: Pro Gly Phe Xaa Gly Gly Gly He Leu Arg Arg Thr Thr Asn Gly Thr 1 5 10 15 Phe Gly Thr Leu Arg Val Thr Val Asn Ser Pro Leu Thr Gin Arg Tyr 20 25 30 Arg Val Arg Val Arg Phe Ala Ser Ser Gly Asn Phe Ser He Arg He 35 40 45 Leu Arg Gly Asn Thr Ser He Ala Tyr Gin Arg Phe Gly Ser Thr Met 50 55 60 Asn Arg Gly Gin Glu Leu Thr Tyr Glu Ser Phe Val Thr Ser Glu Phe 65 70 75 80 Thr Thr Asn Gin Ser Asp Leu Pro Phe Thr Phe Thr Gin Ala Gin Glu 85 90 95 Asn Leu Thr He Leu Ala Glu Gly Val Ser Thr Gly Ser Glu Tyr Phe 100 105 110 He Asp Arg He Glu He He Pro Val Asn Pro Ala Arg Glu Ala Glu 115 120 125 Glu Asp Leu Glu Ala Ala Lys Lys Ala Val Ala Ser Leu Phe 130 135 140 (2) INFORMATION FOR SEQ ID NO: 60: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 428 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 60: CCAGGWTTTA YAGGAGGGGG TATACTCCGA AGAACAACTA ATGGCACATT TGGAACGTTA 60 AGAGTAACAG TTAATTCACC ATTAACACAA AGATATCGCG TAAGAGTTCG TTTTGCTTCA 120 TCAGGAAATT TCAGCATAAG GATACTGCGT GGAAATACCT CTATAGCTTA TCAAAGATTT 180 GGGAGTACAA TGAACAGAGG ACAGGAACTA ACTTACGAAT CATTTGTCAC AAGTGAGTTC 240 ACTACTAATC AGAGCGATCT GCCTTTTACA TTTACACAAG CTCAAGAAAA TTTAACAATC 300 CTTGCAGAAG GTGTTAGCAC CGGTAGTGAA TATTTTATAG ATAGAATTGA AATCATCCCT 360 GTGAACCCGG CACGAGAAGC AGAAGAGGAT TTAGAAGCAG CGAAGAAAGC GGTGGCGAGC 420 TTGTTTAC 428 (2) INFORMATION FOR SEQ ID NO: 61: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 136 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 61: Pro Gly Phe He Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser 1 5 10 15 Leu Gly Val Leu Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr 20 25 30 Arg He Arg Val Arg Tyr Ala Ser Thr Thr Asn He Arg Leu Ser Val 35 40 45 Asn Gly Ser Phe Gly Thr He Ser Gin Asn Leu Pro Ser Thr Met Arg 50 55 60 Leu Gly Glu Asp Leu Arg Tyr Gly Ser Phe Ala He Arg Glu Phe Asn 65 70 75 80 Thr Ser He Arg Pro Thr Ala Ser Pro Asp Gin He Arg Leu Thr He 85 90 95 Glu Pro Ser Phe He Arg Gin Glu Val Tyr Val Asp Arg He Glu Phe 100 105 110 He Pro Val Asn Pro Thr Arg Glu Ala Lys Glu Asp Leu Glu Ala Ala 115 120 125 Lys Lys Ala Val Ala Ser Leu Phe 130 135 (2) INFORMATION FOR SEQ ID NO:62: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 410 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 62: CCAGGTTTTA TAGGAGGAGC TCTACTTCAA AGGACTGACC ATGGTTCGCT TGGAGTATTG 60 AGGGTCCAAT TTCCACTTCA CTTAAGACAA CAATATCGTA TTAGAGTCCG TTATGCTTCT 120 ACAACAAATA TTCGATTGAG TGTGAATGGC AGTTTCGGTA CTATTTCTCA AAATCTCCCT 180 AGTACAATGA GATTAGGAGA GGATTTAAGA TACGGATCTT TTGCTATAAG AGAGTTTAAT 240 ACTTCTATTA GACCCACTGC AAGTCCGGAC CAAATTCGAT TGACAATAGA ACCATCTTTT 300 ATTAGACAAG AGGTCTATGT AGATAGAATT GAGTTCATTC CAGTTAATCC GACGCGAGAG 360 GCGAAAGAGG ATCTAGAAGC AGCAAAAAAA GCGGTGGCGA GCTTGTTTAC 410 (2) INFORMATION FOR SEQ ID NO : 63 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 63: GTTCATTGGT ATAAGAGTTG GTG 23 (2) INFORMATION FOR SEQ ID NO: 64: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 64: CCACTGCAAG TCCGGACCAA ATTCG 25 (2) INFORMATION FOR SEQ ID NO: 65: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 65: GAATATATTC CCGTCYATCT CTGG 24 (2) INFORMATION FOR SEQ ID NO: 66: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 66: GCACGAATTA CTGTAGCGAT AGG 23 (2) INFORMATION FOR SEQ ID NO : 67 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 67: GCTGGTAACT TTGGAGATAT GCGTG 25 (2) INFORMATION FOR SEQ ID NO: 68: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:68: GATTTCTTTG TAACACGTGG AGG 23 (2) INFORMATION FOR SEQ ID NO: 69: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 69: CACTACTAAT CAGAGCGATC TG 22 (2) INFORMATION FOR SEQ ID NO: 70: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1156 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:70: Met Asn Gin Aεn Lys His Gly He He Gly Ala Ser Asn Cys Gly Cys 1 5 10 15 Ala Ser Asp Asp Val Ala Lys Tyr Pro Leu Ala Asn Asn Pro Tyr Ser 20 25 30 Ser Ala Leu Asn Leu Asn Ser Cys Gin Aεn Ser Ser He Leu Asn Trp 35 40 45 He Asn He He Gly Asp Ala Ala Lys Glu Ala Val Ser He Gly Thr 50 55 60 Thr He Val Ser Leu He Thr Ala Pro Ser Leu Thr Gly Leu He Ser 65 70 75 80 He Val Tyr Asp Leu He Gly Lys Val Leu Gly Gly Ser Ser Gly Gin 85 90 95 Ser He Ser Asp Leu Ser He Cys Asp Leu Leu Ser He He Asp Leu 100 105 110 Arg Val Ser Gin Ser Val Leu Asn Asp Gly He Ala Asp Phe Asn Gly 115 120 125 Ser Val Leu Leu Tyr Arg Asn Tyr Leu Glu Ala Leu Asp Ser Trp Asn 130 135 140 Lys Asn Pro Asn Ser Ala Ser Ala Glu Glu Leu Arg Thr Arg Phe Arg 145 150 155 160 He Ala Asp Ser Glu Phe Asp Arg He Leu Thr Arg Gly Ser Leu Thr 165 170 175 Asn Gly Gly Ser Leu Ala Arg Gin Asn Ala Gin He Leu Leu Leu Pro 180 185 190 Ser Phe Ala Ser Ala Ala Phe Phe His Leu Leu Leu Leu Arg Asp Ala 195 200 205 Thr Arg Tyr Gly Thr Asn Trp Gly Leu Tyr Asn Ala Thr Pro Phe He 210 215 220 Asn Tyr Gin Ser Lys Leu Val Glu Leu He Glu Leu Tyr Thr Asp Tyr 225 230 235 240 Cys Val His Trp Tyr Asn Arg Gly Phe Asn Glu Leu Arg Gin Arg Gly 245 250 255 Thr Ser Ala Thr Ala Trp Leu Glu Phe His Arg Tyr Arg Arg Glu Met 260 265 270 Thr Leu Met Val Leu Asp He Val Ala Ser Phe Ser Ser Leu Asp He 275 280 285 Thr Aεn Tyr Pro He Glu Thr Aεp Phe Gin Leu Ser Arg Val He Tyr 290 295 300 Thr Aεp Pro He Gly Phe Val His Arg Ser Ser Leu Arg Gly Glu Ser 305 310 315 320 Trp Phe Ser Phe Val Asn Arg Ala Asn Phe Ser Asp Leu Glu Asn Ala 325 330 335 He Pro Asn Pro Arg Pro Ser Trp Phe Leu Asn Asn Met He He Ser 340 345 350 Thr Gly Ser Leu Thr Leu Pro Val Ser Pro Ser Thr Asp Arg Ala Arg 355 360 365 Val Trp Tyr Gly Ser Arg Asp Arg He Ser Pro Ala Asn Ser Gin Phe 370 375 380 He Thr Glu Leu He Ser Gly Gin His Thr Thr Ala Thr Gin Thr He 385 390 395 400 Leu Gly Arg Asn He Phe Arg Val Asp Ser Gin Ala Cys Asn Leu Asn 405 410 415 Asp Thr Thr Tyr Gly Val Asn Arg Ala Val Phe Tyr His Asp Ala Ser 420 425 430 Glu Gly Ser Gin Arg Ser Val Tyr Glu Gly Tyr He Arg Thr Thr Gly 435 440 445 He Asp Asn Pro Arg Val Gin Aεn He Asn Thr Tyr Leu Pro Gly Glu 450 455 460 Asn Ser Asp He Pro Thr Pro Glu Asp Tyr Thr His He Leu Ser Thr 465 470 475 480 Thr He Asn Leu Thr Gly Gly Leu Arg Gin Val Ala Ser Asn Arg Arg 485 490 495 Ser Ser Leu Val Met Tyr Gly Trp Thr His Lys Ser Leu Ala Arg Asn 500 505 510 Asn Thr He Asn Pro Asp Arg He Thr Gin He Pro Leu Thr Lys Val 515 520 525 Asp Thr Arg Gly Thr Gly Val Ser Tyr Val Asn Asp Pro Gly Phe He 530 535 540 Gly Gly Ala Leu Leu Gin Arg Thr Asp His Gly Ser Leu Gly Val Leu 545 550 555 560 Arg Val Gin Phe Pro Leu His Leu Arg Gin Gin Tyr Arg He Arg Val 565 570 575 Arg Tyr Ala Ser Thr Thr Asn He Arg Leu Ser Val Asn Gly Ser Phe 580 585 590 Gly Thr He Ser Gin Asn Leu Pro Ser Thr Met Arg Leu Gly Glu Asp 595 600 605 Leu Arg Tyr Gly Ser Phe Ala He Arg Glu Phe Asn Thr Ser He Arg 610 615 620 Pro Thr Ala Ser Pro Asp Gin He Arg Leu Thr He Glu Pro Ser Phe 625 630 635 640 He Arg Gin Glu Val Tyr Val Asp Arg He Glu Phe He Pro Val Asn 645 650 655 Pro Thr Arg Glu Ala Lys Glu Asp Leu Glu Ala Ala Lys Lys Ala Val 660 665 670 Ala Ser Leu Phe Thr Arg Thr Arg Asp Gly Leu Gin Val Asn Val Lys 675 680 685 Asp Tyr Gin Val Asp Gin Ala Ala Asn Leu Val Ser Cys Leu Ser Asp 690 695 700 Glu Gin Tyr Gly Tyr Asp Lys Lyε Met Leu Leu Glu Ala Val Arg Ala 705 710 715 720 Ala Lys Arg Leu Ser Arg Glu Arg Aεn Leu Leu Gin Asp Pro Asp Phe 725 730 735 Asn Thr He Asn Ser Thr Glu Glu Asn Gly Trp Lys Ala Ser Asn Gly 740 745 750 Val Thr He Ser Glu Gly Gly Pro Phe Tyr Lys Gly Arg Ala He Gin 755 760 765 Leu Ala Ser Ala Arg Glu Asn Tyr Pro Thr Tyr He Tyr Gin Lys Val 770 775 780 Asp Ala Ser Glu Leu Lys Pro Tyr Thr Arg Tyr Arg Leu Asp Gly Phe 785 790 795 800 Val Lys Ser Ser Gin Asp Leu Glu He Asp Leu He His His His Lys 805 810 815 Val His Leu Val Lys Asn Val Pro Aεp Aεn Leu Val Ser Aεp Thr Tyr 820 825 830 Pro Asp Asp Ser Cys Ser Gly He Asn Arg Cys Gin Glu Gin Gin Met 835 840 845 Val Asn Ala Gin Leu Glu Thr Glu His His His Pro Met Asp Cys Cys 850 855 860 Glu Ala Ala Gin Thr His Glu Phe Ser Ser Tyr He Asp Thr Gly Asp 865 870 875 880 Leu Asn Ser Ser Val Asp Gin Gly He Trp Ala He Phe Lys Val Arg 885 890 895 Thr Thr Aεp Gly Tyr Ala Thr Leu Gly Asn Leu Glu Leu Val Glu Val 900 905 910 Gly Pro Leu Ser Gly Glu Ser Leu Glu Arg Glu Gin Arg Asp Asn Thr 915 920 925 Lys Trp Ser Ala Glu Leu Gly Arg Lys Arg Ala Glu Thr Asp Arg Val 930 935 940 Tyr Gin Asp Ala Lys Gin Ser He Asn His Leu Phe Val Asp Tyr Gin 945 950 955 960 Asp Gin Gin Leu Asn Pro Glu He Gly Met Ala Asp He Met Asp Ala 965 970 975 Gin Asn Leu Val Ala Ser He Ser Asp Val Tyr Ser Asp Ala Val Leu 980 985 990 Gin He Pro Gly He Asn Tyr Glu He Tyr Thr Glu Leu Ser Asn Arg 995 1000 1005 Leu Gin Gin Ala Ser Tyr Leu Tyr Thr Ser Arg Asn Ala Val Gin Asn 1010 1015 1020 Gly Asp Phe Asn Asn Gly Leu Asp Ser Trp Asn Ala Thr Ala Gly Ala 1025 1030 1035 1040 Ser Val Gin Gin Asp Gly Asn Thr His Phe Leu Val Leu Ser His Trp 1045 1050 1055 Aεp Ala Gin Val Ser Gin Gin Phe Arg Val Gin Pro Asn Cys Lys Tyr 1060 1065 1070 Val Leu Arg Val Thr Ala Glu Lys Val Gly Gly Gly Asp Gly Tyr Val 1075 1080 1085 Thr He Arg Asp Asp Ala His His Thr Glu Thr Leu Thr Phe Aεn Ala 1090 1095 1100 Cys Aεp Tyr Aεp He Asn Gly Thr Tyr Val Thr Asp Asn Thr Tyr Leu 1105 1110 1115 1120 Thr Lys Glu Val Val Phe His Pro Glu Thr Gin His Met Trp Val Glu 1125 1130 1135 Val Asn Glu Thr Glu Gly Ala Phe His He Asp Ser He Glu Phe Val 1140 1145 1150 Glu Thr Glu Lys 1155 (2) INFORMATION FOR SEQ ID NO: 71: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3471 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 71: ATGAATCAAA ATAAACACGG AATTATTGGC GCTTCCAATT GTGGTTGTGC ATCTGATGAT 60 GTTGCGAAAT ATCCTTTAGC CAACAATCCA TATTCATCTG CTTTAAATTT AAATTCTTGT 120 CAAAATAGTA GTATTCTCAA CTGGATTAAC ATAATAGGCG ATGCAGCAAA AGAAGCAGTA 180 TCTATTGGGA CAACCATAGT CTCTCTTATC ACAGCACCTT CTCTTACTGG ATTAATTTCA 240 ATAGTATATG ACCTTATAGG TAAAGTACTA GGAGGTAGTA GTGGACAATC CATATCAGAT 300 TTGTCTATAT GTGACTTATT ATCTATTATT GATTTACGGG TAAGTCAGAG TGTTTTAAAT 360 GATGGGATTG CAGATTTTAA TGGTTCTGTA CTCTTATACA GGAACTATTT AGAGGCTCTG 420 GATAGCTGGA ATAAGAATCC TAATTCTGCT TCTGCTGAAG AACTCCGTAC TCGTTTTAGA 480 ATCGCCGACT CAGAATTTGA TAGAATTTTA ACCCGAGGGT CTTTAACGAA TGGTGGCTCG 540 TTAGCTAGAC AAAATGCCCA AATATTATTA TTACCTTCTT TTGCGAGCGC TGCATTTTTC 600 CATTTATTAC TACTAAGGGA TGCTACTAGA TATGGCACTA ATTGGGGGCT ATACAATGCT 660 ACACCTTTTA TAAATTATCA ATCAAAACTA GTAGAGCTTA TTGAACTATA TACTGATTAT 720 TGCGTACATT GGTATAATCG AGGTTTCAAC GAACTAAGAC AACGAGGCAC TAGTGCTACA 780 GCTTGGTTAG AATTTCATAG ATATCGTAGA GAGATGACAT TGATGGTATT AGATATAGTA 840 GCATCATTTT CAAGTCTTGA TATTACTAAT TACCCAATAG AAACAGATTT TCAGTTGAGT 900 AGGGTCATTT ATACAGATCC AATTGGTTTT GTACATCGTA GTAGTCTTAG GGGAGAAAGT 960 TGGTTTAGCT TTGTTAATAG AGCTAATTTC TCAGATTTAG AAAATGCAAT ACCTAATCCT 1020 AGACCGTCTT GGTTTTTAAA TAATATGATT ATATCTACTG GTTCACTTAC ATTGCCGGTT 1080 AGCCCAAGTA CTGATAGAGC GAGGGTATGG TATGGAAGTC GAGATCGAAT TTCCCCTGCT 1140 AATTCACAAT TTATTACTGA ACTAATCTCT GGACAACATA CGACTGCTAC ACAAACTATT 1200 TTAGGGCGAA ATATATTTAG AGTAGATTCT CAAGCTTGTA ATTTAAATGA TACCACATAT 1260 GGAGTGAATA GGGCGGTATT TTATCATGAT GCGAGTGAAG GTTCTCAAAG ATCCGTGTAC 1320 GAGGGGTATA TTCGAACAAC TGGGATAGAT AACCCTAGAG TTCAAAATAT TAACACTTAT 1380 TTACCTGGAG AAAATTCAGA TATCCCAACT CCAGAAGACT ATACTCATAT ATTAAGCACA 1440 ACAATAAATT TAACAGGAGG ACTTAGACAA GTAGCATCTA ATCGCCGTTC ATCTTTAGTA 1500 ATGTATGGTT GGACACATAA AAGTCTGGCT CGTAACAATA CCATTAATCC AGATAGAATT 1560 ACACAGATAC CATTGACGAA GGTTGATACC CGAGGCACAG GTGTTTCTTA TGTGAATGAT 1620 CCAGGATTTA TAGGAGGAGC TCTACTTCAA AGGACTGACC ATGGTTCGCT TGGAGTATTG 1680 AGGGTCCAAT TTCCACTTCA CTTAAGACAA CAATATCGTA TTAGAGTCCG TTATGCTTCT 1740 ACAACAAATA TTCGATTGAG TGTGAATGGC AGTTTCGGTA CTATTTCTCA AAATCTCCCT 1800 AGTACAATGA GATTAGGAGA GGATTTAAGA TACGGATCTT TTGCTATAAG AGAGTTTAAT 1360 ACTTCTATTA GACCCACTGC AAGTCCGGAC CAAATTCGAT TGACAATAGA ACCATCTTTT 1920 ATTAGACAAG AGGTCTATGT AGATAGAATT GAGTTCATTC CAGTTAATCC GACGCGAGAG 1980 GCGAAAGAGG ATCTAGAAGC AGCAAAAAAA GCGGTGGCGA GCTTGTTTAC ACGCACAAGG 2040 GACGGATTAC AAGTAAATGT GAAAGATTAT CAAGTCGATC AAGCGGCAAA TTTAGTGTCA 2100 TGCTTATCAG ATGAACAATA TGGGTATGAC AAAAAGATGT TATTGGAAGC GGTACGTGCG 2160 GCAAAACGAC TTAGCCGAGA ACGCAACTTA CTTCAGGATC CAGATTTTAA TACAATCAAT 2220 AGTACAGAAG AAAATGGATG GAAAGCAAGT AACGGCGTTA CTATTAGTGA GGGCGGGCCA 2280 TTCTATAAAG GCCGTGCAAT TCAGCTAGCA AGTGCACGAG AAAATTACCC AACATACATC 2340 TATCAAAAAG TAGATGCATC GGAGTTAAAG CCGTATACAC GTTATAGACT GGATGGGTTC 2400 GTGAAGAGTA GTCAAGATTT AGAAATTGAT CTCATTCACC ATCATAAAGT CCATCTTGTG 2460 AAAAATGTAC CAGATAATTT AGTATCTGAT ACTTACCCAG ATGATTCTTG TAGTGGAATC 2520 AATCGATGTC AGGAACAACA GATGGTAAAT GCGCAACTGG AAACAGAGCA TCATCATCCG 2580 ATGGATTGCT GTGAAGCAGC TCAAACACAT GAGTTTTCTT CCTATATTGA TACAGGGGAT 2640 TTAAATTCGA GTGTAGACCA GGGAATCTGG GCGATCTTTA AAGTTCGAAC AACCGATGGT 2700 TATGCGACGT TAGGAAATCT TGAATTGGTA GAGGTCGGAC CGTTATCGGG TGAATCTTTA 2760 GAACGTGAAC AAAGGGATAA TACAAAATGG AGTGCAGAGC TAGGAAGAAA GCGTGCAGAA 2820 ACAGATCGCG TGTATCAAGA TGCCAAACAA TCCATCAATC ATTTATTTGT GGATTATCAA 2880 GATCAACAAT TAAATCCAGA AATAGGGATG GCAGATATTA TGGACGCTCA AAATCTTGTC 2940 GCATCAATTT CAGATGTATA TAGCGATGCC GTACTGCAAA TCCCTGGAAT TAACTATGAG 3000 ATTTACACAG AGCTGTCCAA TCGCTTACAA CAAGCATCGT ATCTGTATAC GTCTCGAAAT 3060 GCGGTGCAAA ATGGGGACTT TAACAACGGG CTAGATAGCT GGAATGCAAC AGCGGGTGCA 3120 TCGGTACAAC AGGATGGCAA TACGCATTTC TTAGTTCTTT CTCATTGGGA TGCACAAGTT 3180 TCTCAACAAT TTAGAGTGCA GCCGAATTGT AAATATGTAT TACGTGTAAC AGCAGAGAAA 3240 GTAGGCGGCG GAGACGGATA CGTGACTATC CGGGATGATG CTCATCATAC AGAAACGCTT 3300 ACATTTAATG CATGTGATTA TGATATAAAT GGCACGTACG TGACTGATAA TACGTATCTA 3360 ACAAAAGAAG TGGTATTCCA TCCGGAGACA CAACACATGT GGGTAGAGGT AAATGAAACA 3420 GAAGGTGCAT TTCATATAGA TAGTATTGAA TTCGTTGAAA CAGAAAAGTA A 3471 (2) INFORMATION FOR SEQ ID NO:72: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1156 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 72: Met Asn Arg Asn Asn Gin Aεn Glu Tyr Glu He He Asp Ala Pro His 1 5 10 15 Cys Gly Cys Pro Ser Asp Aεp Aεp Val Arg Tyr Pro Leu Ala Ser Aεp 20 25 30 Pro Asn Ala Ala Leu Gin Asn Met Asn Tyr Lys Asp Tyr Leu Gin Met 35 40 45 Thr Asp Glu Asp Tyr Thr Asp Ser Tyr He Asn Pro Ser Leu Ser He 50 55 60 Ser Gly Arg Asp Ala Val Gin Thr Ala Leu Thr Val Val Gly Arg He 65 70 75 80 Leu Gly Ala Leu Gly Val Pro Phe Ser Gly Gin He Val Ser Phe Tyr 85 90 95 Gin Phe Leu Leu Asn Thr Leu Trp Pro Val Asn Asp Thr Ala He Trp 100 105 110 Glu Ala Phe Met Arg Gin Val Glu Glu Leu Val Asn Gin Gin He Thr 115 120 125 Glu Phe Ala Arg Asn Gin Ala Leu Ala Arg Leu Gin Gly Leu Gly Asp 130 135 140 Ser Phe Asn Val Tyr Gin Arg Ser Leu Gin Asn Trp Leu Ala Asp Arg 145 150 155 160 Asn Asp Thr Arg Asn Leu Ser Val Val Arg Ala Gin Phe He Ala Leu 165 170 175 Asp Leu Asp Phe Val Asn Ala He Pro Leu Phe Ala Val Asn Gly Gin 180 185 190 Gin Val Pro Leu Leu Ser Val Tyr Ala Gin Ala Val Asn Leu His Leu 195 200 205 Leu Leu Leu Lys Asp Ala Ser Leu Phe Gly Glu Gly Trp Gly Phe Thr 210 215 220 Gin Gly Glu He Ser Thr Tyr Tyr Asp Arg Gin Leu Glu Leu Thr Ala 225 230 235 240 Lys Tyr Thr Asn Tyr Cys Glu Thr Trp Tyr Asn Thr Gly Leu Asp Arg 245 250 255 Leu Arg Gly Thr Asn Thr Glu Ser Trp Leu Arg Tyr His Gin Phe Arg 260 265 270 Arg Glu Met Thr Leu Val Val Leu Asp Val Val Ala Leu Phe Pro Tyr 275 280 285 Tyr Asp Val Arg Leu Tyr Pro Thr Gly Ser Asn Pro Gin Leu Thr Arg 290 295 300 Glu Val Tyr Thr Asp Pro He Val Phe Asn Pro Pro Ala Asn Val Gly 305 310 315 320 Leu Cys Arg Arg Trp Gly Thr Asn Pro Tyr Asn Thr Phe Ser Glu Leu 325 330 335 Glu Asn Ala Phe He Arg Pro Pro His Leu Phe Asp Arg Leu Asn Ser 340 345 350 Leu Thr He Ser Ser Asn Arg Phe Pro Val Ser Ser Asn Phe Met Asp 355 360 365 Tyr Trp Ser Gly His Thr Leu Arg Arg Ser Tyr Leu Asn Asp Ser Ala 370 375 380 Val Gin Glu Asp Ser Tyr Gly Leu He Thr Thr Thr Arg Ala Thr He 385 390 395 400 Asn Pro Gly Val Asp Gly Thr Asn Arg He Glu Ser Thr Ala Val Asp 405 410 415 Phe Arg Ser Ala Leu He Gly He Tyr Gly Val Asn Arg Ala Ser Phe 420 425 430 Val Pro Gly Gly Leu Phe Asn Gly Thr Thr Ser Pro Ala Asn Gly Gly 435 440 445 Cys Arg Asp Leu Tyr Asp Thr Asn Asp Glu Leu Pro Pro Aεp Glu Ser 450 455 460 Thr Gly Ser Ser Thr His Arg Leu Ser Hiε Val Thr Phe Phe Ser Phe 465 470 475 480 Gin Thr Asn Gin Ala Gly Ser He Ala Asn Ala Gly Ser Val Pro Thr 485 490 495 Tyr Val Trp Thr Arg Arg Asp Val Asp Leu Asn Asn Thr He Thr Pro 500 505 510 Asn Arg He Thr Gin Leu Pro Leu Val Lys Ala Ser Ala Pro Val Ser 515 520 525 Gly Thr Thr Val Leu Lys Gly Pro Gly Phe Thr Gly Gly Gly He Leu 530 535 540 Arg Arg Thr Thr Asn Gly Thr Phe Gly Thr Leu Arg Val Thr Val Asn 545 550 555 560 Ser Pro Leu Thr Gin Arg Tyr Arg Val Arg Val Arg Phe Ala Ser Ser 565 570 575 Gly Asn Phe Ser He Arg He Leu Arg Gly Asn Thr Ser He Ala Tyr 580 585 590 Gin Arg Phe Gly Ser Thr Met Asn Arg Gly Gin Glu Leu Thr Tyr Glu 595 600 605 Ser Phe Val Thr Ser Glu Phe Thr Thr Asn Gin Ser Asp Leu Pro Phe 610 615 620 Thr Phe Thr Gin Ala Gin Glu Asn Leu Thr He Leu Ala Glu Gly Val 625 630 635 640 Ser Thr Gly Ser Glu Tyr Phe He Asp Arg He Glu He He Pro Val 645 650 655 Asn Pro Ala Arg Glu Ala Glu Glu Asp Leu Glu Ala Ala Lys Lys Ala 660 665 670 Val Ala Asn Leu Phe Thr Arg Thr Arg Asp Gly Leu Gin Val Asn Val 675 680 685 Thr Asp Tyr Gin Val Asp Gin Ala Ala Asn Leu Val Ser Cys Leu Ser 690 695 700 Asp Glu Gin Tyr Gly His Asp Lys Lys Met Leu Leu Glu Ala Val Arg 705 710 715 720 Ala Ala Lys Arg Leu Ser Arg Glu Arg Asn Leu Leu Gin Asp Pro Asp 725 730 735 Phe Asn Thr He Asn Ser Thr Glu Glu Asn Gly Trp Lys Ala Ser Asn 740 745 750 Gly Val Thr He Ser Glu Gly Gly Pro Phe Phe Lys Gly Arg Ala Leu 755 760 765 Gin Leu Ala Ser Ala Arg Glu Aεn Tyr Pro Thr Tyr He Tyr Gin Lys 770 775 780 Val Asp Ala Ser Val Leu Lys Pro Tyr Thr Arg Tyr Arg Leu Asp Gly 785 790 795 800 Phe Val Lys Ser Ser Gin Asp Leu Glu He Asp Leu He His His His 805 810 815 Lys Val His Leu Val Lys Asn Val Pro Asp Asn Leu Val Ser Asp Thr 820 825 830 Tyr Ser Asp Gly Ser Cys Ser Gly He Asn Arg Cys Asp Glu Gin His 835 840 845 Gin Val Asp Met Gin Leu Asp Ala Glu His His Pro Met Asp Cys Cys 850 855 860 Glu Ala Ala Gin Thr His Glu Phe Ser Ser Tyr He Asn Thr Gly Asp 865 870 875 880 Leu Asn Ala Ser Val Asp Gin Gly He Trp Val Val Leu Lys Val Arg 885 890 895 Thr Thr Asp Gly Tyr Ala Thr Leu Gly Asn Leu Glu Leu Val Glu Val 900 905 910 Gly Pro Leu Ser Gly Glu Ser Leu Glu Arg Glu Gin Arg Asp Asn Ala 915 920 925 Lys Trp Asn Ala Glu Leu Gly Arg Lys Arg Ala Glu He Asp Arg Val 930 935 940 Tyr Leu Ala Ala Lys Gin Ala He Asn His Leu Phe Val Asp Tyr Gin 945 950 955 960 Asp Gin Gin Leu Asn Pro Glu He Gly Leu Ala Glu He Asn Glu Ala 965 970 975 Ser Aεn Leu Val Glu Ser He Ser Gly Val Tyr Ser Aεp Thr Leu Leu 980 985 990 Gin He Pro Gly He Aεn Tyr Glu He Tyr Thr Glu Leu Ser Asp Arg 995 1000 1005 Leu Gin Gin Ala Ser Tyr Leu Tyr Thr Ser Arg Asn Ala Val Gin Asn 1010 1015 1020 Gly Asp Phe Asn Ser Gly Leu Aεp Ser Trp Asn Thr Thr Met Asp Ala 1025 1030 1035 1040 Ser Val Gin Gin Asp Gly Asn Met His Phe Leu Val Leu Ser His Trp 1045 1050 1055 Asp Ala Gin Val Ser Gin Gin Leu Arg Val Asn Pro Asn Cys Lys Tyr 1060 1065 1070 Val Leu Arg Val Thr Ala Arg Lys Val Gly Gly Gly Asp Gly Tyr Val 1075 1080 1085 Thr He Arg Asp Gly Ala His His Gin Glu Thr Leu Thr Phe Asn Ala 1090 1095 1100 Cys Asp Tyr Asp Val Asn Gly Thr Tyr Val Asn Asp Asn Ser Tyr He 1105 1110 1115 1120 Thr Glu Glu Val Val Phe Tyr Pro Glu Thr Lys His Met Trp Val Glu 1125 1130 1135 Val Ser Glu Ser Glu Gly Ser Phe Tyr He Asp Ser He Glu Phe He 1140 1145 1150 Glu Thr Gin Glu 1155 (2) INFORMATION FOR SEQ ID NO: 73: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3471 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 73: ATGAATCGAA ATAATCAAAA TGAATATGAA ATTATTGATG CCCCCCATTG TGGGTGTCCA 60 TCAGATGACG ATGTGAGGTA TCCTTTGGCA AGTGACCCAA ATGCAGCGTT ACAAAATATG 120 AACTATAAAG ATTACTTACA AATGACAGAT GAGGACTACA CTGATTCTTA TATAAATCCT 180 AGTTTATCTA TTAGTGGTAG AGATGCAGTT CAGACTGCGC TTACTGTTGT TGGGAGAATA 240 CTCGGGGCTT TAGGTGTTCC GTTTTCTGGA CAAATAGTGA GTTTTTATCA ATTCCTTTTA 300 AATACACTGT GGCCAGTTAA TGATACAGCT ATATGGGAAG CTTTCATGCG ACAGGTGGAG 360 GAACTTGTCA ATCAACAAAT AACAGAATTT GCAAGAAATC AGGCACTTGC AAGATTGCAA 420 GGATTAGGAG ACTCTTTTAA TGTATATCAA CGTTCCCTTC AAAATTGGTT GGCTGATCGA 480 AATGATACAC GAAATTTAAG TGTTGTTCGT GCTCAATTTA TAGCTTTAGA CCTTGATTTT 540 GTTAATGCTA TTCCATTGTT TGCAGTAAAT GGACAGCAGG TTCCATTACT GTCAGTATAT 600 GCACAAGCTG TGAATTTACA TTTGTTATTA TTAAAAGATG CATCTCTTTT TGGAGAAGGA 660 TGGGGATTCA CACAGGGGGA AATTTCCACA TATTATGACC GTCAATTGGA ACTAACCGCT 720 AAGTACACTA ATTACTGTGA AACTTGGTAT AATACAGGTT TAGATCGTTT AAGAGGAACA 780 AATACTGAAA GTTGGTTAAG ATATCATCAA TTCCGTAGAG AAATGACTTT AGTGGTATTA 840 GATGTTGTGG CGCTATTTCC ATATTATGAT GTACGACTTT ATCCAACGGG ATCAAACCCA 900 CAGCTTACAC GTGAGGTATA TACAGATCCG ATTGTATTTA ATCCACCAGC TAATGTTGGA 960 CTTTGCCGAC GTTGGGGTAC TAATCCCTAT AATACTTTTT CTGAGCTCGA AAATGCCTTC 1020 ATTCGCCCAC CACATCTTTT TGATAGGCTG AATAGCTTAA CAATCAGCAG TAATCGATTT 1080 CCAGTTTCAT CTAATTTTAT GGATTATTGG TCAGGACATA CGTTACGCCG TAGTTATCTG 1140 AACGATTCAG CAGTACAAGA AGATAGTTAT GGCCTAATTA CAACCACAAG AGCAACAATT 1200 AATCCTGGAG TTGATGGAAC AAACCGCATA GAGTCAACGG CAGTAGATTT TCGTTCTGCA 1260 TTGATAGGTA TATATGGCGT GAATAGAGCT TCTTTTGTCC CAGGAGGCTT GTTTAATGGT 1320 ACGACTTCTC CTGCTAATGG AGCATGTAGA GATCTCTATG ATACAAATGA TGAATTACCA 1380 CCAGATGAAA GTACCGGAAG TTCTACCCAT AGACTATCTC ATGTTACCTT TTTTAGTTTT 1440 CAAACTAATC AGGCTGGATC TATAGCTAAT GCAGGAAGTG TACCTACTTA TGTTTGGACC 1500 CGTCGTGATG TGGACCTTAA TAATACGATT ACCCCAAATA GAATTACACA ATTACCATTG 1560 GTAAAGGCAT CTGCACCTGT TTCGGGTACT ACGGTCTTAA AAGGTCCAGG ATTTACAGGA 1620 GGGGGTATAC TCCGAAGAAC AACTAATGGC ACATTTGGAA CGTTAAGAGT AACAGTTAAT 1680 TCACCATTAA CACAAAGATA TCGCGTAAGA GTTCGTTTTG CTTCATCAGG AAATTTCAGC 1740 ATAAGGATAC TGCGTGGAAA TACCTCTATA GCTTATCAAA GATTTGGGAG TACAATGAAC 1800 AGAGGACAGG AACTAACTTA CGAATCATTT GTCACAAGTG AGTTCACTAC TAATCAGAGC 1860 GATCTGCCTT TTACATTTAC ACAAGCTCAA GAAAATTTAA CAATCCTTGC AGAAGGTGTT 1920 AGCACCGGTA GTGAATATTT TATAGATAGA ATTGAAATCA TCCCTGTGAA CCCGGCACGA 1980 GAAGCAGAAG AGGATTTAGA AGCAGCGAAG AAAGCGGTGG CGAACTTGTT TACACGTACA 2040 AGGGACGGAT TACAGGTAAA TGTGACAGAT TATCAAGTGG ACCAAGCGGC AAATTTAGTG 2100 TCATGCTTAT CCGATGAACA ATATGGGCAT GACAAAAAGA TGTTATTGGA AGCGGTAAGA 2160 GCGGCAAAAC GCCTCAGCCG CGAACGCAAC TTACTTCAAG ATCCAGATTT TAATACAATC 2220 AATAGTACAG AAGAGAATGG CTGGAAGGCA AGTAACGGTG TTACTATTAG CGAGGGCGGT 2280 CCATTCTTTA AAGGTCGTGC ACTTCAGTTA GCAAGCGCAA GAGAAAATTA TCCAACATAC 2340 ATTTATCAAA AAGTAGATGC ATCGGTGTTA AAGCCTTATA CACGCTATAG ACTAGATGGA 2400 TTTGTGAAGA GTAGTCAAGA TTTAGAAATT GATCTCATCC ACCATCATAA AGTCCATCTT 2460 GTAAAAAATG TACCAGATAA TTTAGTATCT GATACTTACT CAGATGGTTC TTGCAGCGGA 2520 ATCAACCGTT GTGATGAACA GCATCAGGTA GATATGCAGC TAGATGCGGA GCATCATCCA 2580 ATGGATTGCT GTGAAGCGGC TCAAACACAT GAGTTTTCTT CCTATATTAA TACAGGGGAT 2640 CTAAATGCAA GTGTAGATCA GGGCATTTGG GTTGTATTAA AAGTTCGAAC AACAGATGGG 2700 TATGCGACGT TAGGAAATCT TGAATTGGTA GAGGTTGGGC CATTATCGGG TGAATCTCTA 2760 GAACGGGAAC AAAGAGATAA TGCGAAATGG AATGCAGAGC TAGGAAGAAA ACGTGCAGAA 2820 ATAGATCGTG TGTATTTAGC TGCGAAACAA GCAATTAATC ATCTGTTTGT AGACTATCAA 2880 GATCAACAAT TAAATCCAGA AATTGGGCTA GCAGAAATTA ATGAAGCTTC AAATCTTGTA 2940 GAGTCAATTT CGGGTGTATA TAGTGATACA CTATTACAGA TTCCTGGGAT TAACTACGAA 3000 ATTTACACAG AGTTATCCGA TCGCTTACAA CAAGCATCGT ATCTGTATAC GTCTAOAAAT 3060 GCGGTGCAAA ATGGAGACTT TAACAGTGGT CTAGATAGTT GGAATACAAC TATGGATGCA 3120 TCGGTTCAGC AAGATGGCAA TATGCATTTC TTAGTTCTTT CGCATTGGGA TGCACAAGTT 3180 TCCCAACAAT TGAGAGTAAA TCCGAATTGT AAGTATGTCT TACGTGTGAC AGCAAGAAAA 3240 GTAGGAGGCG GAGATGGATA CGTCACAATC CGAGATGGCG CTCATCACCA AGAAACTCTT 3300 ACATTTAATG CATGTGACTA CGATGTAAAT GGTACGTATG TCAATGACAA TTCGTATATA 3360 ACAGAAGAAG TGGTATTCTA CCCAGAGACA AAACATATGT GGGTAGAGGT GAGTGAATCC 3420 GAAGGTTCAT TCTATATAGA CAGTATTGAG TTTATTGAAA CACAAGAGTA G 3471 (2) INFORMATION FOR SEQ ID NO: 74: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1150 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 74: Met Asn Arg Asn Asn Pro Asn Glu Tyr Glu He He Aεp Ala Pro Tyr 1 5 10 15 Cys Gly Cys Pro Ser Asp Asp Asp Val Arg Tyr Pro Leu Ala Ser Asp 20 25 30 Pro Asn Ala Ala Phe Gin Asn Met Asn Tyr Lys Glu Tyr Leu Gin Thr 35 40 45 Tyr Asp Gly Asp Tyr Thr Gly Ser Leu He Asn Pro Asn Leu Ser He 50 55 60 Asn Pro Arg Asp Val Leu Gin Thr Gly He Asn He Val Gly Arg He 65 70 75 80 Leu Gly Phe Leu Gly Val Pro Phe Ala Gly Gin Leu Val Thr Phe Tyr 85 90 95 Thr Phe Leu Leu Asn Gin Leu Trp Pro Thr Asn Asp Asn Ala Val Trp 100 105 110 Glu Ala Phe Met Ala Gin He Glu Glu Leu He Asp Gin Lys He Ser 115 120 125 Ala Gin Val Val Arg Asn Ala Leu Asp Asp Leu Thr Gly Leu His Asp 130 135 140 Tyr Tyr Glu Glu Tyr Leu Ala Ala Leu Glu Glu Trp Leu Glu Arg Pro 145 150 155 160 Asn Gly Ala Arg Ala Asn Leu Val Thr Gin Arg Phe Glu Asn Leu His 165 170 175 Thr Ala Phe Val Thr Arg Met Pro Ser Phe Gly Thr Gly Pro Gly Ser 180 185 190 Gin Arg Asp Ala Val Ala Leu Leu Thr Val Tyr Ala Gin Ala Ala Asn 195 200 205 Leu His Leu Leu Leu Leu Lys Asp Ala Glu He Tyr Gly Ala Arg Trp 210 215 220 Gly Leu Gin Gin Gly Gin He Asn Leu Tyr Phe Asn Ala Gin Gin Glu 225 230 235 240 Arg Thr Arg He Tyr Thr Asn His Cys Val Glu Thr Tyr Asn Arg Gly 245 250 255 Leu Glu Asp Val Arg Gly Thr Asn Thr Glu Ser Trp Leu Asn Tyr His 260 265 270 Arg Phe Arg Arg Glu Met Thr Leu Met Ala Met Asp Leu Val Ala Leu 275 280 285 Phe Pro Phe Tyr Asn Val Arg Gin Tyr Pro Asn Gly Ala Asn Pro Gin 290 295 300 Leu Thr Arg Glu He Tyr Thr Asp Pro He Val Tyr Asn Pro Pro Ala 305 310 315 320 Asn Gin Gly He Cys Arg Arg Trp Gly Asn Asn Pro Tyr Asn Thr Phe 325 330 335 Ser Glu Leu Glu Asn Ala Phe He Arg Pro Pro His Leu Phe Glu Arg 340 345 350 Leu Aεn Arg Leu Thr He Ser Arg Asn Arg Tyr Thr Ala Pro Thr Thr 355 360 365 Asn Ser Phe Leu Asp Tyr Trp Ser Gly His Thr Leu Gin Ser Gin His 370 375 380 Ala Asn Asn Pro Thr Thr Tyr Glu Thr Ser Tyr Gly Gin He Thr Ser 385 390 395 400 Asn Thr Arg Leu Phe Asn Thr Thr Asn Gly Ala Arg Ala He Asp Ser 405 410 415 Arg Ala Arg Asn Phe Gly Asn Leu Tyr Ala Asn Leu Tyr Gly Val Ser 420 425 430 Ser Leu Asn He Phe Pro Thr Gly Val Met Ser Glu He Thr Asn Ala 435 440 445 Ala Asn Thr Cys Arg Gin Asp Leu Thr Thr Thr Glu Glu Leu Pro Leu 450 455 460 Glu Asn Asn Asn Phe Asn Leu Leu Ser His Val Thr Phe Leu Arg Phe 465 470 475 480 Asn Thr Thr Gin Gly Gly Pro Leu Ala Thr Leu Gly Phe Val Pro Thr 485 490 495 Tyr Val Trp Thr Arg Glu Asp Val Asp Phe Thr Asn Thr He Thr Ala 500 505 510 Asp Arg He Thr Gin Leu Pro Trp Val Lys Ala Ser Glu He Gly Gly 515 520 525 Gly Thr Thr Val Val Lys Gly Pro Gly Phe Thr Gly Gly Asp He Leu 530 535 540 Arg Arg Thr Asp Gly Gly Ala Val Gly Thr He Arg Ala Asn Val Asn 545 550 555 560 Ala Pro Leu Thr Gin Gin Tyr Arg He Arg Leu Arg Tyr Ala Ser Thr 565 570 575 Thr Ser Phe Val Val Asn Leu Phe Val Asn Asn Ser Ala Ala Gly Phe 580 585 590 Thr Leu Pro Ser Thr Met Ala Gin Asn Gly Ser Leu Thr Tyr Glu Ser 595 600 605 Phe Asn Thr Leu Glu Val Thr His Thr He Arg Phe Ser Gin Ser Asp 610 615 620 Thr Thr Leu Arg Leu Asn He Phe Pro Ser He Ser Gly Gin Glu Val 625 630 635 640 Tyr Val Aεp Lyε Leu Glu He Val Pro He Asn Pro Thr Arg Glu Ala 645 650 655 Glu Glu Asp Leu Glu Asp Ala Lys Lys Ala Val Ala Ser Leu Phe Thr 660 665 670 Arg Thr Arg Asp Gly Leu Gin Val Asn Val Thr Asp Tyr Gin Val Asp 675 680 685 Gin Ala Ala Asn Leu Val Ser Cys Leu Ser Asp Glu Gin Tyr Gly His 690 695 700 Asp Lys Lys Met Leu Leu Glu Ala Val Arg Ala Ala Lys Arg Leu Ser 705 710 715 720 Arg Glu Arg Asn Leu Leu Gin Asp Pro Asp Phe Asn Glu He Asn Ser 725 730 735 Thr Glu Glu Asn Gly Trp Lys Ala Ser Asn Gly Val Thr He Ser Glu 740 745 750 Gly Gly Pro Phe Phe Lys Gly Arg Ala Leu Gin Leu Ala Ser Ala Arg 755 760 765 Glu Asn Tyr Pro Thr Tyr He Tyr Gin Lys Val Asp Ala Ser Thr Leu 770 775 780 Lys Pro Tyr Thr Arg Tyr Lys Leu Asp Gly Phe Val Gin Ser Ser Gin 785 790 795 800 Asp Leu Glu He Asp Leu He His His His Lys Val His Leu Val Lys 805 810 815 Asn Val Pro Asp Asn Leu Val Ser Asp Thr Tyr Ser Asp Gly Ser Cys 820 825 830 Ser Gly He Asn Arg Cys Glu Glu Gin His Gin Val Asp Val Gin Leu 835 840 845 Aεp Ala Glu Aεp His Pro Lys Aεp Cys Cys Glu Ala Ala Gin Thr His 850 855 860 Glu Phe Ser Ser Tyr He His Thr Gly Asp Leu Asn Ala Ser Val Asp 865 870 875 880 Gin Gly He Trp Val Val Leu Gin Val Arg Thr Thr Asp Gly Tyr Ala 8B5 890 895 Thr Leu Gly Asn Leu Glu Leu Val Glu Val Gly Pro Leu Ser Gly Glu 900 905 910 Ser Leu Glu Arg Glu Gin Arg Asp Asn Ala Lys Trp Asn Glu Glu Val 915 920 925 Gly Arg Lys Arg Ala Glu Thr Asp Arg He Tyr Gin Asp Ala Lys Gin 930 935 940 Ala He Asn His Leu Phe Val Asp Tyr Gin Asp Gin Gin Leu Ser Pro 945 950 955 960 Glu Val Gly Met Ala Asp He He Asp Ala Gin Asn Leu He Ala Ser 965 970 975 He Ser Asp Val Tyr Ser Asp Ala Val Leu Gin He Pro Gly He Asn 980 985 990 Tyr Glu Met Tyr Thr Glu Leu Ser Asn Arg Leu Gin Gin Ala Ser Tyr 995 1000 1005 Leu Tyr Thr Ser Arg Asn Val Val Gin Asn Gly Asp Phe Asn Ser Gly 1010 1015 1020 Leu Asp Ser Trp Asn Ala Thr Thr Asp Thr Ala Val Gin Gin Asp Gly 1025 1030 1035 1040 Asn Met His Phe Leu Val Leu Ser His Trp Asp Ala Gin Val Ser Gin 1045 1050 1055 Gin Phe Arg Val Gin Pro Asn Cys Lys Tyr Val Leu Arg Val Thr Ala 1060 1065 1070 Lys Lys Val Gly Asn Gly Asp Gly Tyr Val Thr He Gin Asp Gly Ala 1075 1080 1085 His His Arg Glu Thr Leu Thr Phe Asn Ala Cys Asp Tyr Asp Val Asn 1090 1095 1100 Gly Thr His Val Asn Asp Asn Ser Tyr He Thr Lys Glu Leu Val Phe 1105 1110 1115 1120 Tyr Pro Lys Thr Glu His Met Trp Val Glu Val Ser Glu Thr Glu Gly 1125 1130 1135 Thr Phe Tyr He Asp Ser He Glu Phe He Glu Thr Gin Glu 1140 1145 1150 (2) INFORMATION FOR SEQ ID NO:75: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3453 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 75: ATGAATCGAA ATAATCCAAA TGAATATGAA ATTATTGATG CCCCCTATTG TGGGTGTCCG .60 TCAGATGATG ATGTGAGGTA TCCTTTGGCA AGTGACCCAA ATGCAGCGTT CCAAAATATG 120 AACTATAAAG AGTATTTACA AACGTATGAT GGAGACTACA CAGGTTCTCT TATCAATCCT 180 AACTTATCTA TTAATCCTAG AGATGTACTA CAAACAGGTA TTAATATTGT GGGAAGAATA 240 CTAGGGTTTT TAGGTGTTCC ATTTGCGGGT CAACTAGTTA CTTTCTATAC CTTTCTCTTA 300 AATCAGTTGT GGCCAACTAA TGATAATGCA GTATGGGAAG CTTTTATGGC GCAAATAGAA 360 GAGCTAATCG ATCAAAAAAT ATCGGCGCAA GTAGTAAGGA ATGCACTCGA TGACTTAACT 420 GGATTACACG ATTATTATGA GGAGTATTTA GCAGCATTAG AGGAGTGGCT GGAAAGACCG 480 AACGGAGCAA GAGCTAACTT AGTTACACAG AGGTTTGAAA ACCTGCATAC TGCATTTGTA 540 ACTAGAATGC CAAGCTTTGG TACGGGTCCT GGTAGTCAAA GAGATGCGGT AGCGTTGTTG 600 ACGGTATATG CACAAGCAGC GAATTTGCAT TTGTTATTAT TAAAAGATGC AGAAATCTAT 660 GGGGCAAGAT GGGGACTTCA ACAAGGGCAA ATTAACTTAT ATTTTAATGC TCAACAAGAA 720 CGTACTCGAA TTTATACCAA TCATTGCGTG GAAACATATA ATAGAGGATT AGAAGATGTA 780 AGAGGAACAA ATACAGAAAG TTGGTTAAAT TACCATCGAT TCCGTAGAGA GATGACATTA 840 ATGGCAATGG ATTTAGTGGC CCTATTCCCA TTCTATAATG TGCGACAATA TCCAAATGGG 900 GCAAATCCAC AGCTTACACG TGAAATATAT ACAGATCCAA TCGTATATAA TCCACCAGCT 960 AATCAGGGAA TTTGCCGACG TTGGGGGAAT AATCCGTATA ATACATTTTC TGAACTTGAA 1020 AATGCTTTTA TTCGCCCGCC ACATCTTTTT GAAAGGTTGA ACAGATTAAC TATTTCTAGA 1080 AACCGATATA CAGCTCCAAC AACTAATAGC TTCCTAGACT ATTGGTCAGG TCATACTTTA 1140 CAAAGCCAAC ATGCAAATAA CCCGACGACA TATGAAACTA GTTACGGTCA GATTACCTCT 1200 AACACACGTT TATTCAATAC GACTAATGGA GCCCGTGCAA TAGATTCAAG GGCAAGAAAT 1260 TTTGGTAACT TATACGCTAA TTTGTATGGC GTTAGCAGCT TGAACATTTT CCCAACAGGT 1320 GTGATGAGTG AAATCACCAA TGCAGCTAAT ACGTGTCGGC AAGACCTTAC TACAACTGAA 1380 GAACTACCAC TAGAGAATAA TAATTTTAAT CTTTTATCTC ATGTTACTTT CTTACGCTTC 1440 AATACTACTC AGGGTGGCCC CCTTGCAACT CTAGGGTTTG TACCCACATA TGTGTGGACA 1500 CGTGAAGATG TAGATTTTAC GAACACAATT ACTGCGGATA GAATTACACA ACTACCATGG 1560 GTAAAGGCAT CTGAAATAGG TGGGGGTACT ACTGTCGTGA AAGGTCCAGG ATTTACAGGA 1620 GGGGATATAC TTCGAAGAAC GGACGGTGGT GCAGTTGGAA CGATTAGAGC TAATGTTAAT 1680 GCCCCATTAA CACAACAATA TCGTATAAGA TTACGCTATG CTTCGACAAC AAGTTTTGTT 1740 GTTAATTTAT TTGTTAATAA TAGTGCGGCT GGCTTTACTT TACCGAGTAC AATGGCTCAA 1800 AATGGTTCTT TAACATACGA GTCGTTTAAT ACCTTAGAGG TAACTCATAC TATTAGATTT 1860 TCACAGTCAG ATACTACACT TAGGTTGAAT ATATTCCCGT CTATCTCTGG TCAAGAAGTG 1920 TATGTAGATA AACTTGAAAT CGTTCCAATT AACCCGACAC GAGAAGCGGA AGAAGATTTA 1980 GAAGATGCAA AGAAAGCGGT GGCGAGCTTG TTTACACGTA CAAGGGATGG ATTACAGGTA 2040 AATGTGACAG ATTACCAAGT CGATCAGGCG GCAAATTTAG TGTCGTGCTT ATCAGATGAA 2100 CAATATGGGC ATGATAAAAA GATGTTATTG GAAGCCGTAC GCGCAGCAAA ACGCCTCAGC 2160 CGCGAACGCA ACTTACTTCA AGATCCAGAT TTTAATGAAA TAAATAGCAC AGAAGAAAAT 2220 GGCTGGAAGG CAAGTAACGG TGTTACTATT AGCGAGGGCG GTCCATTCTT TAAAGGTCGT 2280 GCACTTCAGT TAGCAAGCGC ACGTGAAAAT TACCCAACAT ACATCTATCA AAAGGTAGAT 2340 GCATCGACGT TAAAACCTTA TACACGATAT AAACTAGATG GATTTGTGCA AAGTAGTCAA 2400 GATTTAGAAA TTGACCTCAT TCATCATCAT AAAGTCCACC TCGTGAAAAA TGTACCAGAT 2460 AATTTAGTAT CTGATACTTA TTCTGATGGC TCATGTAGTG GAATTAACCG TTGTGAGGAA 2520 CAACATCAGG TAGATGTGCA GCTAGATGCG GAGGATCATC CAAAGGATTG TTGTGAAGCG 2580 GCTCAAACAC ATGAGTTTTC TTCCTATATT CATACAGGTG ATCTAAATGC AAGTGTAGAT 2640 CAAGGCATTT GGGTTGTATT GCAGGTTCGA ACAACAGATG GTTATGCGAC GTTAGGAAAT 2700 CTTGAATTGG TAGAGGTTGG TCCATTATCG GGTGAATCTT TAGAACGAGA ACAAAGAGAT 2760 AATGCGAAAT GGAATGAAGA GGTAGGAAGA AAGCGTGCAG AAACAGATCG CATATATCAA 2820 GATGCGAAAC AAGCAATTAA CCATCTATTT GTAGACTATC AAGATCAACA ATTAAGTCCA 2880 GAGGTAGGGA TGGCGGATAT TATTGATGCT CAAAATCTTA TCGCATCAAT TTCAGATGTA 2940 TATAGCGATG CAGTACTGCA AATCCCTGGG ATTAACTACG AGATGTATAC AGAGTTATCC 3000 AATCGATTAC AACAAGCATC GTATCTGTAT ACGTCTCGAA ATGTCGTGCA AAATGGGGAC 3060 TTTAACAGTG GTTTAGATAG TTGGAATGCA ACAACTGATA CAGCTGTTCA GCAGGATGGC 3120 AATATGCATT TCTTAGTTCT TTCCCATTGG GATGCACAAG TTTCTCAACA ATTTAGAGTA 3180 CAGCCGAATT GTAAATATGT GTTACGTGTG ACAGCGAAGA AAGTAGGGAA CGGAGATGGA 3240 TATGTTACGA TCCAAGATGG CGCTCATCAC CGAGAAACAC TGACATTCAA TGCATGTGAC 3300 TACGATGTAA ATGGTACGCA TGTAAATGAT AATTCGTATA TTACAAAAGA ATTGGTGTTC 3360 TATCCAAAGA CGGAACATAT GTGGGTAGAG GTAAGTGAAA CAGAAGGTAC CTTCTATATA 3420 GACAGCATTG AGTTCATTGA AACACAAGAG TAG 3453 (2) INFORMATION FOR SEQ ID NO: 76: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1134 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 76: Met Asp Asn Asn Pro Asn He Asn Glu Cys He Pro Tyr Aεn Cys Leu 1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Gly Asn Val Arg 20 25 30 Thr Gly Leu Gin Thr Gly He Asp He Val Ala Val Val Val Gly Ala 35 40 45 Leu Gly Gly Pro Val Gly Gly He Leu Thr Gly Phe Leu Ser Thr Leu 50 55 60 Phe Gly Phe Leu Trp Pro Ser Asn Asp Gin Ala Val Trp Glu Ala Phe 65 70 75 80 He Glu Gin Met Glu Glu Leu He Glu Gin Arg He Ser Asp Gin Val 85 90 95 Val Arg Thr Ala Leu Asp Asp Leu Thr Gly He Gin Asn Tyr Tyr Asn 100 105 110 Gin Tyr Leu He Ala Leu Lys Glu Trp Glu Glu Arg Pro Asn Gly Val 115 120 125 Arg Ala Asn Leu Val Leu Gin Arg Phe Glu He Leu His Ala Leu Phe 130 135 140 Val Ser Ser Met Pro Ser Phe Gly Ser Gly Pro Gly Ser Gin Arg Phe 145 150 155 160 Gin Ala Gin Leu Leu Val Val Tyr Ala Gin Ala Ala Asn Leu His Leu 165 170 175 Leu Leu Leu Ala Asp Ala Glu Lys Tyr Gly Ala Arg Trp Gly Leu Arg 180 185 190 Glu Ser Gin He Gly Asn Leu Tyr Phe Asn Glu Leu Gin Thr Arg Thr 195 200 205 Arg Asp Tyr Thr Asn His Cys Val Asn Ala Tyr Asn Asn Gly Leu Ala 210 215 220 Gly Leu Arg Gly Thr Ser Ala Glu Ser Trp Leu Lys Tyr His Gin Phe 225 230 235 240 Arg Arg Glu Ala Thr Leu Met Ala Met Asp Leu He Ala Leu Phe Pro 245 250 255 Tyr Tyr Asn Thr Arg Arg Tyr Pro He Ala Val Asn Pro Gin Leu Thr 260 265 270 Arg Glu Val Tyr Thr Asp Pro Leu Gly Val Pro Ser Glu Glu Ser Ser 275 280 285 Leu Phe Pro Glu Leu Arg Cys Leu Arg Trp Gin Glu Thr Ser Ala Met 290 295 300 Thr Phe Ser Asn Leu Glu Aεn Ala He He Ser Ser Pro His Leu Phe 305 310 315 320 Asp Thr He Asn Asn Leu Met He Tyr Thr Gly Ser Phe Ser Val His 325 330 335 Leu Thr Asn Gin Leu He Glu Gly Trp He Gly His Ser Val Thr Ser 340 345 350 Ser Leu Leu Ala Ser Gly Pro Thr Thr Val Leu Arg Arg Asn Tyr Gly 355 360 365 Ser Thr Thr Ser He Val Aεn Tyr Phe Ser Phe Asn Asp Arg Aεp Val 370 375 380 Tyr Gin He Asn Thr Arg Ser His Thr Gly Leu Gly Phe Gin Asn Ala 385 390 395 400 Pro Leu Phe Gly He Thr Arg Ala Gin Phe Tyr Pro Gly Gly Thr Tyr 405 410 415 Ser Val Thr Gin Arg Asn Ala Leu Thr Cys Glu Gin Asn Tyr Asn Ser 420 425 430 He Asp Glu Leu Pro Ser Leu Asp Pro Asn Glu Pro He Ser Arg Ser 435 440 445 Tyr Ser His Arg Leu Ser His He Thr Ser Tyr Leu His Arg Val Leu 450 455 460 Thr He Asp Gly He Asn He Tyr Ser Gly Asn Leu Pro Thr Tyr Val 465 470 475 480 Trp Thr His Arg Asp Val Asp Leu Thr Asn Thr He Thr Ala Asp Arg 485 490 495 He Thr Gin Leu Pro Leu Val Lys Ser Phe Glu He Pro Ala Gly Thr 500 505 510 Thr Val Val Arg Gly Pro Gly Phe Thr Gly Gly Asp He Leu Arg Arg 515 520 525 Thr Gly Val Gly Thr Phe Gly Thr He Arg Val Arg Thr Thr Ala Pro 530 535 540 Leu Thr Gin Arg Tyr Arg He Arg Phe Arg Phe Ala Ser Thr Thr Asn 545 550 555 560 Leu Phe He Gly He Arg Val Gly Asp Arg Gin Val Asn Tyr Phe Asp 565 570 575 Phe Gly Arg Thr Met Asn Arg Gly Asp Glu Leu Arg Tyr Glu Ser Phe 580 585 590 Ala Thr Arg Glu Phe Thr Thr Asp Phe Asn Phe Arg Gin Pro Gin Glu 595 600 605 Leu He Ser Val Phe Ala Asn Ala Phe Ser Ala Gly Gin Glu Val Tyr 610 615 620 Phe Asp Arg He Glu He He Pro Val Asn Pro Ala Arg Glu Ala Lyε 625 630 635 640 Glu Asp Leu Glu Ala Ala Lys Lys Ala Val Ala Ser Leu Phe Thr Arg 645 650 655 Thr Arg Aεp Gly Leu Gin Val Asn Val Lyε Aεp Tyr Gin Val Asp Gin 660 665 670 Ala Ala Asn Leu Val Ser Cys Leu Ser Asp Glu Gin Tyr Gly Tyr Asp 675 680 685 Lys Lys Met Leu Leu Glu Ala Val Arg Ala Ala Lys Arg Leu Ser Arg 690 695 700 Glu Arg Asn Leu Leu Gin Aεp Pro Aεp Phe Aεn Thr He Asn Ser Thr 705 710 715 720 Glu Glu Asn Gly Trp Lys Ala Ser Aεn Gly Val Thr He Ser Glu Gly 725 730 735 Gly Pro Phe Tyr Lyε Gly Arg Ala Leu Gin Leu Ala Ser Ala Arg Glu 740 745 750 Asn Tyr Pro Thr Tyr He Tyr Gin Lys Val Asp Ala Ser Glu Leu Lys 755 760 765 Pro Tyr Thr Arg Tyr Arg Ser Asp Gly Phe Val Lys Ser Ser Gin Asp 770 775 780 Leu Glu He Asp Leu He His His His Lys Val His Leu Val Lys Asn 785 790 795 800 Val Pro Asp Asn Leu Val Ser Asp Thr Tyr Pro Aεp Aεp Ser Cys Ser 805 810 815 Gly He Asn Arg Cys Gin Glu Gin Gin Met Val Asn Ala Gin Leu Glu 820 825 830 Thr Glu His His His Pro Met Asp Cys Cys Glu Ala Ala Gin Thr His 835 840 845 Glu Phe Ser Ser Tyr He Aεp Thr Gly Asp Leu Asn Ser Ser Val Asp 850 855 860 Gin Gly He Trp Ala He Phe Lys Val Arg Thr Thr Asp Gly Tyr Ala 865 870 875 880 Thr Leu Gly Asn Leu Glu Leu Val Glu Val Gly Pro Leu Ser Gly Glu 885 890 895 Ser Leu Glu Arg Glu Gin Arg Asp Asn Thr Lys Trp Ser Ala Glu Leu 900 905 910 Gly Arg Lys Arg Ala Glu Thr Asp Arg Val Tyr Gin Asp Ala Lys Gin 915 920 925 Ser He Asn His Leu Phe Val Asp Tyr Gin Asp Gin Gin Leu Asn Pro 930 935 940 Glu He Gly Met Ala Asp He Met Asp Ala Gin Asn Leu Val Ala Ser 945 950 955 960 He Ser Asp Val Tyr Ser Asp Ala Val Leu Gin He Pro Gly He Asn 965 970 975 Tyr Glu He Tyr Thr Glu Leu Ser Asn Arg Leu Gin Gin Ala Ser Tyr 980 985 990 Leu Tyr Thr Ser Arg Asn Ala Val Gin Aεn Gly Asp Phe Asn Asn Gly 995 1000 1005 Leu Asp Ser Trp Asn Ala Thr Ala Gly Ala Ser Val Gin Gin Asp Gly 1010 1015 1020 Asn Thr His Phe Leu Val Leu Ser His Trp Asp Ala Gin Val Ser Gin 1025 1030 1035 1040 Gin Phe Arg Val Gin Pro Aεn Cys Lys Tyr Val Leu Arg Val Thr Ala 1045 1050 1055 Glu Lys Val Gly Gly Gly Asp Gly Tyr Val Thr He Arg Asp Gly Ala 1060 1065 1070 His His Thr Glu Thr Leu Thr Phe Asn Ala Cys Asp Tyr Asp He Asn 1075 1080 1085 Gly Thr Tyr Val Thr Asp Asn Thr Tyr Leu Thr Lys Glu Val He Phe 1090 1095 1100 Tyr Ser His Thr Glu His Met Trp Val Glu Val Asn Glu Thr Glu Gly 1105 1110 1115 1120 Ala Phe His He Asp Ser He Glu Phe Val Glu Thr Glu Lys 1125 1130 (2) INFORMATION FOR SEQ ID NO: 77: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3411 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:77: ATGGATAACA ATCCGAACAT CAATGAATGC ATTCCTTATA ATTGTTTAAG TAACCCTGAA 60 GTAGAAGTAT TAGGTGGAGA AAGAGGAAAT GTTAGAACTG GACTACAAAC TGGAATTGAT 120 ATTGTTGCAG TAGTAGTAGG TGCTTTAGGT GGACCAGTTG GTGGCATACT CACTGGTTTT 180 CTTTCTACTC TTTTTGGTTT TCTTTGGCCA TCTAATGATC AAGCAGTATG GGAAGCTTTT 240 ATAGAACAAA TGGAAGAACT GATTGAACAA AGGATATCAG ATCAAGTAGT AAGGACTGCA 300 CTCGATGACT TAACTGGAAT TCAAAATTAT TATAATCAAT ATCTAATAGC ATTAAAGGAA 360 TGGGAGGAAA GACCAAACGG CGTAAGAGCA AACTTAGTTT TGCAAAGATT TGAAATCTTG 420 CACGCGCTAT TTGTAAGTAG TATGCCAAGT TTTGGTAGTG GCCCTGGAAG TCAAAGGTTT 480 CAGGCACAAT TGTTGGTTGT TTATGCGCAA GCAGCAAATC TTCATTTACT ATTATTAGCT 540 GATGCTGAAA AGTATGGGGC AAGATGGGGA CTCCGTGAAT CCCAGATAGG AAATTTATAT 600 TTTAATGAAC TACAAACTCG TACTCGAGAT TACACCAACC ATTGTGTAAA CGCGTATAAT 660 AACGGGTTAG CCGGGTTACG AGGAACGAGC GCTGAAAGTT GGTTAAAGTA CCATCAATTC 720 CGCAGAGAAG CAACCTTAAT GGCAATGGAT TTGATAGCTT TATTTCCATA TTATAACACC 780 CGGCGATATC CAATCGCAGT AAATCCTCAG CTTACACGTG AGGTATATAC AGATCCATTA 840 GGCGTTCCTT CTGAAGAATC AAGTTTATTT CCAGAATTGA GATGCTTAAG ATGGCAAGAG 900 ACTTCTGCCA TGACTTTTTC AAATTTGGAA AATGCAATAA TTTCGTCACC ACATCTATTT 960 GACACAATAA ACAATTTAAT GATTTATACC GGTTCCTTTT CCGTTCACCT AACCAATCAA 1020 TTAATTGAAG GGTGGATTGG ACATTCTGTA ACTAGTAGTT TGTTGGCCAG TGGACCAACA 1080 ACAGTACTGA GAAGAAATTA CGGTAGCACG ACATCTATTG TAAACTATTT TAGTTTTAAT 1140 GATCGTGATG TTTATCAGAT TAATACGAGA TCACATACTG GGTTGGGATT CCAGAACGCA 1200 CCTTTATTTG GAATCACTAG AGCTCAATTT TACCCAGGTG GGACTTATTC AGTAACTCAA 1260 CGAAATGCAT TAACATGTGA ACAAAATTAT AATTCAATTG ATGAGTTACC GAGCCTAGAC 13 0 CCAAATGAAC CTATCAGTAG AAGTTATAGT CATAGATTAT CTCATATTAC CTCCTATTTG 1380 CATCGTGTAT TGACTATTGA TGGTATTAAT ATATATTCAG GAAATCTCCC TACTTATGTA 1440 TGGACCCATC GCGATGTGGA CCTTACAAAC ACGATTACCG CAGATAGAAT TACACAACTA 1500 CCATTGGTAA AGTCATTTGA AATACCTGCG GGTACTACTG TCGTAAGAGG ACCAGGTTTT 1560 ACAGGAGGGG ATATACTCCG AAGAACAGGG GTTGGTACAT TTGGAACAAT AAGGGTAAGG 1620 ACTACTGCCC CCTTAACACA AAGATATCGC ATAAGATTCC GTTTCGCTTC TACCACAAAT 1680 TTGTTCATTG GTATAAGAGT TGGTGATAGA CAAGTAAATT ATTTTGACTT CGGAAGAACA 1740 ATGAACAGAG GAGATGAATT AAGGTACGAA TCTTTTGCTA CAAGGGAGTT TACTACTGAT 1800 TTTAATTTTA GACAACCTCA AGAATTAATC TCAGTGTTTG CAAATGCATT TAGCGCTGGT 1860 CAAGAAGTTT ATTTTGATAG AATTGAGATT ATCCCCGTTA ATCCCGCACG AGAGGCGAAA 1920 GAGGATCTAG AAGCAGCAAA GAAAGCGGTG GCGAGCTTGT TTACACGCAC AAGGGACGGA 1980 TTACAAGTAA ATGTGAAAGA TTATCAAGTC GATCAAGCGG CAAATTTAGT GTCATGCTTA 2040 TCAGATGAAC AATATGGGTA TGACAAAAAG ATGTTATTGG AAGCGGTACG CGCGGCAAAA 2100 CGCCTCAGCC GAGAACGTAA CTTACTTCAG GATCCAGATT TTAATACAAT CAATAGTACA 2160 GAAGAAAATG GATGGAAAGC AAGTAACGGC GTTACTATTA GTGAGGGCGG TCCATTCTAT 2220 AAAGGCCGTG CACTTCAGCT AGCAAGTGCA CGAGAAAATT ATCCAACATA CATTTATCAA 2280 AAAGTAGATG CATCGGAGTT AAAACCTTAT ACACGTTATA GATCAGATGG GTTCGTGAAG 2340 AGTAGTCAAG ATTTAGAAAT TGATCTCATT CACCATCATA AAGTCCATCT TGTGAAAAAT 2400 GTACCAGATA ATTTAGTATC TGATACTTAC CCAGATGATT CTTGTAGTGG AATCAATCGA 2460 TGTCAGGAAC AACAGATGGT AAATGCGCAA CTGGAAACAG AGCATCATCA TCCGATGGAT 2520 TGCTGTGAAG CAGCTCAAAC ACATGAGTTT TCTTCCTATA TTGATACAGG GGATTTAAAT 2580 TCGAGTGTAG ACCAGGGAAT CTGGGCGATC TTTAAAGTTC GAACAACCGA TGGTTATGCG 2640 ACGTTAGGAA ATCTTGAATT GGTAGAGGTC GGACCGTTAT CGGGTGAATC TTTAGAACGT 2700 GAACAAAGGG ATAATACAAA ATGGAGTGCA GAGCTAGGAA GAAAGCGTGC AGAAACAGAT 2760 CGCGTGTATC AAGATGCCAA ACAATCCATC AATCATTTAT TTGTGGATTA TCAAGATCAA 2820 CAATTAAATC CAGAAATAGG GATGGCAGAT ATTATGGACG CTCAAAATCT TGTCGCATCA 2880 ATTTCAGATG TATATAGCGA TGCCGTACTG CAAATCCCTG GAATTAACTA TGAGATTTAC 2940 ACAGAGCTGT CCAATCGCTT ACAACAAGCA TCGTATCTGT ATACGTCTCG AAATGCGGTG 3000 CAAAATGGGG ACTTTAACAA CGGGCTAGAT AGCTGGAATG CAACAGCGGG TGCATCGGTA 3060 CAACAGGATG GCAATACGCA TTTCTTAGTT CTTTCTCATT GGGATGCACA AGTTTCTCAA 3120 CAATTTAGAG TGCAGCCGAA TTGTAAATAT GTATTACGTG TAACAGCAGA GAAAGTAGGC 3180 GGCGGAGACG GATACGTGAC TATCCGGGAT GGTGCTCATC ATACAGAAAC GCTTACATTT 3240 AATGCATGTG ATTATGATAT AAATGGCACG TACGTGACTG ATAATACGTA TCTAACAAAA 3300 GAAGTGATAT TCTATTCACA TACAGAACAC ATGTGGGTAG AGGTAAATGA AACAGAAGGT 3360 GCATTTCATA TAGATAGTAT TGAATTCGTT GAAACAGAAA AGTAAGGTAC C 3411 (2) INFORMATION FOR SEQ ID NO: 78: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:78: Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Aεp Thr Gly Gly Aεp Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Asp He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Aεn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lyε He Ala Aεn Glu Gin 85 90 95 Asn Gin Val Leu Asn Aεp Val Asn Aεn Lyε Leu Asp Ala He Aεn Thr 100 105 110 Met Leu Arg Val Tyr Leu Pro Lyε He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lyε Leu Aεp He He Asn Val Aεn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Aεn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Thr Lys Glu Asn Val Lys Ala Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly His Ala Leu He Gly Phe Glu He Ser Aεn Aεp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Aεn Aεn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Aεp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Aεn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Glu Asp Tyr Gin Thr He Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Aεp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr Asn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO: 79: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2370 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 79: ATGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAACATGAT TTTTAAAACG 120 GATACAGGTG GTGATCTAAC CCTAGACGAA ATTTTAAAGA ATCAGCAGTT ACTAAATGAT 180 ATTTCTGGTA AATTGGATGG GGTGAATGGA AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATATTA AAAATTGCAA ATGAACAAAA TCAAGTTTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCGGGTATA TCTACCTAAA 360 ATTACCTCTA TGTTGAGTGA TGTAATGAAA CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAGATTTCT GATAAGTTGG ATATTATTAA TGTAAATGTA 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCGTATC AAAGGATTAA ATATGTGAAC 540 GAAAAATTTG AGGAATTAAC TTTTGCTACA GAAACTAGTT CAAAAGTAAA AAAGGATGGC 600 TCTCCTGCAG ATATTCTTGA TGAGTTAACT GAGTTAACTG AACTAGCGAA AAGTGTAACA 660 AAAAATGATG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCATCGG AATTAATTAC TAAAGAAAAT 780 GTGAAAGCAA GTGGCAGTGA GGTCGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840 CTGCAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTCC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GACATGCATT GATTGGGTTT 1080 GAAATTAGTA ATGATTCAAT TACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTCG ATAAGGATTC CTTATCGGAA GTTATTTATG GTGATATGGA TAAATTATTG 1200 TGCCCAGATC AATCTGAACA AATCTATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGGG TGTATATGCC GTTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCC TCCAAGCTGA TGAAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1560 AGCAATAAAG AAACTAAATT GATTGTCCCG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1620 AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1680 GTAGATCATA CAGGCGGAGT GAATGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1740 ATTTCACAAT TTATTGGAGA TAAGTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1800 GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1860 GATACAAATA ATAATTTAGA AGATTATCAA ACTATTAATA AACGTTTTAC TACAGGAACT 1920 GATTTAAAGG GAGTGTATTT AATTTTAAAA AGTCAAAATG GAGATGAAGC TTGGGGAGAT 1980 AACTTTATTA TTTTGGAAAT TAGTCCTTCT GAAAAGTTAT TAAGTCCAGA ATTAATTAAT 2040 ACAAATAATT GGACGAGTAC GGGATCAACT AATATTAGCG GTAATACACT CACTCTTTAT 2100 CAGGGAGGAC GAGGGATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTTC AACTTATAGA 2160 GTGTATTTTT CTGTGTCCGG AGATGCTAAT GTAAGGATTA GAAATTCTAG GGAAGTGTTA 2220 TTTGAAAAAA GATATATGAG CGGTGCTAAA GATGTTTCTG AAATGTTCAC TACAAAATTT 2280 GAGAAAGATA ACTTTTATAT AGAGCTTTCT CAAGGGAATA ATTTATATGG TGGTCCTATT 2340 GTACATTTTT ACGATGTCTC TATTAAGTAA 2370 (2) INFORMATION FOR SEQ ID NO: 80: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:80: Met Asn Lys Asp Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Asp He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Glu Val Asn Aεn Lyε Leu Glu Ala He Ser Thr 100 105 110 He Phe Arg Val Tyr Leu Pro Lys Asn Thr Ser Arg Gly Gly Gly Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin Met Glu Asn Leu Ser Lyε 130 135 140 Gin Leu Gin Glu He Ser Val Lyε Trp Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Aεn Thr Phe Ser Aεn Pro Aεn Tyr Ala 325 330 335 Lyε Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly His Ala Leu He Gly Phe Glu He Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Aεn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lyε Lyε Lyε Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Xaa He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Glu Aεp Tyr Gin Thr He Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Aεn Aεn Trp Thr Ser Thr Gly 675 680 685 Ser Thr Aεn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO: 81: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2375 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 81: ATGAACAAGG ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAACATGAT TTTTAAAACG 120 GATACAGGTG GTGATCTAAC CCTAGACGAA ATTTTAAAGA ATCAGCAGTT ACTAAATGAT 180 ATTTCTGGTA AATTGGATGG GGTGAATGGA AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATATTA AAAATTGCAA ATGAACAAAA TCAAGTTTTA 300 AATGAGGTTA ATAACAAACT CGAGGCGATA AGTACGATTT TTCGGGTATA TTTACCTAAA 360 AATACCTCTA GGGGGGGGGG GGTAATGAAA CAAAATTATG CGCTAAGTCT GCAAATGGAA 420 AACTTGAGTA AACAATTACA AGAGATTTCT GTTAAGTGGG ATATTATTAA TGTAAATGTA 480 CTTATTAACT CTACACTTAC CGAAATTACA CCTGCGTATC AAAGGATTAA ATATGTGAAC 540 GAAAAATTTG AGGAATTAAC TTTTGCTACA GAAACTAGTT CAAAAGTAAA AAAGGATGGC 600 TCTCCCGCAG ATATTCTTGA TGAGTTAACT GAGTTAACTG AACTAGCGAA AAGTGTAACA 660 AAAAATGATG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCATCGG AATTAATTAC TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA GGTCGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840 CTGCAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTCC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GACATGCATT GATTGGGTTT 1080 GAAATTAGTA ATGATTCAAT TACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTCG ATAAGGATTC CTTATCGGAA GTTATTTATG GTGATATGGA TAAATTATTG 1200 TGCCCAGATC AATCTGAACA AATCTATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGGG TGTATATGCC GTTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCC TCCAAGCTGA TGAAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACCGACTTA 1560 AGCAATAAAG AAACTAAATT GATCGTCCCG CCAAGTGGTT TTATTAGCSA TATTGTAGAG 1620 AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1680 GTAGATCATA CAGGCGGAGT GAATGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1740 ATTTCACAAT TTATTGGAGA TAAGTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1800 GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1860 GATACAAATA ATAATTTAGA AGATTATCAA ACTATTAATA AACGTTTTAC TACAGGAACT 1920 GATTTAAAGG GAGTGTATTT AATTTTAAAA AGTCAAAATG GAGATGAAGC TTGGGGAGAT 1980 AACTTTATTA TTTTGGAAAT TAGTCCTTCT GAAAAGTTAT TAAGTCCAGA ATTAATTAAT 2040 ACAAATAATT GGACGAGTAC GGGATCAACT AATATTAGCG GTAATACACT CACTCTTTAT 2100 CAGGGAGGAC GAGGGATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTTC AACTTATAGA 160 GTGTATTTTT CTGTGTCCGG AGATGCTAAT GTAAGGATTA GAAATTCTAG GGAAGTGTTA 2220 TTTGAAAAAA GATATATGAG CGGTGCTAAA GATGTTTCTG AAATGTTCAC TACAAAATTT 2280 GAGAAAGATA ACTTTTATAT AGAGCTTTCT CAAGGGAATA ATTTATATGG TGGTCCTATT 2340 GTTCATTTTT ACGATGTCTC TATTAAGTAA CCCAA 2375 (2) INFORMATION FOR SEQ ID NO: 82: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 82: Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asn Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Glu He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu His He Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lyε Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Thr Leu Lys Val Lys Lys Asp Ser Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Aεp Val Met Val Gly 225 230 235 240 Aεn Aεn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Ala Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly Tyr Ala Leu Val Gly Phe Glu Met Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lyε Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Thr Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lyε 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Gly Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Leu Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Aεn Leu Glu Pro Trp Lys Ala Aεn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly Phe Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Lys Asp Tyr Gin Thr He Thr Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr His He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Asn 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO:83: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2375 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 83: ATGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAATATGAT TTTTAAAACG 120 GATACAGGTG GTAATCTAAC CTTAGATGAA ATCCTAAAGA ATCAGCAGTT ACTAAATGAG 180 ATTTCTGGTA AATTGGATGG GGTAAATGGG AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATCTTA AAAATTGCAA ATGAACAGAA TCAAGTCTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCATATATA TCTACCTAAA 360 ATTACATCTA TGTTAAGTGA TGTAATGAAG CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAAATTTCT GATAAATTAG ATATTATTAA CGTAAATGTT 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCATATC AACGGATTAA ATATGTGAAT 540 GAAAAATTTG AAGAATTAAC TTTTGCTACA GAAACCACTT TAAAAGTAAA AAAGGATAGC 600 TCGCCTGCTG ATATTCTTGA TGAGTTAACT GAATTAACTG AACTAGCGAA AAGTGTTACA 660 AAAAATGACG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCTTCAG AATTAATTGC TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA AGTAGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840 CTACAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTTC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GATATGCATT GGTTGGGTTT 1080 GAAATGAGCA ATGATTCAAT CACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTTG ATAAGGATTC CTTATCGGAA GTTATTTATG GTGATACGGA TAAATTATTG 1200 TGTCCAGATC AATCTGAACA AATATATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGAG TGTATATGCC ATTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATAAAT GGGTTTGGCC TCCAAGCTGA TGGAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1560 AGCAATAAAG AAACTAAATT GATCGTCCTG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1620 AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1680 GTAGATCATA CAGGCGGAGT GAATGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1740 TTTTCACAAT TTATTGGAGA TAAGTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1800 GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1860 GATACAAATA ATAATTTAAA AGATTATCAA ACTATTACTA AACGTTTTAC TACAGGAACT 1920 GATTTAAAGG GAGTGTATTT AATTTTAAAA AGTCAAAATG GAGATGAAGC TTGGGGAGAT 1980 AACTTTATTA TTTTGGAAAT TAGTCCTTCT GAAAAGTTAT TAAGTCCAGA ATTAATTAAT 2040 ACAAATAATT GGACGAGTAC GGGATCAACT CATATTAGCG GTAATACACT CACTCTTTAT 2100 CAGGGAGGAC GAGGAATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTTC AACTTATAGA 2160 GTGTATTTTT CTGTGTCCGG AGATGCTAAT GTAAGGATTA GAAATTCTAG GGAAGTGTTA 2220 TTTGAAAAAA GATATATGAG CGGTGCTAAA GATGTTTCTG AAATGTTCAC TACAAAATTT 2280 GAGAAAGATA ACTTTTATAT AGAGCTTTCT CAAGGGAATA ATTTATATGG TGGTCCTATT 2340 GTACATTTTA ACGATGTCTC TATTAAGTAA CCCAA 2375 (2) INFORMATION FOR SEQ ID NO: 84: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 84: Met Asn Lys Asn Asn Thr Lys Leu Ser Ala Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asn Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Glu He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu His He Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Ser Ser Lys Val Lys Lys Asp Ser Pro Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Ala Lyε Glu Aεn Val Lyε Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu Hiε Leu Asn Lys Glu Lyε Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly Tyr Ala Leu Val Gly Phe Glu Met Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Thr Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Aεn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Gly Aεn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly Phe Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Aεn Leu Lyε Aεp Tyr Gin Thr He Thr Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr Hiε He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Aεn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Aεp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Gly Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO: 85: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2375 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 85: ATGAACAAGA ATAATACTAA ATTAAGCGCA AGGGCCCTAC CGAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAATATGAT TTTTAAAACG 120 GATACAGGTG GTAATCTAAC CTTAGATGAA ATCCTAAAGA ATCAGCAGTT ACTAAATGAG 180 ATTTCTGGTA AATTGGATGG GGTAAATGGG AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATCTTA AAAATTGCAA ATGAACAGAA TCAAGTCTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCATATATA TCTACCTAAA 360 ATTACATCTA TGTTAAGTGA TGTAATGAAA CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAAATTTCT GATAAATTAG ATATTATTAA CGTAAATGTC 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCATATC AACGGATTAA ATATGTGAAT 540 GAAAAATTTG AAGAATTAAC TTTTGCTACA GAAACTAGTT CAAAAGTAAA AAAGGATAGC 600 CCCCCTGCTG ATATTCTTGA TGAGTTAACT GAATTAACTG AACTAGCGAA AAGTGTAACA 660 AAAAATGACG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCTTCAG AATTAATTGC TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA AGTAGGAAAT GTTTATAATT TCTTAATTGT ATTAACAGCT 840 CTACAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTTC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GATATGCATT GGTTGGTTTT 1080 GAAATGAGCA ATGATTCAAT CACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTTG ATAAGGATTC CTTATCGGAG GTTATTTATG GTGATACGGA TAAATTATTG 1200 TGTCCAGATC AATCTGAACA AATATATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGAG TGTATATGCC ATTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATAAAT GGGTTTGGCC TCCAAGCTGA TGGAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1560 AGCAATAAAG AAACTAAATT GATCGTCCCG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1620 AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1680 GTAGATCATA CAGGCGGAGT GAATGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1740 TTTTCACAAT TTATTGGAGA TAAGTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1800 GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1860 GATACAAATA ATAATTTAAA AGATTATCAA ACTATTACTA AACGTTTTAC TACAGGAACT 1920 GATTTAAAGG GAGTGTATTT AATTTTAAAA AGTCAAAATG GAGATGAAGC TTGGGGAGAT 1980 AACTTTATTA TTTTGGAAAT TAGTCCTTCT GAAAAGTTAT TAAGTCCAGA ATTAATTAAT 2040 ACAAATAATT GGACGAGTAC GGGATCAACT CATATTAGCG GTAATACACT CACTCTTTAT 2100 CAGGGAGGAC GAGGAATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTTC AACTTATAGA 2160 GTGTATTTTT CTGTGTCCGG AGATGCTAAT GTAAGGATTA GAAATTCTAG GGAAGTGTTA 2220 TTTGAAAAAG GATATATGAG CGGTGCTAAA GATGTTTCTG AAATGTTCAC TACAAAATTT 2280 GAGAAAGATA ACTTTTATAT AGAGCTTTCT CAAGGGAATA ATTTATATGG TGGTCCTATT 2340 GTACATTTTT ACGATGTCTC TATTAAGTAA CCAAG 2375 (2) INFORMATION FOR SEQ ID NO: 86: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 759 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 86: Met Asn Lys Asn Asn Thr Lys Leu Ser Ala Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Aεp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asn Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Glu He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lyε Glu He Leu Lys He Ala Aεn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu Arg He Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Asn Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Xaa Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu He Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Asn Asn Leu He Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Xaa Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly Tyr Ala Leu Val Gly Phe Glu Met Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Thr Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Aεn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser His 530 535 540 Arg Arg Gly Gin Phe Arg Ala Val Glu Ser Lys Glu Cys Val Cys Arg 545 550 555 560 Ser Tyr Arg Arg Ser Glu Trp Asn Ser Phe He Cys Ser Gly Arg Arg 565 570 575 Asn Phe Thr He Tyr Trp Arg Val Lys Thr Glu Asn Val Cys Asn Pro 580 585 590 He Tyr Cys Arg Lys Thr Phe Tyr Ser Phe Lys Arg Lys Tyr Trp He 595 600 605 Tyr Ser Leu Arg Tyr Lys Phe Lys Arg Leu Ser Asn Tyr Tyr Thr Phe 610 615 620 Tyr Tyr Arg Asn Phe Lys Gly Ser Val Phe Asn Phe Lyε Lyε Ser Lys 625 630 635 640 Trp Arg Ser Leu Gly Arg Leu Tyr Tyr Phe Gly Asn Ser Phe Lys Val 645 650 655 He Lys Ser Arg He Asn Tyr Lys Leu Asp Glu Tyr Gly He Asn Ser 660 665 670 Tyr Arg Tyr Thr His Ser Leu Ser Gly Arg Thr Arg Aεn Ser Lys Thr 675 680 685 Lys Pro Ser He Arg Phe Phe Asn Leu Ser Val Phe Phe Cys Val Arg 690 695 700 Arg Cys Cys Lys Asp Lys Phe Gly Ser Val He Lys Lys He Tyr Glu 705 710 715 720 Arg Cys Arg Cys Phe Asn Val His Tyr Lys He Glu Arg Leu Leu Tyr 725 730 735 Arg Ala Phe Ser Arg Glu Phe He Trp Trp Ser Tyr Cys Thr Phe Leu 740 745 750 Arg Cys Leu Tyr Val Thr Gin 755 (2) INFORMATION FOR SEQ ID NO: 87: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2376 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:87: ATGAACAAGA ATAATACTAA ATTAAGCGCA AGAGCCCTAC CGAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAATATGAT TTTTAAAACG 120 GATACAGGTG GTAATCTAAC CTTAGATGAA ATCCTAAAGA ATCAGCAGTT ACTAAATGAG 180 ATTTCTGGTA AATTGGATGG GGTAAATGGG AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATCTTA AAAATTGCAA ATGAACAAAA TCAAGTCTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCGGATATA TCTACCTAAA 360 ATTACATCTA TGTTAAGTGA TGTAATGAAC CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAAATTTCT GATAAATTGG ATATTATTAA TGTAAATGTA 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCGTATC AAAGGATTAA ATATGTGAAC 540 GAAAAATTTG AGGAATTAAC TTTTGCTACA GAAACTAKTT CAAAAGTAAA AAAGGATGGC 600 TCTCCTGCAG ATATTCTTGA TGAGTTAACT GAGTTAACTG AACTAGCGAA AAGTGTAACA 660 AAAAATGATG TGGATGGTTT TGAAATTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAA TCGGGCGTTC AGCTTTAAAA ACTGCATCGG AATTAATTAS TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA GGTAGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840 CTACAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTTC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GATATGCATT GGTTGGTTTT 1080 GAAATGAGCA ATGATTCAAT CACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTTG ATAAGGATTC CTTATCGGAG GTTATTTATG GTGATACGGA TAAATTATTG 1200 TGTCCAGATC AATCTGAACA AATATATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGAG TGTATATGCC GTTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCC TCCAAGCTGA TGAAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1560 AGCAATAAAG AAACTAAATT GATCGTCCCG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1620 AACGGGTCCC ATAGAAGAGG ACAATTTAGA GCCGTGGAAA GCAAATAATA AGAATGCGTA 1680 TGTAGATCAT ACAGGCGGAG TGAATGGAAC TAAAGCTTTA TATGTTCATA AGGACGGAGG 1740 AATTTCACAA TTTATTGGAG ATAAGTTAAA ACCGAAAACT GAGTATGTAA TCCAATATAC 1800 TGTTAAAGGA AAACCTTCTA TTCATTTAAA AGATGAAAAT ACTGGATATA TTCATTATGA 1860 AGATACAAAT AATAATTTAA AAGATTATCA AACTATTACT AAACGTTTTA CTACAGGAAC 1920 TGATTTAAAG GGAGTGTATT TAATTTTAAA AAGTCAAAAT GGAGATGAAG CTTGGGGAGA 1980 TAACTTTATT ATTTTGGAAA TTAGTCCTTC TGAAAAGTTA TTAAGTCCAG AATTAATTAA 2040 TACAAATAAT TGGACGAGTA CGGGATCAAC TCATATTAGC GGTAATACAC TCACTCTTTA 2100 TCAGGGAGGA CGAGGAATTC TAAAACAAAA CCTTCAATTA GATAGTTTTT CAACTTATAG 2160 AGTGTATTTT TCTGTGTCCG GAGATGCTAA TGTAAGGATT AGAAATTCTA GGGAAGTGTT 2220 ATTTGAAAAA AGATATATGA GCGGTGCTAA AGATGTTTCT GAAATGTTCA CTACAAAATT 2280 TGAGAAAGAT AACTTTTATA TAGAGCTTTC TCAAGGGAAT AATTTATATG GTGGTCCTAT 2340 TGTACATTTT TACGATGTCT CTATTAAGTA ACCCAA 2376 (2) INFORMATION FOR SEQ ID NO: 88: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 511 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 88: Tyr Leu Ser Lys Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He 1 5 10 15 Asn Val Asn Val Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala 20 25 30 Tyr Gin Arg He Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe 35 40 45 Ala Thr Glu Thr Thr Leu Lyε Val Lyε Lys Asp Ser Ser Pro Ala Asp 50 55 60 He Leu Asp Glu Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr 65 70 75 80 Lys Asn Asp Val Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp 85 90 95 Val Met Val Gly Asn Aεn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala 100 105 110 Ser Glu Leu He Ala Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val 115 120 125 Gly Asn Val Tyr Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys 130 135 140 Ala Phe Leu Thr Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp 145 150 155 160 He Asp Tyr Thr Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu 165 170 175 Glu Phe Arg Val Aεn He Leu Pro Thr Leu Ser Aεn Thr Phe Ser Aεn 180 185 190 Pro Asn Tyr Ala Lys Val Lys Gly Ser Aεp Glu Aεp Ala Lys Met He 195 200 205 Val Glu Ala Lys Pro Gly Tyr Ala Leu Val Gly Phe Glu Met Ser Asn 210 215 220 Asp Ser He Thr Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn 225 230 235 240 Tyr Gin Val Asp Lys Asp Pro Leu Ser Glu Val He Tyr Gly Asp Thr 245 250 255 Asp Lys Leu Leu Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn 260 265 270 Asn He Val Phe Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr 275 280 285 Lys Lys Met Lys Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp 290 295 300 Ser Ser Thr Gly Glu He Asp Leu Aεn Lys Lys Lys Val Glu Ser Ser 305 310 315 320 Glu Ala Glu Tyr Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met 325 330 335 Pro Leu Gly Val He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe 340 345 350 Gly Leu Gin Ala Asp Gly Asn Ser Arg Leu He Thr Leu Thr Cys Lys 355 360 365 Ser Tyr Leu Arg Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu 370 375 380 Thr Lys Leu He Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu 385 390 395 400 Asn Gly Ser He Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Aεn 405 410 415 Lys Asn Ala Tyr Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala 420 425 430 Leu Tyr Val His Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys 435 440 445 Leu Lys Pro Lys Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys 450 455 460 Pro Ser He His Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu 465 470 475 480 Asp Thr Asn Asn Asn Leu Lys Asp Tyr Gin Thr He Thr Lys Arg Phe 485 490 495 Thr Thr Gly Thr Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser 500 505 510 (2) INFORMATION FOR SEQ ID NO: 89: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1533 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: TACTTAAGTA AACAATTGCA AGAAATTTCT GATAAATTAG ATATTATTAA CGTAAATGTT 60 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCATATC AACGGATTAA ATATGTGAAT 120 GAAAAATTTG AAGAATTAAC TTTTGCTACA GAAACCACTT TAAAAGTAAA AAAGGATAGC 180 TCGCCTGCTG ATATTCTTGA TGAGTTAACT GAATTAACTG AACTAGCGAA AAGTGTTACA 240 AAAAATGACG TTGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 300 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCTTCAG AATTAATTGC TAAAGAAAAT 360 GTGAAAACAA GTGGCAGTGA AGTAGGAAAT GTTTATAATT TCTTAATTGT ATTAACAGCT 420 CTACAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 480 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 540 AACATCCTYC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 600 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GATATGCATT GGTTGGTTTT 660 GAAATGAGCA ATGATTCAAT CACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 720 TATCAAGTTG ATAAGGATCC CTTATCGGAG GTTATTTATG GTGATACGGA TAAATTATTG 780 TGTCCAGATC AATCTGAACA AATATATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 840 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 900 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 960 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGAG TGTATATGCC ATTAGGTGTC 1020 ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCC TCCAAGCTGA TGGAAATTCA 1080 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1140 AGCAATAAAG AAACTAAATT GATCGTCCCG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1200 AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1260 GTAGATCATA CAGGCGGAGT GAATGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1320 ATTTCACAAT TTATTGGAGA TAAGTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1380 GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1440 GATACAAATA ATAATTTAAA AGATTATCAA ACTATTACTA AACGTTTTAC TACAGGAACT 1500 GATTTAAAGG GAGTGTATTT AATTTTAAAA AGT 1533 (2) INFORMATION FOR SEQ ID NO: 90: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:90: Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Aεn Gin Gin Leu Leu Asn Asp He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asp Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu Arg Val Tyr Leu Pro Lys He Thr Xaa Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Aεp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly His Ala Leu Val Gly Phe Glu He Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400 Cys Pro Aεp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Aεn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Pro Gin Ala 485 490 495 Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Lys Leu Leu Leu Ala Thr Asp Phe Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Leu Pro Pro Ser Gly Phe He Ser Asn He Val Xaa Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Gly Lys Ala Asn Asn Arg Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lyε Gly Lyε Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Glu Asp Tyr Gin Thr He Thr Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Aεp Aεn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr Asn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Aεp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu He Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Asn Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO: 91: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2367 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: εingle (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 91: ATGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAACATGAT TTTTAAAACG 120 GATACAGGTG GTGATCTAAC CCTAGACGAA ATTTTAAAGA ATCAGCAGTT ACTAAATGAT 180 ATTTCTGGTA AATTGGATGG GGTGAATGGA AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA AGAAATATTA AAAATTGCAA ATGAACAAAA TCAAGTTTTA 300 AATGATGTTG ATAACAAACT CGATGCGATA AATACGATGC TTCGGGTATA TCTACCTAAA 360 ATTACCCTAT GTTGAGTGAT GTAATGAAAC AAAATTATGC GCTAAGTCTG CAAATAGAAT 420 ACTTAAGTAA ACAATTGCAA GAGATTTCTG ATAAGTTGGA TATTATTAAT GTAAATGTAC 480 TTATTAACTC TACACTTACT GAAATTACAC CTGCGTATCA AAGGATTAAA TATGTGAACG 540 AAAAATTTGA GGAATTAACT TTTGCTACAG AAACTAGTTC AAAAGTAAAA AAGGATGGCT 600 CTCCTGCAGA TATTCTTGAT GAGTTAACTG AGTTAACTGA ACTAGCGAAA AGTGTAACAA 660 AAAATGATGT GGATGGTTTT GAATTTTACC TTAATACATT CCACGATGTA ATGGTAGGAA 720 ATAATTTATT CGGGCGTTCA GCTTTAAAAA CTGCATCGGA ATTAATTACT AAAGAAAATG 780 TGAAAACAAG TGGCAGTGAG GTCGGAAATG TTTATAACTT CTTAATTGTA TTAACAGCTC 840 TGCAAGCAAA AGCTTTTCTT ACTTTAACAA CATGCCGAAA ATTATTAGGC TTAGCAGATA 900 TTGATTATAC TTCTATTATG AATGAACATT TAAATAAGGA AAAAGAGGAA TTTAGAGTAA 960 ACATCCTCCC TACACTTTCT AATACTTTTT CTAATCCTAA TTATGCAAAA GTTAAAGGAA 1020 GTGATGAAGA TGCAAAGATG ATTGTGGAAG CTAAACCAGG ACATGCATTG GTTGGGTTTG 1080 AAATTAGTAA TGATTCAATT ACAGTATTAA AAGTATATGA GGCTAAGCTA AAACAAAATT 1140 ATCAAGTTGA TAAGGATTCC TTATCGGAAG TTATTTATGG TGATATGGAT AAATTATTGT 1200 GCCCAGATCA ATCTGAACAA ATCTATTATA CAAATAACAT AGTATTTCCA AATGAATATG 1260 TAATTACTAA AATTGATTTT ACTAAAAAAA TGAAAACTTT AAGATATGAG GTAACAGCGA 1320 ATTTTTATGA TTCTTCTACA GGAGAAATTG ACTTAAATAA GAAAAAAGTA GAATCAAGTG 1380 AAGCGGAGTA TAGAACGTTA AGTGCTAATG ATGATGGAGT GTATATGCCG TTAGGTGTCA 1440 TCAGTGAAAC ATTTTTGACT CCGATTAATG GGTTTGGCCC CCAAGCTGAT GAAAATTCAA 1500 GATTAATTAC TTTAACATGT AAATCATATT TAAGAAAACT ACTGCTAGCA ACAGACTTTA 1560 GCAATAAAGA AACTAAATTG ATCCTCCCGC CAAGTGGTTT TATTAGCAAT ATTGTAGAAA 1620 CGGGTCCATA GAAGAGGACA ATTTAGAGCC GGGGAAAGCA AATAATAGGA ATGCGTATGT 1680 AGATCATACA GGCGGAGTGA ATGGAACTAA AGCTTTATAT GTTCATAAGG ACGGAGGAAT 1740 TTCACAATTT ATTGGAGATA AGTTAAAACC GAAAACTGAG TATGTAATCC AATATACTGT 1800 TAAAGGAAAA CCTTCTATTC ATTTAAAAGA TGAAAATACT GGATATATTC ATTATGAAGA 1860 TACAAATAAT AATTTAGAAG ATTATCAAAC TATTACTAAA CGTTTTACTA CAGGAACTGA 1920 TTTAAAGGGA GTGTATTTAA TTTTAAAAAG TCAAAATGGA GATGAAGCTT GGGGAGATAA 1980 CTTTATTATT TTGGAAATTA GTCCTTCTGA AAAGTTATTA AGTCCAGAAT TAATTAATAC 2040 AAATAATTGG ACGAGTACGG GATCAACTAA TATTAGCGGT AATACACTCA CTCTTTATCA 2100 GGGAGGACGA GGAATTCTAA AACAAAACCT TCAATTAGAT AGTTTTTCAA CTTATAGAGT 2160 GTATTTTTCT GTGTCCGGAG ATGCTAATGT AAGGATTAGA AATTCTAGGG AAGTGTTATT 2220 TGAAAAAAGA TATATGAGCG GTGCTAAAGA TGTTTCTGAA ATTTTCACTA CAAAATTTGA 2280 GAAAGATAAC TTTTATATAG AGCTTTCTCA AGGGAATAAT TTAAATGGTG GCCCTATTGT 2340 ACATTTTTAC GATGTCTCTA TTAAGTA 2367 (2) INFORMATION FOR SEQ ID NO: 92: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 92: Met Asn Lys Asn Asn Thr Lys Leu Ser Ala Arg Ala Leu Pro Ser Phe 1 5 10 15 He Aεp Tyr Phe Aεn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asn Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Glu He Ser Gly Lys 50 55 60 Leu Gly Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu His He Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Thr Leu Lys Val Lys Lys Asp Ser Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Ala Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu Hiε Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly Tyr Ala Leu Val Gly Phe Glu Met Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Aεp 370 375 380 Lyε Asp Ser Leu Ser Glu Val He Tyr Gly Asp Thr Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Aεp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Aεn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Gly Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val Hiε 565 570 575 Lys Aεp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Lys Asp Tyr Gin Thr He Thr Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr His He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO: 93: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2369 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 93: ATGAACAAGA ATAATACTAA ATTAAGCGCA AGGGCCCTAC CGAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAATATGAT TTTTAAAACG 120 GATACAGGTG GTAATCTAAC CTTAGATGAA ATCCTAAAGA ATCAGCAGTT ACTAAATGAG 180 ATTTCTGGTA AATTGGGGGG GGTAAATGGG AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATCTTA AAAATTGCAA ATGAACAAAT CAAGTCTTAA 300 ATGATGTTAA TAACAAACTC GATGCGATAA ATACGATGCT TCATATATAT CTACCTAAAA 360 TTACATCTAT GTTAAGTGAT GTAATGAAGC AAAATTATGC GCTAAGTCTG CAAATAGAAT 420 ACTTAAGTAA ACAATTGCAA GAAATTTCTG ATAAATTAGA TATTATTAAC GTAAATGTTC 480 TTATTAACTC TACACTTACT GAAATTACAC CTGCATATCA ACGGATTAAA TATGTGAATG 540 AAAAATTTGA AGAATTAACT TTTGCTACAG AAACCACTTT AAAAGTAAAA AAGGATAGCT 600 CGCCTGCTGA TATTCTTGAT GAGTTAACTG AATTAACTGA ACTAGCGAAA AGTGTTACAA 660 AAAATGACGT TGATGGTTTT GAATTTTACC TTAATACATT CCACGATGTA ATGGTAGGAA 720 ATAATTTATT CGGGCGTTCA GCTTTAAAAA CTGCTTCAGA ATTAATTGCT AAAGAAAATG 780 TGAAAACAAG TGGCAGTGAA GTAGGAAATG TTTATAATTT CTTAATTGTA TTAACAGCTC 840 TACAAGCAAA AGCTTTTCTT ACTTTAACAA CATGCCGAAA ATTATTAGGC TTAGCAGATA 900 TTGATTATAC TTCTATTATG AATGAACATT TAAATAAGGA AAAAGAGGAA TTTAGAGTAA 960 ACATCCTTCC TACACTTTCT AATACTTTTT CTAATCCTAA TTATGCAAAA GTTAAAGGAA 1020 GTGATGAAGA TGCAAAGATG ATTGTGGAAG CTAAACCAGG ATATGCATTG GTTGGTTTTG 1080 AAATGAGCAA TGATTCAATC ACAGTATTAA AAGTATATGA GGCTAAGCTA AAACAAAATT 1140 ATCAAGTTGA TAAGGATTCC TTATCGGAGG TTATTTATGG TGATACGGAT AAATTATTGT 1200 GTCCAGATCA ATCTGAACAA ATATATTATA CAAATAACAT AGTATTTCCA AATGAATATG 1260 TAATTACTAA AATTGATTTC ACTAAAAAAA TGAAAACTTT AAGATATGAG GTAACAGCGA 1320 ATTTTTATGA TTCTTCTACA GGAGAAATTG ACTTAAATAA GAAAAAAGTA GAATCAAGTG 1380 AAGCGGAGTA TAGAACGTTA AGTGCTAATG ATGATGGAGT GTATATGCCA TTAGGTGTCA 1440 TCAGTGAAAC ATTTTTGACT CCGATAAATG GGTTTGGCCT CCAAGCTGAT OGAAATTCAA 1500 GATTAATTAC TTTAACATGT AAATCATATT TAAGAGAACT ACTGCTAGCA ACAGACTTAA 1560 GCAATAAAGA AACTAAATTG ATTGTCCCGC CAAGTGGTTT TATTAGCAAT ATTGTAGAGA 1620 ACGGGTCCAT AGAAGAGGAC AATTTAGAGC CGTGGAAAGC AAATAATAAG AATGCGTATG 1680 TAGATCATAC AGGCGGAGTG AATGGAACTA AAGCTTTATA TGTTCATAAG GACGGAGGAA 1740 TTTCACAATT TATTGGAGAT AAGTTAAAAC CGAAAACTGA GTATGTAATC CAATATACTG 1800 TTAAAGGAAA ACCTTCTATT CATTTAAAAG ATGAAAATAC TGGATATATT CATTATGAAG 1860 ATACAAATAA TAATTTAAAA GATTATCAAA CTATTACTAA ACGTTTTACT ACAGGAACTG 1920 ATTTAAAGGG AGTGTATTTA ATTTTAAAAA GTCAAAATGG AGATGAAGCT TGGGGAGATA 1980 ACTTTATTAT TTTGGAAATT AGTCCTTCTG AAAAGTTATT AAGTCCAGAA TTAATTAATA 2040 CAAATAATTG GACGAGTACG GGATCAACTC ATATTAGCGG TAATACACTC ACTCTTTATC 2100 AGGGAGGACG AGGAATTCTA AAACAAAACC TTCAATTAGA TAGTTTTTCA ACTTATAGAG 2160 TGTATTTTTC TGTGTCCGGA GATGCTAATG TAAGGATTAG AAATTCTAGG GAAGTGTTAT 2220 TTGAAAAAAG ATATATGAGC GGTGCTAAAG ATGTTTCTGA AATGTTCACT ACAAAATTTG 2280 AGAAAGATAA CTTTTATATA GAGCTTTCTC AAGGGAATAA TTTATATGGT GGTCCTATTG 2340 TACATTTTTA CGATGTCTCT ATTAAGTAA 2369 (2) INFORMATION FOR SEQ ID NO: 94: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 94 : Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Aεn Asp He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu Arg Val Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Ala Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Aεp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lyε Gly Ser Aεp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly His Ala Leu He Gly Phe Glu He Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Glu Asp Tyr Gin Thr He Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr Asn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO: 95: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2370 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 95: TTGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAACATGAT TTTTAAAACG 120 GATACAGGTG GTGATCTAAC CCTAGACGAA ATTTTAAAGA ATCAGCAGTT ACTAAATGAT 180 ATTTCTGGTA AATTGGATGG GGTGAATGGA AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATATTA AAAATTGCAA ATGAACAAAA TCAAGTTTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCGGGTATA TCTACCTAAA 360 ATTACCTCTA TGTTGAGTGA TGTAATGAAA CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAGATTTCT GATAAGTTGG ATATTATTAA TGTAAATGTA 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCGTATC AAAGGATTAA ATATGTGAAC 540 GAAAAATTTG AGGAATTAAC TTTTGCTACA GAAACTAGTT CAAAAGTAAA AAAGGATGGC 600 TCTCCTGCAG ATATTCTTGA TGAGTTAGCT GAGTTAACTG AACTAGCGAA AAGTGTAACA 660 AAAAATGATG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCATCGG AATTAATTAC TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA GGTCGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840 CTGCAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTCC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GACATGCATT GATTGGGTTT 1080 GAAATTAGTA ATGATTCAAT TACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTCG ATAAGGATTC CTTATCGGAA GTTATTTATG GTGATATGGA TAAATTATTG 1200 TGCCCAGATC AATCTGAACA AATCTATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGGG TGTATATGCC GTTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCC TCCAAGCTGA TGAAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1560 AGCAATAAAG AAACTAAATT GATTGTCCCG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1620 AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1680 GTAGATCATA CAGGCGGAGT GAATGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1740 ATTTCACAAT TTATTGGAGA TAAGTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1800 GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1860 GATACAAATA ATAATTTAGA AGATTATCAA ACTATTAATA AACGTTTTAC TACAGGAACT 1920 GATTTAAAGG GAGTGTATTT AATTTTAAAA AGTCAAAATG GAGATGAAGC TTGGGGAGAT 1980 AACTTTATTA TTTTGGAAAT TAGTCCTTCT GAAAAGTTAT TAAGTCCAGA ATTAATTAAT 2040 ACAAATAATT GGACGAGTAC GGGATCAACT AATATTAGCG GTAATACACT CACTCTTTAT 2100 CAGGGAGGAC GAGGGATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTTC AACTTATAGA 2160 GTGTATTTTT CTGTGTCCGG AGATGCTAAT GTAAGGATTA GAAATTCTAG GGAAGTGTTA 2220 TTTGAAAAAA GATATATGAG CGGTGCTAAA GATGTTTCTG AAATGTTCAC TACAAAATTT 2280 GAGAAAGATA ACTTTTATAT AGAGCTTTCT CAAGGGAATA ATTTATATGG TGGTCCTATT 2340 GTACATTTTT ACGATGTCTC TATTAAGTAA 2370 (2) INFORMATION FOR SEQ ID NO: 96: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 96: Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Asp He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu Arg Val Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Aεp Val 210 215 220 Aεp Gly Phe Glu Phe Tyr Leu Aεn Thr Phe His Aεp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly His Ala Leu He Gly Phe Glu He Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Asn Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Aεn 610 615 620 Asn Leu Glu Asp Tyr Gin Thr He Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr Asn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO : 97 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2374 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 97: ATGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAACATGAT TTTTAAAACG 120 GATACAGGTG GTGATCTAAC CCTAGACGAA ATTTTAAAGA ATCAGCAGTT ACTAAATGAT 180 ATTTCTGGTA AATTGGATGG GGTGAATGGA AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATATTA AAAATTGCAA ATGAACAAAA TCAAGTTTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCGGGTATA TCTACCTAAA 360 ATTACCTCTA TGTTGAGTGA TGTAATGAAA CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAGATTTCT GATAAGTTGG ATATTATTAA TGTAAATGTA 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCGTATC AAAGGATTAA ATATGTGAAC 540 GAAAAATTTG AGGAATTAAC TTTTGCTACA GAAACTAGTT CAAAAGTAAA AAAGGATGGC 600 TCTCCTGCAG ATATTCTTGA TGAGTTAACT GAGTTAACTG AACTAGCGAA AAGTGTAACA 660 AAAAATGATG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCATCGG AATTAATTAC TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA GGTCGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840 CTGCAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTCC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GACATGCATT GATTGGGTTT 1080 GAAATTAGTA ATGATTCAAT TACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTCG ATAAGGATTC CTTATCGGAA GTTATTTATG GTGATATGGA TAAATTATTG 1200 TGCCCAGATC AATCTGAACA AATCTATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAACGT CGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGGG TGTATATGCC GTTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCC TCCAAGCTGA TGAAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAGAAC TACTGCTAGC AACAGACTTA 1560 AGCAATAAAG AAACTAAATT GATGTCCCGC CAAGTGGTTT TATTAGCAAT ATTGTAGAGA 1620 ACGGGTCCAT AGAAGAGGAC AATTTAGAGC CGTGGAAAGC AAATAATAAG AATGCGTATG 1680 TAGATCATAC AGGCGGAGTG AATGGAACTA AAGCTTTATA TGTTCATAAG GACGGAGGAA 1740 TTTCACAATT TATTGGAGAT AAGTTAAAAC CGAAAACTGA GTATGTAATC CAATATACTG 1800 TTAAAGGAAA ACCTTCTATT CATTTAAAAG ATGAAAATAC TGGATATATT CATTATGAAG 1860 ATACAAATAA TAATTTAGAA GATTATCAAA CTATTAATAA ACGTTTTACT ACAGGAACTG 1920 ATTTAAAGGG AGTGTATTTA ATTTTAAAAA GTCAAAATGG AGATGAAGCT TGGGGAGATA 1980 ACTTTATTAT TTTGGAAATT AGTCCTTCTG AAAAGTTATT AAGTCCAGAA TTAATTAATA 2040 CAAATAATTG GACGAGTACG GGATCAACTA ATATTAGCGG TAATACACTC ACTCTTTATC 2100 AGGGAGGACG AGGGATTCTA AAACAAAACC TTCAATTAGA TAGTTTTTCA ACTTATAGAG 2160 TGTATTTTTC TGTGTCCGGA GATGCTAATG TAAGGATTAG AAATTCTAGG GAAGTGTTAT 2220 TTGAAAAAAG ATATATGAGC GGTGCTAAAG ATGTTTCTGA AATGTTCACT ACAAAATTTG 2280 AGAAAGATAA CTTTTATATA GAGCTTTCTC AAGGGAATAA TTTATATGGT GGTCCTATTG 2340 TACATTTTTA CGATGTCTCT ATTAAGTAAC CCAA 2374 (2) INFORMATION FOR SEQ ID NO: 98: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 98: Met Asn Lys Aεn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asn Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Glu He Ser Gly Lyε 50 55 60 Leu Aεp Gly Val Aεn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Aεn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu His He Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Xaa Glu He Ser Asp Lyε Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Thr Leu Lys Val Lys Lys Asp Ser Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Ala Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Xaa Lys Leu Leu Gly Leu Ala Asn He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Aεn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly Tyr Ala Leu Val Gly Phe Glu Met Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Thr Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Xaa He Xaa Gly Phe Gly Leu Gin Ala 485 490 495 Asp Gly Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Aεp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly Phe Ser Gin Phe He Gly Asp Xaa Leu Lys Pro Lyε 580 585 590 Thr Glu Tyr Xaa He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Lys Asp Tyr Gin Thr He Thr Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr His He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO: 99: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2366 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 99: ATGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CGAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAATATGAT TTTTAAAACG 120 GATACAGGTG GTAATCTAAC CTTAGATGAA ATCCTAAAGA ATCAGCAGTT ACTAAATGAG 180 ATTTCTGGTA AATTGGATGG GGTAAATGGG AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATCTTA AAAATTGCAA ATGAACAGAA TCAAGTCTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCATATATA TCTACCTAAA 360 ATTACATCTA TGTTAAGTGA TGTAATGAAG CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA GAATTTCTGA TAAATTAGAT ATTATTAACG TAAATGTTCT 480 TATTAACTCT ACACTTACTG AAATTACACC TGCATATCAA CGGATTAAAT ATGTGAAGAA 540 AAATTTGAAG AATTAACTTT TGCTACAGAA ACCACTTTAA AAGTAAAAAA GGATAGCTCG 600 CCTGCTGATA TTCTTGATGA GTTAACTGAA TTAACTGAAC TAGCGAAAAG TGTTACAAAA 660 AATGACGTTG ATGGTTTTGA ATTTTACCTT AATACATTCC ACGATGTAAT GGTAGGAAAT 720 AATTTATTCG GGCGTTCAGC TTTAAAAACT GCTTCAGAAT TAATTGCTAA AGAAAATGTG 780 AAAACAAGTG GCAGTGAAGT AGGAAATGTT TATAATTTCT TAATTGTATT AACAGCTCTA 840 CAAGCAAAAG CTTTTCTTAC TTTAACAACA TGCCAAAATT ATTAGGCTTA GCAAATATTG 900 ATTATACTTC TATTATGAAT GAACATTTAA ATAAGGAAAA AGAGGAATTT AGAGTAAACA 960 TCCTTCCTAC ACTTTCTAAT ACTTTTTCTA ATCCTAATTA TGCAAAAGTT AAAGGAAGTG 1020 ATGAAGATGC AAAGATGATT GTGGAAGCTA AACCAGGATA TGCATTGGTT GGTTTTGAAA 1080 TGAGCAATGA TTCAATCACA GTATTAAAAG TATATGAGGC TAAGCTAAAA CAAAATTATC 1140 AAGTTGATAA GGATTCCTTA TCGGAGGTTA TTTATGGTGA TACGGATAAA TTATTGTGTC 1200 CAGATCAATC TGAACAAATA TATTATACAA ATAACATAGT ATTTCCAAAT GAATATGTAA 1260 TTACTAAAAT TGATTTCACT AAAAAAATGA AAACTTTAAG ATATGAGGTA ACAGCGAATT 1320 TTTATGATTC TTCTACAGGA GAAATTGACT TAAATAAGAA AAAAGTAGAA TCAAGTGAAG 1380 CGGAGTATAG AACGTTAAGT GCTAATGATG ATGGAGTGTA TATGCCATTA GGTGTCATCA 1440 GTGAAACATT TTTGACTCGA TTATGGGTTT GGCCTCCAAG CTGATGGAAA TTCAAGATTA 1500 ATTACTTTAA CATGTAAATC ATATTTAAGA GAACTACTGC TAGCAACAGA CTTAAGCAAT 1560 AAAGAAACTA AATTGATTGT CCCCCAAGTG GTTTTATTAG CAATATTGTA GAGAACGGGT 1620 CCATAGAAGA GGACAATTTA GAGCCGTGGA AAGCAAATAA TAAGAATGCG TATGTAGATC 1680 ATACAGGCGG AGTGAATGGA ACTAAAGCTT TATATGTTCA TAAGGACGGA GGATTTTCAC 1740 AATTTATTGG AGATAATTAA AACCGAAAAC TGAGTATTAA TCCAATATAC TGTTAAAGGA 1800 AAACCTTCTA TTCATTTAAA AGATGAAAAT ACTGGATATA TTCATTATGA AGATACAAAT 1860 AATAATTTAA AAGATTATCA AACTATTACT AAACGTTTTA CTACAGGAAC TGATTTAAAG 1920 GGAGTGTATT TAATTTTAAA AAGTCAAAAT GGAGATGAAG CTTGGGGAGA TAACTTTATT 1980 ATTTTGGAAA TTAGTCCTTC TGAAAAGTTA TTAAGTCCAG AATTAATTAA TACAAATAAT 2040 TGGACGAGTA CGGGATCAAC TCATATTAGC GGTAATACAC TCACTCTTTA TCAGGGAGGA 2100 CGAGGAATTC TAAAACAAAA CCTTCAATTA GATAGTTTTT CAACTTATAG AGTGTATTTT 2160 TCTGTGTCCG GAGATGCTAA TGTAAGGATT AGAAATTCTA GGGAAGTGTT ATTTGAAAAA 2220 AGATATATGA GCGGTGCTAA AGATGTTTCT GAAATGTTCA CTACAAAATT TGAGAAAGAT 2280 AACTTTTATA TAGAGCTTTC TCAAGGGAAT AATTTATATG GTGGTCCTAT TGTACATTTT 2340 TACGATGTCT CTATTAAGTA ACCCAA 2366 (2) INFORMATION FOR SEQ ID NO: 100: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 789 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:100: Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lys Asp 20 25 30 He Met Asn Met He Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Asp He Ser Gly Lys 50 55 60 Leu Aεp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Aεn Glu Gin 85 90 95 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu Arg Val Tyr Leu Pro Lys He Thr Phe Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Aεn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Aεn Aεn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lyε Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lys 340 345 350 Pro Gly His Ala Leu He Gly Phe Glu He Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Glu Asn Ser Arg Leu He Thr Leu Thr Cyε Lys Ser Tyr Leu Arg 500 505 510 Glu Leu Leu Leu Ala Thr Aεp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Xaa Asn Xaa Asn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Lys Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Asp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Xaa Xaa Tyr Gin Thr He Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Xaa Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Xaa Leu He Asn Thr Xaa Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr Asn He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Xaa Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Xaa Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Aεp Aεn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Ser He Lys 785 (2) INFORMATION FOR SEQ ID NO : 101: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2362 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 101: ATGAACAAGA ATAATACTAA ATTAAGCACA AGAGCCTTAC CAAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAACATGAT TTTTAAAACG 120 GATACAGGTG GTGATCTAAC CCTAGACGAA ATTTTAAAGA ATCAGCAGTT ACTAAATGAT 180 ATTTCTGGTA AATTGGATGG GGTGAATGGA AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATATTA AAAATTGCAA ATGAACAAAA TCAAGTTTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCGGGTATA TCTACCTAAA 360 ATTACCTTTA TGTTGAGTGA TGTAATGAAA CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAGATTTCT GATAAGTTGG ATATTATTAA TGTAAATGTA 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCGTATC AAAGGATTAA ATATGTGAAC 540 GAAAAATTTG AGGAATTAAC TTTTGCTACA GAAACTAGTT CAAAAGTAAA AAAGGATGGC 600 TCTCCTGCAG ATATTCTTGA TGAGTTAACT GAGTTAACTG AACTAGCGAA AAGTGTAACA 660 AAAAATGATG TGGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCATCGG AATTAATTAC TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA GGTCGGAAAT GTTTATAACT TCTTAATTGT ATTAACAGCT 840 CTGCAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG GTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTCC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GACATGCATT GATTGGGTTT 1080 GAAATTAGTA ATGATTCAAT TACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTCG ATAAGGATTC CTTATCGGAA GTTATTTATG GTGATATGGA TAAATTATTG 1200 TGCCCAGATC AATCTGAACA AATCTATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGGG TGTATATGCC GTTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATTAAT GGGTTTGGCT CCAAGCTGAT GAAAATTCAA 1500 GATTAATTAC TTTAACATGT AAATCATATT TAAGAGAACT ACTGCTAGCA ACAGACTTAA 1560 GCAATAAAGA AACTAAATTG ATCGTCCCGC CAAGTGGTTT TATTAGCAAT ATTGTAGAGA 1620 ACGGGTCCAT AGAAGAGGAC AATTTAGAGC CCTGGAAAGC AATAATAGAA TGCGTATGTA 1680 GATCATACAG GCGGAGTGAA TGGAACTAAA GCTTTATATG TTCATAAGGA CGGAGGAATT 1740 TCACAATTTA TTGGAGATAA GTTAAAACCG AAAACTGAGT ATGTAATCCA ATATACTGTT 1800 AAAGGAAAAC CTTCTATTCA TTTAAAAGAT GAAAATACTG GATATATTCA TTATGAAGAT 1860 ACAAATAATA ATTTAAATTA TCAAACTATT AATAAACGTT TTACTACAGG AACTGATTTA 1920 AAGGGAGTGT ATTTAATTTT AAAAAGTCAA AATGGAATGA AGCTTGGGGA GATAACTTTA 1980 TTATTTTGGA AATTAGTCCT TCTGAAAAGT TATTAAGTCC AAATTAATTA ATACAATAAT 2040 TGGACAGTAC GGGATCAACT AATATTAGCG GTAATACACT CACTCTTTAT CAGGGAGGAC 2100 GAGGGATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTCA ACTTATAGAG TGTATTTTTC 2160 TGTGTCCGGA GATGCTAATG TAAGGATTAG AAATTCTAGG GAAGTGTTAT TTGAAAAAAG 2220 ATATATGAGC GGTGCTAAAA TGTTTCTGAA ATGTTCACAC AAAATTTGAG AAAGATAACT 2280 TTTATATAGA GCTTTCTCAA GGGAATAATT TATATGGTGG TCCTATTGTA CATTTTTACG 2340 ATGTCTCTAT TAAGTAACCC AA 2362 (2) INFORMATION FOR SEQ ID NO: 102: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 790 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 102 : Met His Glu Asn Asn Thr Lys Leu Ser Ala Arg Ala Leu Pro Ser Phe 1 5 10 15 He Asp Tyr Phe Asn Gly He Tyr Gly Phe Ala Thr Gly He Lyε Aεp 20 25 30 He Met Aεn Met He Phe Lyε Thr Asp Thr Gly Gly Asn Leu Thr Leu 35 40 45 Asp Glu He Leu Lys Asn Gin Gin Leu Leu Asn Glu He Ser Gly Lys 50 55 60 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu He Ala Gin Gly Asn 65 70 75 80 Leu Asn Thr Glu Leu Ser Lys Glu He Leu Lys He Ala Asn Glu Gin 85 90 95 Ser Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala He Asn Thr 100 105 110 Met Leu His He Tyr Leu Pro Lys He Thr Ser Met Leu Ser Asp Val 115 120 125 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin He Glu Tyr Leu Ser Lys 130 135 140 Gin Leu Gin Glu He Ser Asp Lys Leu Asp He He Asn Val Asn Val 145 150 155 160 Leu He Asn Ser Thr Leu Thr Glu He Thr Pro Ala Tyr Gin Arg He 165 170 175 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190 Thr Leu Lys Val Lys Lys Asp Xaa Ser Pro Ala Asp He Leu Asp Glu 195 200 205 Leu Thr Glu Leu Thr Glu Leu Ala Lyε Ser Val Thr Lys Asn Asp Val 210 215 220 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu He 245 250 255 Ala Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu He Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285 Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp He Asp Tyr Thr 290 295 300 Ser He Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320 Asn He Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met He Val Glu Ala Lyε 340 345 350 Pro Gly Tyr Ala Leu Val Gly Phe Glu Met Ser Asn Asp Ser He Thr 355 360 365 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380 Lys Asp Ser Leu Ser Glu Val He Tyr Gly Asp Thr Asp Lys Leu Leu 385 390 395 400 Cys Pro Asp Gin Ser Glu Gin He Tyr Tyr Thr Asn Asn He Val Phe 405 410 415 Pro Asn Glu Tyr Val He Thr Lys He Asp Phe Thr Lys Lys Met Lys 420 425 430 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445 Glu He Asp Leu Asn Lys Lyε Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 He Ser Glu Thr Phe Leu Thr Pro He Asn Gly Phe Gly Leu Gin Ala 485 490 495 Asp Gly Asn Ser Arg Leu He Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510 Lys Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu He 515 520 525 Val Pro Pro Ser Gly Phe He Ser Asn He Val Glu Asn Gly Ser He 530 535 540 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Aεn Ala Tyr 545 550 555 560 Val Asp His Thr Gly Gly Val Lys Gly Thr Lys Ala Leu Tyr Val His 565 570 575 Lys Asp Gly Gly He Ser Gin Phe He Gly Asp Xaa Leu Lys Pro Lys 580 585 590 Thr Glu Tyr Val He Gin Tyr Thr Val Lys Gly Lys Pro Ser He His 595 600 605 Leu Lys Aεp Glu Asn Thr Gly Tyr He His Tyr Glu Asp Thr Asn Asn 610 615 620 Asn Leu Lys Asp Tyr Gin Thr He Thr Lys Arg Phe Thr Thr Gly Thr 625 630 635 640 Asp Leu Lys Gly Val Tyr Leu He Leu Lys Ser Gin Asn Gly Aεp Glu 645 650 655 Ala Trp Gly Asp Asn Phe He He Leu Glu He Ser Pro Ser Glu Lys 660 665 670 Leu Leu Ser Pro Glu Leu He Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685 Ser Thr His He Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700 Gly He Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg He Arg Asn Ser 725 730 735 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr He Glu 755 760 765 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro He Val His Phe Tyr 770 775 780 Asp Val Xaa He Lys Pro 785 790 (2) INFORMATION FOR SEQ ID NO:103: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2375 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 103: ATGCACGAGA ATAATACTAA ATTAAGCGCA AGGGCCTTAC CGAGTTTTAT TGATTATTTT 60 AATGGCATTT ATGGATTTGC CACTGGTATC AAAGACATTA TGAATATGAT TTTTAAAACG 120 GATACAGGTG GTAATCTAAC CTTAGATGAA ATCCTAAAGA ATCAGCAGTT ACTAAATGAG 180 ATTTCTGGTA AATTGGATGG GGTAAATGGG AGCTTAAATG ATCTTATCGC ACAGGGAAAC 240 TTAAATACAG AATTATCTAA GGAAATCTTA AAAATTGCAA ATGAACAGAG TCAAGTTTTA 300 AATGATGTTA ATAACAAACT CGATGCGATA AATACGATGC TTCATATATA TCTACCTAAA 360 ATTACATCTA TGTTAAGTGA TGTAATGAAG CAAAATTATG CGCTAAGTCT GCAAATAGAA 420 TACTTAAGTA AACAATTGCA AGAAATTTCT GATAAATTAG ATATTATTAA CGTAAATGTT 480 CTTATTAACT CTACACTTAC TGAAATTACA CCTGCATATC AACGGATTAA ATATGTGAAT 540 GAAAAATTTG AAGAATTAAC TTTTGCTACA GAAACCACTT TAAAAGTAAA AAAGGATRAC 600 TCGCCTGCTG ATATTCTTGA TGAATTAACT GAATTAACTG AACTAGCGAA AAGTGTTACA 660 AAAAATGACG TTGATGGTTT TGAATTTTAC CTTAATACAT TCCACGATGT AATGGTAGGA 720 AATAATTTAT TCGGGCGTTC AGCTTTAAAA ACTGCTTCAG AATTAATTGC TAAAGAAAAT 780 GTGAAAACAA GTGGCAGTGA AGTAGGAAAT GTTTATAATT TCTTAATTGT ATTAACAGCT 840 CTACAAGCAA AAGCTTTTCT TACTTTAACA ACATGCCGAA AATTATTAGG CTTAGCAGAT 900 ATTGATTATA CTTCTATTAT GAATGAACAT TTAAATAAGG AAAAAGAGGA ATTTAGAGTA 960 AACATCCTTC CTACACTTTC TAATACTTTT TCTAATCCTA ATTATGCAAA AGTTAAAGGA 1020 AGTGATGAAG ATGCAAAGAT GATTGTGGAA GCTAAACCAG GATATGCATT GGTTGGTTTT 1080 GAAATGAGCA ATGATTCAAT CACAGTATTA AAAGTATATG AGGCTAAGCT AAAACAAAAT 1140 TATCAAGTTG ATAAGGATTC CTTATCGGAG GTTATTTATG GTGATACGGA TAAATTATTG 1200 TGTCCAGATC AATCTGAACA AATATATTAT ACAAATAACA TAGTATTTCC AAATGAATAT 1260 GTAATTACTA AAATTGATTT CACTAAAAAA ATGAAAACTT TAAGATATGA GGTAACAGCG 1320 AATTTTTATG ATTCTTCTAC AGGAGAAATT GACTTAAATA AGAAAAAAGT AGAATCAAGT 1380 GAAGCGGAGT ATAGAACGTT AAGTGCTAAT GATGATGGAG TGTATATGCC ATTAGGTGTC 1440 ATCAGTGAAA CATTTTTGAC TCCGATAAAT GGGTTTGGCC TCCAAGCTGA TGGAAATTCA 1500 AGATTAATTA CTTTAACATG TAAATCATAT TTAAGAAAAC TACTGCTAGC AACAGACTTA 1560 AGCAATAAAG AAACTAAATT GATCGTCCCG CCAAGTGGTT TTATTAGCAA TATTGTAGAG 1620 AACGGGTCCA TAGAAGAGGA CAATTTAGAG CCGTGGAAAG CAAATAATAA GAATGCGTAT 1680 GTAGATCATA CAGGCGGAGT GAAAGGAACT AAAGCTTTAT ATGTTCATAA GGACGGAGGA 1740 ATTTCACAAT TTATTGGAGA TAAKTTAAAA CCGAAAACTG AGTATGTAAT CCAATATACT 1800 GTTAAAGGAA AACCTTCTAT TCATTTAAAA GATGAAAATA CTGGATATAT TCATTATGAA 1860 GATACAAATA ATAATTTAAA AGATTATCAA ACTATTACTA AACGTTTTAC TACAGGAACT 1920 GATTTAAAGG GAGTGTATTT AATTTTAAAA AGTCAAAATG GAGATGAAGC TTGGGGAGAT 1980 AACTTTATTA TTTTGGAAAT TAGTCCTTCT GAAAAGTTAT TAAGTCCAGA ATTAATTAAT 2040 ACAAATAATT GGACGAGTAC GGGATCAACT CATATTAGCG GTAATACACT CACTCTTTAT 2100 CAGGGAGGAC GAGGAATTCT AAAACAAAAC CTTCAATTAG ATAGTTTTTC AACTTATAGA 2160 GTGTATTTTT CTGTGTCCGG AGATGCTAAT GTAAGGATTA GAAATTCTAG GGAAGTGTTA 2220 TTTGAAAAAA GATATATGAG CGGTGCTAAA GATGTTTCTG AAATGTTCAC TACAAAATTT 2280 GAGAAAGATA ACTTTTATAT AGAGCTTTCT CAAGGGAATA ATTTATATGG TGGTCCTATT 2340 GTGCATTTTT ACGATGTCYC TATTAAGTAA CCCAA 2375 (2) INFORMATION FOR SEQ ID NO:104: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 554 amino acids (C) STRANDEDNESS: single (D) TOPOLOGY: linear (n ) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 104: Thr Leu His Leu Leu Lys Leu His Leu Arg He Lys Gly Leu Asn Met 1 5 10 15 Thr Lys Asn Leu Arg Asn Leu Leu Leu Xaa Xaa Leu Xaa Gin Lys Lys 20 25 30 Arg Met Ala Leu Leu Gin He Phe Xaa Met Ser Leu Ser Xaa Asn Arg 35 40 45 Lys Val Gin Lys Met Met Trp Met Val Leu Asn Phe Thr Leu He His 50 55 60 Ser Thr Met Xaa Glu He He Tyr Ser Gly Val Gin Leu Lys Leu Xaa 65 70 75 80 Arg Asn Leu Leu Lys Lys Met Lys Gin Val Ala Val Xaa Xaa Glu Met 85 90 95 Phe He Xaa Ser Leu Tyr Gin Leu Xaa Lys Gin Lys Leu Phe Leu Leu 100 105 110 Gin His Ala Glu Asn Tyr Xaa Gin He Leu He He Leu Leu Leu Met 115 120 125 Asn He He Arg Lys Lys Arg Asn Leu Glu Thr Ser Xaa Leu His Phe 130 135 140 Leu He Leu Phe Leu He Leu He Met Gin Lys Leu Lys Glu Val Met 145 150 155 160 Lys Met Gin Arg Leu Trp Lys Leu Aεn Gin Aεp Met His Trp Leu Val 165 170 175 Leu Lys Ala Met He Gin Ser Gin Tyr Lys Tyr Met Arg Leu Ser Asn 180 185 190 Lys He He Lys Leu He Arg He Pro Tyr Arg Arg Leu Phe Met Val 195 200 205 He Arg He Asn Tyr Cys Val Gin He Asn Leu Aεn Lys Tyr He He 210 215 220 Gin He Thr Tyr Phe Gin Met Asn Met Leu Leu Lys Leu He Ser Leu 225 230 235 240 Lys Lys Lys Leu Asp Met Arg Gin Arg He Phe Met He Leu Leu Gin 245 250 255 Glu Lys Leu Thr He Arg Lys Lys Asn Gin Val Lys Arg Ser He Glu 260 265 270 Arg Val Leu Met Met Met Xaa Cys He Cys Hiε Val Ser Ser Val Lyε 275 280 285 Hiε Phe Leu Arg Met Gly Leu Ala Ser Lyε Leu Arg Gin He Gin Asp 290 295 300 Leu Leu His Val Asn His He Glu Asn Tyr Cys Gin Gin Thr Ala He 305 310 315 320 Arg Lys Leu Asn Ser Ser Arg Gin Val Phe Tyr Gin Tyr Cys Arg Glu 325 330 335 Arg Val Leu Arg Arg Gly Gin Phe Arg Ala Val Glu Ser Lys Glu Cys 340 345 350 Val Cys Arg Ser Tyr Arg Arg Ser Glu Trp Asn Ser Phe He Cys Ser 355 360 365 Gly Arg Arg Asn Phe Thr He Tyr Trp Arg Val Lys Thr Glu Asn Val 370 375 380 Cys Asn Pro He Tyr Cys Arg Lys Thr Phe Tyr Ser Phe Lys Arg Lys 385 390 395 400 Tyr Trp He Tyr Ser Leu Arg Tyr Lys Phe Lys Arg Leu Ser Asn Tyr 405 410 415 Tyr Thr Phe Tyr Tyr Arg Asn Phe Lys Gly Ser Val Phe Asn Phe Lyε 420 425 430 Lys Ser Lys Trp Arg Ser Leu Gly Arg Leu Tyr Tyr Phe Gly Asn Ser 435 440 445 Phe Lys Val He Lys Ser Arg He Asn Tyr Lys Leu Asp Glu Tyr Gly 450 455 460 He Asn Ser Tyr Arg Tyr Thr His Ser Leu Ser Gly Arg Thr Arg Asn 465 470 475 480 Ser Lys Thr Lys Pro Ser He Arg Phe Phe Asn Leu Ser Val Phe Phe 485 490 495 Cys Val Arg Arg Cys Cys Lys Asp Lys Phe Gly Ser Val He Lys Lys 500 505 510 He Tyr Glu Arg Cys Arg Cys Phe Aεn Val His Tyr Lys He Glu Arg 515 520 525 Leu Leu Tyr Arg Ala Phe Ser Arg Glu Phe He Trp Trp Ser Tyr Cys 530 535 540 Thr Phe Leu Arg Cys Leu Tyr Val Thr Gin 545 550 (2) INFORMATION FOR SEQ ID NO: 105: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1888 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 105: ACTCTACACT TACTGAAATT ACACCTGCGT ATCAAAGGAT TAAATATGTG AACGAAAAAT 60 TTGAGGAATT AACTTTTGCT ACRGAMACTA KTTCAAAAGT AAAAAMGGAT GGCTCTCCTS 120 CAGATATTCT KGATGAGTTA ACTGAGTTAA CWGAACTAGC GAAAAGTGTA ACAAAAAATG 180 ATGTGGATGG TTTTRAATTT TACCTTAATA CATTCCACGA TGTAAKGGTA GGAAATAATT 240 TATTCGGGCG TTCAGCTTTA AAAACTGCWT CGGAATTAAT TRCTAAAGAA AATGTGAAAA 300 CAAGTGGCAG TGARGTMGGA AATGTTTATA AYTTCTTAAT TGTATTAACA GCTCTRCAAG 360 CAAAAGCTTT TCTTACTTTA ACAACATGCC GAAAATTATT AGGSTTAGCA GATATTGATT 420 ATACTTCTAT TATGAATGAA CATTTAAATA AGGAAAAAGA GGAATTTAGA GTAAACATCC 480 TYCCTACACT TTCTAATACT TTTTCTAATC CTAATTATGC AAAAGTTAAA GGAAGTGATG 540 AAGATGCAAA GATGATTGTG GAAGCTAAAC CAGGATATGC ATTGGTTGGT TTTGAAATGA 600 GCAATGATTC AATCACAGTA TTAAAAGTAT ATGAGGCTAA GCTAAAACAA AATTATCAAG 660 TTGATAAGGA TTCCTTATCG GAGGTTATTT ATGGTGATAC GGATAAATTA TTGTGTCCAG 720 ATCAATCTGA ACAAATATAT TATACAAATA ACATAGTATT TCCAAATGAA TATGTAATTA 780 CTAAAATTGA TTTCACTAAA AAAATGAAAA CTTTAAGATA TGAGGTAACA GCGAATTTTT 840 ATGATTCTTC TACAGGAGAA ATTGACTTAA ATAAGAAAAA AGTAGAATCA AGTGAAGCGG 900 AGTATAGAAC GTTAAGTGCT AATGATGATG GRGTGTATAT GCCATTAGGT GTCATCAGTG 960 AAACATTTTT GACTCCGATA AATGGGTTTG GCCTCCAAGC TGAGGCAAAT TCAAGATTAA 1020 TTACTTTAAC ATGTAAATCA TATTTAAGAG AACTACTGCT AGCAACAGAC TTAAGCAATW 1080 AGGAAACTAA ATTGATCTTC CCGCCAAGTG TTTTATTAGC AATATTGTAG AGAACGGGTC 1140 CTTAGAAGAG GACAATTTAG AGCCGTGGAA AGCAAATAAT AAGAATGCGT ATGTAGATCA 1200 TACAGGCGGA GTGAATGGAA CTAAAGCTTT ATATGTTCAT AAGGACGGAG GAATTTCACA 1260 ATTTATTGGA GATAAGTTAA AACCGAAAAC TGAGTATGTA ATCCAATATA CTGTTAAAGG 1320 AAAACCTTCT ATTCATTTAA AAGATGAAAA TACTGGATAT ATTCATTATG AAGATACAAA 1380 TAATAATTTA AAAGATTATC AAACTATTAC TAAACGTTTT ACTACAGGAA CTGATTTAAA 1440 GGGAGTGTAT TTAATTTTAA AAAGTCAAAA TGGAGATGAA GCTTGGGGAG ATAACTTTAT 1500 TATTTTGGAA ATTAGTCCTT CTGAAAAGTT ATTAAGTCCA GAATTAATTA ATACAAATAA 1560 TTGGACGAGT ACGGGATCAA CTCATATTAG CGGTAATACA CTCACTCTTT ATCAGGGAGG 1620 ACGAGGAATT CTAAAACAAA ACCTTCAATT AGATAGTTTT TCAACTTATA GAGTGTATTT 1680 TTCTGTGTCC GGAGATGCTA ATGTAAGGAT TAGAAATTCT AGGGAAGTGT TATTTGAAAA 1740 AAGATATATG AGCGGTGCTA AAGATGTTTC TGAAATGTTC ACTACAAAAT TTGAGAAAGA 1800 TAACTTTTAT ATAGAGCTTT CTCAAGGGAA TAATTTATAT GGTGGTCCTA TTGTACATTT 1860 TTACGATGTC TCTATTAAGT AACCCAAA 1888

Claims: Claims 1 A biologically pure culture of a Bacillus thuringiensis isolate active against a non- mammalian pest, wherein said isolate is selected from the group consisting of PS 185U2, PS 11 B , PS218G2, PS213E5, PS28C, PS86BB1, PS89J3, PS94R1, PS27J2, PS202S, PS101DD, PS31G1, and mutants thereof. 2. An isolated polynucleotide comprising a nucleotide sequence which encodes all or part of a toxm active against a non-mammalian pest, wherein said nucleotide sequence hybπdizes with a nucleotide sequence which encodes an ammo acid sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO 9, SEQ ID NO. 11 , SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO 21 , SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31 , SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO 43, SEQ ID NO 45, SEQ ID NO. 47, SEQ ID NO 49, SEQ ID NO. 51 , SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO 59, and SEQ ID NO. 61. 3. The isolated polynucleotide, according to claim 2, compπsing a nucleotide sequence which hybπdizes with a nucleotide sequence selected from the group consisting of SEQ ID NO 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14, SEQ ID NO 16, SEQ ID NO 18, SEQ ID NO. 20, SEQ ID NO. 22, SEQ ID NO. 24, SEQ ID NO. 26, SEQ ID NO. 28, SEQ ID NO 30, SEQ ID NO 32, SEQ ID NO. 34, SEQ ID NO. 36, SEQ ID NO. 38, SEQ ID NO. 40, SEQ ID NO. 42, SEQ ID NO 44, SEQ ID NO. 46, SEQ ID NO. 48, SEQ ID NO. 50, SEQ ID NO. 52, SEQ ID NO. 54, SEQ ID NO. 56, SEQ ID NO. 58, SEQ ID NO. 60, and SEQ ID NO. 62 4. An isolated polynucleotide comprising a nucleotide sequence which encodes all or part of a toxm which is active against a non-mammalian pest wherein said nucleotide sequence encodes a toxm which compπses an amino acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 1 , SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21 , SEQ ID NO 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO 45, SEQ ID NO 47, SEQ ID NO 49, SEQ ID NO 51 , SEQ ID NO. 53. SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 5. The isolated polynucleotide, according to claim 4, wherein said nucleotide sequence encodes a toxin which compπses an ammo acid sequence having at least about 90% homology with a sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 1 1 , SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21 , SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41 , SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51, SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 6. An isolated polynucleotide comprising a nucleotide sequence which encodes all or part of a toxm active against a non-mammalian pest wherein said toxin immunoreacts with an antibody to a toxin from a B.t. isolate selected from the group consisting of PS 185U2, PS11B, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD1 10, HD10, PS202S, HD29, PS101DD, HD129, and PS31G1. 7. An isolated polynucleotide comprising a nucleotide sequence which encodes all or part of a toxm active against a non-mammalian pest wherein said toxm has at least about 75% homology with a toxin from a B.t. isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1 , HD525, HD573 A, PS27J2, HD 1 10, HD 10, PS202S, HD29, PS 101 DD, HD 129, and PS31 G 1. 8. The isolated polynucleotide, according to claim 7, wherein said nucleotide sequence encodes a protein which has at least about 90% homology with a toxin from a B t. isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD110, HD10, PS202S, HD29, PS101DD, HD129, and PS31Gl . 9. An isolated nucleotide sequence selected from the group consisting of SEQ ID NO. 1 , SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 63, SEQ ID NO. 64, SEQ ID NO. 65, SEQ ID NO. 66, SEQ ID NO. 67, SEQ ID NO. 68, and SEQ ID NO. 69. 10. A purified or recombinant tox having activity against a non-mammalian pest, wherein said toxin compπses an ammo acid sequence encoded by a nucleotide sequence which hybπdizes with a nucleotide sequence which encodes an amino acid sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 1 1 , SEQ ID NO. 13 , SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21 , SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51 , SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO 57, SEQ ID NO. 59, and SEQ ID NO. 61. 1 1. The toxin, according to claim 10, wherein said toxin compπses an ammo acid sequence encoded by a nucleotide sequence which hybridizes with a nucleotide sequence selected from the group consisting of SEQ ID NO. 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14, SEQ ID NO. 16, SEQ ID NO. 18, SEQ ID NO. 20, SEQ ID NO. 22, SEQ ID NO. 24, SEQ ID NO. 26, SEQ ID NO. 28, SEQ ID NO. 30, SEQ ID NO. 32, SEQ ID NO 34, SEQ ID NO. 36, SEQ ID NO. 38, SEQ ID NO. 40, SEQ ID NO. 42, SEQ ID NO. 44, SEQ ID NO. 46, SEQ ID NO. 48, SEQ ID NO. 50, SEQ ID NO. 52, SEQ ID NO. 54, SEQ ID NO. 56, SEQ ID NO. 58, SEQ ID NO. 60, and SEQ ID NO. 62. 12. The toxin, according to claim 11, wherein said toxin comprises an amino acid sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 11 , SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31 , SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41 , SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51, SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 13. A purified or recombinant toxin having activity against a non-mammalian pest, wherein said toxin compπses an ammo acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO 11, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21 , SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31 , SEQ ID NO 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51 , SEQ ID NO. 53, SEQ ID NO 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 14. The toxin, according to claim 13, which comprises an am o acid sequence having at least about 90% homology with a sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 11, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51 , SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO 57, SEQ ID NO. 59, and SEQ ID NO. 61. 15. The toxin, according to claim 13, which compπses an amino acid sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 1 1 , SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31 , SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51, SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 16. A purified or recombinant toxm having activity against a non-mammalian pest wherein said toxin immunoreacts with an antibody to a toxin from a B.t. isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD110, HD10, PS202S, HD29, PS101DD, HD129, and PS31Gl. 17. A purified or recombinant toxin having activity against a non-mammalian pest wherein said toxin has at least about 75% homology with a toxin from a B.t. isolate selected from the group consisting of PS185U2, PS11B, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD110, HD10, PS202S, HD29, PS101DD, HD129, and PS31Gl. 18. The toxm, according to claim 17, wherein said toxm has at least about 90% homology with a toxin from a B.t. isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1 , PS94R1, HD525, HD573A, PS27J2, HD110, HD10, PS202S, HD29, PSIOIDD, HD129, and PS31G1 19 A recombinant host transformed with a polynucleotide of claim 2 20. The recombinant host, according to claim 19, wherein said transformed host is a bacterium. 21. The recombinant host, according to claim 20, wherein said bacteπum is selected from the group consisting of E coli, Pseudomonas, and Bacillus thuringiensis. 22 The recombinant host, according to claim 19, wherein said transformed host is a plant. 23. A composition of matter for controlling a non-mammalian pest, wherein said composition compnses a Bacillus thuringiensis isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS28C, PS86BB1, PS89J3, PS94R1, PS27J2, PS202S, PSIOIDD, PS31G1 , and mutants thereof, or a toxin therefrom, in association with an agricultural earner. 24. A method for controlling a non-mammalian pest which comprises contacting said pest with a toxin from a Bacillus thuringiensis isolate selected from the group consisting of PS185U2, PS11B, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD110, HD10, PS202S, HD29, PSIOIDD, HD129, and PS31G1. 25. A method for the control of a non-mammalian pest which compπses contacting said pest with a pesticidal amount of a Bacillus thuringiensis toxin wherein said toxin has a characteristic selected from the group consisting of: (a) said toxm has at least about 75% homology to a toxin from a Bacillus thuringiensis isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD110, HD10, PS202S, HD29, PSIOIDD, HD129, and PS31Gl ; (b) said toxin compπses an amino acid sequence which is encoded by a nucleotide which hybridizes with a nucleotide sequence which encodes an amino acid sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 1 1, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51, SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61; (c) said toxin compπses an ammo acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 1 1 , SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31 , SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO 41, SEQ ID NO 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO 49, SEQ ID NO. 51 , SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO 61; and (d) said toxin immunoreacts with an antibody to a toxin from a Bacillus thuringiensis isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD110, HD10, PS202S, HD29, PSIOIDD, HD129, and PS31Gl. 26 The method, according to claim 25, wherein said toxin has at least about 90% homology to a toxin from a Bacillus thuringiensis isolate selected from the group consisting of PS185U2, PS1 IB, PS218G2, PS213E5, PS86W1, PS28C, PS86BB1, PS89J3, PS86V1, PS94R1, HD525, HD573A, PS27J2, HD1 10, HD10, PS202S, HD29, PSIOIDD, HD129, and PS31G1 27. The method, according to claim 25, wherein said tox is encoded by a nucleotide which hybπdizes with a nucleotide sequence which encodes an ammo acid sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO 1 1, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41 , SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51, SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 28. The method, according to claim 25, wherein said toxin comprises an amino acid sequence encoded by a nucleotide sequence which hybridizes with a sequence selected from the group consisting of SEQ ID NO. 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14, SEQ ID NO. 16, SEQ ID NO. 18, SEQ ID NO. 20, SEQ ID NO. 22, SEQ ID NO. 24, SEQ ID NO. 26, SEQ ID NO. 28, SEQ ID NO. 30, SEQ ID NO. 32, SEQ ID NO. 34, SEQ ID NO. 36, SEQ ID NO. 38, SEQ ID NO. 40, SEQ ID NO. 42, SEQ ID NO. 44, SEQ ID NO. 46, SEQ ID NO. 48, SEQ ID NO. 50, SEQ ID NO. 52, SEQ ID NO. 54, SEQ ID NO. 56, SEQ ID NO. 58, SEQ ID NO. 60, and SEQ ID NO. 62. 29. The method, according to claim 25, wherein said toxin comprises an amino acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 11 , SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31, SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51, SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 30. The method, according to claim 29, wherein said toxin comprises an amino acid sequence having at least about 90% homology with a sequence selected from the group consisting of SEQ ID NO. 7, SEQ ID NO. 9, SEQ ID NO. 11, SEQ ID NO. 13, SEQ ID NO. 15, SEQ ID NO. 17, SEQ ID NO. 19, SEQ ID NO. 21, SEQ ID NO. 23, SEQ ID NO. 25, SEQ ID NO. 27, SEQ ID NO. 29, SEQ ID NO. 31 , SEQ ID NO. 33, SEQ ID NO. 35, SEQ ID NO. 37, SEQ ID NO. 39, SEQ ID NO. 41, SEQ ID NO. 43, SEQ ID NO. 45, SEQ ID NO. 47, SEQ ID NO. 49, SEQ ID NO. 51, SEQ ID NO. 53, SEQ ID NO. 55, SEQ ID NO. 57, SEQ ID NO. 59, and SEQ ID NO. 61. 31. The method, according to claim 25, wherein said pest is a lepidopteran 32. A method for identifying polynucleotide sequences which encode toxins with activity against pests, wherein said method comprises preparing target Bacillus thuringiensis DNA for PCR amplification or for hybπdization with a polynucleotide probe and then either (a) determining whether the target DNA hybπdizes with a polynucleotide sequence selected from the group consisting of SEQ ID NO. 8, SEQ ID NO. 10, SEQ ID NO. 12, SEQ ID NO. 14, SEQ ID NO. 16, SEQ ID NO. 18, SEQ ID NO. 20, SEQ ID NO. 22, SEQ ID NO. 24, SEQ ID NO. 26, SEQ ID NO. 28, SEQ ID NO. 30, SEQ ID NO. 32, SEQ ID NO. 34, SEQ ID NO. 36, SEQ ID NO. 38, SEQ ID NO. 40, SEQ ID NO. 42, SEQ ID NO. 44, SEQ ID NO 46, SEQ ID NO. 48, SEQ ID NO. 50, SEQ ID NO. 52, SEQ ID NO. 54, SEQ ID NO. 56, SEQ ID NO. 58, SEQ ID NO. 60, and SEQ ID NO. 62; or (b) subjecting said target DNA to PCR with a primer pair selected from the group consisting of primer pair 1 (SEQ ID NOS. 1 and 2); pπmer pair 2 (SEQ ID NOS 3 and 4); and pπmer pair 3 (SEQ ID NOS 5 and 6). 33. A polynucleotide sequence encoding a lepidopteran-active toxin wherein said polynucleotide sequence is identified by the process of claim 32. 34. An isolated polynucleotide compπsmg a nucleotide sequence which encodes all or part of a toxin which is active against a non-mammalian pest wherein said toxm comprises an amino acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO. 72, and SEQ ID NO 74 35. The isolated polynucleotide, according to claim 34, wherein said nucleotide sequence encodes a tox which compπses an amino acid sequence having at least about 90% homology with a sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO 72, and SEQ ID NO. 74. 36. The isolated polynucleotide, according to claim 34, wherein said nucleotide sequence encodes a toxin which comprises an ammo acid sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO. 72, and SEQ ID NO. 74. 37. An isolated polynucleotide compπsmg a nucleotide sequence which encodes all or part of a toxin which is active against a non-mammalian pest wherein said nucleotide sequence encodes a toxin which compnses an amino acid sequence having at least about 75% homology with SEQ ID NO. 76 38. The isolated polynucleotide, according to claim 37, wherein said nucleotide sequence encodes a toxin which compπses an am o acid sequence having at least about 90% homology with SEQ ID NO. 76. 39. The isolated polynucleotide, according to claim 37, wherein said nucleotide sequence encodes a toxm which compπses an amino acid sequence having the sequence shown in SEQ ID NO. 76 40. An isolated polynucleotide compπsing a nucleotide sequence which encodes all or part of a toxm which is active against a non-mammalian pest wherein said toxin comprises an ammo acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104. 41 The isolated polynucleotide, according to claim 40, wherein said nucleotide sequence encodes a toxm which compπses an amino acid sequence having at least about 90% homology with a sequence selected from the group consisting of SEQ ID NO. 78, SEQ ID NO 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO 102, and SEQ ID NO. 104. 42. The isolated polynucleotide, according to claim 40, wherein said nucleotide sequence encodes a toxm which compπses an amino acid sequence selected from the group consisting of SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104. 43. An isolated polynucleotide compπsing a nucleotide sequence which encodes all or part of a toxin active against a non-mammalian pest wherein said toxin immunoreacts with an antibody to a toxm selected from the group consisting of SEQ ID NO. 70, SEQ ID NO. 72, SEQ ID NO 74, SEQ ID NO. 76, SEQ ID NO 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO 84, SEQ ID NO 86, SEQ ID NO. 88, SEQ ID NO 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO 102, and SEQ ID NO. 104 44. An isolated polynucleotide compπsing a nucleotide sequence which encodes all or part of a toxin active against a non-mammalian pest, wherein said nucleotide sequence hybπdizes with a nucleotide sequence which encodes an ammo acid sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO 72, SEQ ID NO. 74, SEQ ID NO 76, SEQ ID NO 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104 45. A punfied or recombinant toxin having activity against a non-mammalian pest, wherein said toxm compπses an amino acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO 70, SEQ ID NO. 72, and SEQ ID NO. 74 46. The toxm, according to claim 43, wherein said toxm comprises an ammo acid sequence having at least about 90%) homology with a sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO. 72, and SEQ ID NO. 74 47. The toxin, according to claim 43, wherein said toxm compnses an amino acid sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO 72, and SEQ ID NO. 7. 48. A punfied or recombinant toxin having activity against a non-mammalian pest, wherein said toxin compπses an ammo acid sequence having at least about 75% homology with the sequence shown in SEQ ID NO. 76. 49. The toxin, according to claim 46, wherein said tox comprises an ammo acid sequence having at least about 90% homology with the sequence shown in SEQ ID NO. 76 50. The toxin, according to claim 46, wherein said toxin compnses an amino acid sequence shown m SEQ ID NO. 76. 51. A purified or recombinant toxin having activity against a non-mammalian pest, wherein said toxin compπses an ammo acid sequence having at least about 75% homology with an amino acid sequence selected from the group consisting of SEQ ID NO. 78, SEQ ID NO. 80. SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104. 52. The toxin, according to claim 49, wherein said toxm comprises an ammo acid sequence having at least about 90% homology with an ammo acid sequence selected from the group consisting of SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104. 53. The toxm, according to claim 49, wherein said toxin comprises an am o acid sequence selected from the group consisting of SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104. 54. A recombmant host transformed with a polynucleotide comprising a nucleotide sequence which encodes all or part of a toxin which is active against a non-mammalian pest wherein said toxm compπses an amino acid sequence having at least about 75% homology with a sequence selected from the group consistmg of SEQ ID NO. 70, SEQ ID NO. 72, SEQ ID NO 74, SEQ ID NO. 76, SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104. 55. The recombinant host, according to claim 54, wherein said transformed host is a bacterium. 56. The recombinant host, according to claim 55, wherein said bacterium is selected from the group consisting of E coli, Pseudomonas, and Bacillus thuringiensis. 57. The recombinant host, according to claim 54, wherein said transformed host is a plant. 58. A method for the control of a non-mammalian pest which compπses contacting said pest with a pesticidal amount of a Bacillus thuringiensis toxin wherein said toxm has a characteristic selected from the group consisting of- (a) said toxin compπses an am o acid sequence having at least about 75% homology with a sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO. 72, SEQ ID NO. 74, SEQ ID NO. 76, SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO 102, and SEQ ID NO. 104, (b) said toxin compπses an amino acid sequence which is encoded by a nucleotide which hybridizes with a nucleotide sequence which encodes an amino acid sequence selected from the group consisting of SEQ ID NO. 70, SEQ ID NO 72, SEQ ID NO. 74, SEQ ID NO. 76, SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO. 90, SEQ ID NO. 92, SEQ ID NO. 94, SEQ ID NO 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104; and (c) said toxin immunoreacts with an antibody to a toxm selected from the group consisting of SEQ ID NO. 70, SEQ ID NO. 72, SEQ ID NO. 74, SEQ ID NO 76, SEQ ID NO. 78, SEQ ID NO. 80, SEQ ID NO. 82, SEQ ID NO. 84, SEQ ID NO. 86, SEQ ID NO. 88, SEQ ID NO.90, SEQ ID NO.92, SEQ ID NO. 94, SEQ ID NO. 96, SEQ ID NO. 98, SEQ ID NO. 100, SEQ ID NO. 102, and SEQ ID NO. 104. 59. The method, according to claim 58, wherein said pest is a lepidopteran. 60. The method, according to claim 59, wherein said pest is selected from the group consisting of Agrotis ipsilon, Hehothis virescens, and Hehcoverpa zea.

Inventors: NARVA KENNETH E, SCHNEPF H ERNEST, STOCKHOFF BRIAN A, WALZ MICHELE, WICKER CAROL, NARVA, KENNETH, E., SCHNEPF, H., ERNEST, STOCKHOFF, BRIAN, A., WALZ, MICHELE, WICKER, CAROL
Applicants: MYCOGEN CORP, MYCOGEN CORPORATION
Application year: 1997
Main classification: C12N15
IPC codes: A01N63, C07K14, C07K19, C12N1, C12N15, C12Q1